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Introduction 
 
 
Yeast as a model organism in proteome analysis 
Budding yeast was the first eukaryotic organism to be completely sequenced  
(Goffeau et al. 1996). It has a relative small genome size (12 Mb compared to 3,2 Gb 
in humans) and contains 16 chromosomes encoding approximately 6000 genes. The 
fact that introns in yeast genes are rare (5% of genes) makes in silico gene prediction 
relatively straight forward and systematic gene nomenclature simplifies data 
comparison. Moreover, despite that this unicellular eukaryotic organism is only one 
tenth the size of a white blood cell, many of the cellular functions of higher species 
are present in yeast. S.cerevisiae has nearly 1800 genes homologous to human 
genes of which approximately 200 are related to human disease genes including 23 
related to cancer (Rubin et al. 2000). For these reasons and the fact that yeast cells 
allow efficient homologous DNA recombination, S.cerevisiae has served as the prime 
model organism for post-genome functional analysis.  
Many systematic approaches have been used to study various aspects of the 
function and dynamics of the genome ranging from the analysis of deletion 
phenotypes to biochemical activities (Table 1). The yeast community has the most 
complete repertoire of physical resources: chips, reagents, plasmids, and mutant 
strains, covering the whole genome of this organism. This reflects the power of 
forward and reverse genetic approaches in yeast and hence yeast is certainly the 
best understood eukaryote. 
 
 
 
Project References 
Systematic gene deletion 
EUROFAN I (European Functional Analysis Network) 1995-1999  
800 open reading frames were deleted and functionally analysed 
(Wach et al. 1994;
Oliver 1996) 
Systematic gene deletion 
The Saccharomyces genome deletion project (EUROFANII): 
Creation of a complete set of bar-coded yeast deletion strains 
(1996-2002) & phenotypic analysis of sporulation and mating 
efficiency 
 
(Winzeler et al. 
1999; Giaever et 
al. 2002) 
Random transposon mutagenesis 
TRIPLES (Transposon-Insertion Phenotypes, Localization and 
Expression in Saccharomyces). >20 000 yeast mutants were 
generated by random transposon mutagenesis and their 
phenotypes and localization were subsequently assigned to genes 
by sequencing. 
 
(Ross-Macdonald 
et al. 1999) 
 
Large-scale yeast two-hybrid studies of protein-protein interactions 
(yeast protein interactome) 
 
 
(Uetz et al. 2000; 
Ito et al. 2001) 
 
Systematic identification of protein complexes in yeast by mass 
spectrometry  
 
 
(Gavin et al. 2002;
Ho et al. 2002) 
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Project References 
 
Microarray gene expression studies at different conditions 
(Hughes et al. 
2000) 
Global analysis of protein expression in yeast 
(quantitative immunobloting)  (Ghaemmaghami et al. 2003) 
Yeast genetic interaction network (double deletions) (Tong et al. 2004)
Yeast proteome subcellular localization (GFP and 
immunolocalization) 
(Kumar et al. 
2002; Huh et al. 
2003) 
100 essential genes of unknown function have been fused to a 
'heat-inducible-degron' cassette that targets the protein for 
proteolysis at 37 degrees (degron strains). 
Integrated analysis (affinity purification and mass spectrometry, two-
hybrid analysis, fluorescence microscopy and structure prediction 
methodology) of 100 unknown essential genes. 
(Sanchez-Diaz et 
al. 2004), 
(Kanemaki et al. 
2003), (Hazbun et
al. 2003) 
 
Table 1: Systematic approaches to functional analysis in S.cerevisiae 
 
Mark Johnston, president of the Genetics Society of America, predicted at the Yeast 
Genetics and Molecular Biology meeting in July 2003 in Gothenburg, that the 
organism's 6,000 genes will be “known” (i.e. annotated) by 2007. This was based on 
the annotations in the Yeast Proteome Database which have followed a remarkably 
linear upward trajectory, reaching 4,679 functionally annotated genes in July 2003.  
According to the Saccharomyces Genome Database (Dwight et al. 2004)  still 1677 
(Sept 2004) genes have no known biological function (GO annotations, (Ashburner et 
al. 2000). In addition, even a 'known' gene (i.e. annotated) can still be pretty 
mysterious. This means that despite the overwhelming information available, there 
are plenty of unsolved questions in yeast biology.  
Hoping to contribute to our understanding of how each yeast gene and each network 
of genes works together to create a living cell, this thesis deals with a yeast protein 
domain of “little known” function, the PX domain. 
 
Protein-protein interactions 
Protein-protein interactions affect all processes in a cell. Proteins rarely function in 
isolation. It has been proposed that all proteins in a given cell are connected through 
an extensive network where non-covalent interactions are continuously forming and 
dissociating. The forces that are responsible for such interactions include 
electrostatic forces, hydrogen bonds, van der Waals forces and hydrophobic effects. 
It is believed that hydrophobic effects drive protein-protein interactions, while 
hydrogen bonds and electrostatic interactions govern the specificity of the interface. 
Water is usually excluded from the contact region. 
Note that many proteins are known to interact although at present it remains unclear 
whether all of these interactions have any physiological relevance.  
In a single-cell organism such as yeast each of the roughly 6000 proteins interact 
with 3.3 or more other proteins on average, which adds up to a total of ~20,000 
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interactions or more (Grigoriev 2004). By extrapolation, there may be approximately 
~100,000 interactions in the human body. 
Implications about function can be made via protein-protein interaction studies. The 
function of unknown proteins may be discovered through their interaction with known 
protein partners of known function. 
 
 
Protein Domains in Yeast 
Proteins are constructed in a modular fashion from a combination of interaction and 
catalytic domains. A protein domain is defined as a part of a polypeptide chain that 
can fold into a three-dimensional structure independently.  
Protein-protein interaction domains are independently folding modules of 35-150 
amino acids that can be expressed in isolation from their host proteins while retaining 
their intrinsic ability to bind their physiological partners. Protein interactions are 
usually mediated by defined domains. 
The cell uses a limited set of interaction domains (Fig. 1), which are joined together 
in diverse combinations, achieving in this way the different properties of proteins. 
 
Classification of protein interaction domains 
Interaction domains can be identified through their amino acid sequences, allowing 
the binding properties and biological functions of a protein to be predicted on the 
basis of its domain composition. 
There are several domain databases which base their classification on different 
computational approaches. Some examples are listed below (Table 2). 
 
 
Database Computational  approach URL 
PROSITE patterns               (regular expressions) http://www.expasy.org/prosite/ 
BLOCKS 
PRINTS 
blocks (ungapped HMMs) http://blocks.fhcrc.org/blocks/         http://www.bioinf.man.ac.uk/dbbrowser/ 
PRINTS/ 
SBASE annotated subsequences http://hydra.icgeb.trieste.it/sbase/ 
PRODOM consensus sequences http://protein.toulouse.inra.fr/prodom/ current/html/home.php 
PFAM, ISREC 
PROFILES 
SMART 
full alignments http://www.sanger.ac.uk/Software/Pfam/  http://www.isrec.isb-sib.ch/profile/   
profile.html                                      
http://smart.embl-heidelberg.de/ 
PROCLASS classification by means other than alignments 
http://pir.georgetown.edu/gfserver/ 
proclass.html 
 
Table 2: Domain databases and their computational approaches 
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Protein domains can be divided into separate families that are related either by 
sequence, structure or ligand-binding properties (Fig.1). 
In addition to interaction domains that engage specific peptide motifs, a growing 
number of modules have been identified that recognize selected phospholipids, 
nucleic acids or other molecules. Further, a number of modular domains undergo 
homo- or heterotypic domain-domain interactions rather than binding short peptide 
motifs. A subset of interaction domains are illustrated in Figure 1 and their general 
binding properties are indicated. 
 
 
 
                                                      (Pawson and Nash 2003) 
 
               Figure 1: A subset of interaction domains and their general binding properties 
 
 
According to the SMART Database (Letunic et al. 2004) approximately 300 protein 
domains have been described in yeast, of which ~20 are still of unknown- or little 
known- function. Studying the function of these domains will reveal important 
information about the proteins that contain them. 
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Phosphoinositides 
 
Function 
Cellular membranes composed primarily of lipids and proteins, not only serve as 
structural boundaries that separate the cell from its extracellular milieu and 
compartmentalize its interior into discrete functional organelles but also participate in 
the regulation of many cellular processes. While the functions of a myriad of 
membrane proteins, such as signaling receptors and ion channels, have been well 
studied, it is increasingly recognized that the lipid constituents of the membrane are 
also involved in many regulatory events including cell proliferation, cell survival, 
differentiation, signal transduction, cytoskeleton organization and membrane 
trafficking (Odorizzi et al. 2000; Simonsen et al. 2001; Sprong et al. 2001; 
Vanhaesebroeck et al. 2001; Toker 2002; Gruenberg 2003). Phosphoinositides can 
serve as a platform for molecular assemblies recruiting and/or activating spatial and 
temporally effector proteins, but also as a precursor of intra-cellular signaling 
molecules such as diacylglycerol (DAG) and inoslitol (1,4,5)P3 (Berridge 1981).  
PI is a collective term for Phosphatidyl inositol (PtdIns) and its phosphorylated 
derivatives (Figures 2 and 3) (Odorizzi et al. 2000; Vanhaesebroeck et al. 2001) .  
 
Structure 
PtdIns contains a 1d-myo-inositol phosphate group linked to diacylglycerol (Fig. 2). 
 
 
 
Figure 2: Chemical structure of Phosphatidyl Inositol (PtdIns) 
 
 
The d-myo-inositol head group of PtdIns contains five hydroxy groups (at positions 2, 
3, 4, 5 and 6), three of which (at positions 3, 4 and 5) are known to be targets of 
phosphorylation. These positions may be reversibly phosphorylated singly, doubly (in 
various combinations) or triply, yielding a myriad of PtdIns derivatives: PtdIns3P, 
PtdIns4P, PtdIns5P, PtdIns(3,4)P2, PtdIns(3,5)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 
(Fig. 3).  
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abundance and presence of the different derivatives vary in different species (see 
Table 3). 
 
 
Organism PI(3)P PI(3,5)P2 PI(3,4)P2 PI(4,5)P2 PI(3,4,5)P3 PI(4)P PI(5)P
Mammals + + + + + + + 
D. melanogaster NI NI NI + NI + + 
C. elegans NI NI NI + NI + + 
D. discoideum + NI + + + + NI 
Plants  + + + + - + NI 
Yeast + + - - + + + 
 
Table 3: Occurrence of PIs in eukaryotic species 
NI: not investigated. 
 
 
Localization 
All of these lipid products are membrane-bound, and thus compartmentalized. Direct 
evidence for this comes from the use of PI binding domains that are recruited to 
specific subcellular compartments. Although we have only a limited understanding of 
the distribution of these lipids, it is clearly a critical factor in their selective action. The 
regulation of their activities and the mechanisms of their actions have therefore been 
the subject of much investigation. The activities of specific PIs are regulated by 
intricate networks of proteins that control their synthesis, transport and degradation 
(PI kinases, PI phosphatases (Fig. 3) and PI transfer proteins) which in turn are also 
localized to discrete membrane sites restricting signaling to a specific compartment. 
Generally, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are enriched in the 
plasma membrane, PtdIns(4)P in the Golgi and PtdIns(3)P is enriched in the 
endosomal compartments (Fig.4), (De Matteis et al. 2002). 
 
 
                         De Matteis et al. 2002 
 
Figure 4: Subcellular distribution of the phosphoinositides in (a) yeast and (b) mammalian cells  
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PI are colour-coded for identification. EE, early endosomes; LE, late endosomes; Ly, lysosomes; 
MVB, multivesicular body; N, nucleus; V, vacuole.  
Lipid Binding Domains 
PI signaling is mediated by protein-lipid interactions with proteins that usually contain 
one or several lipid binding domains. In the past decades several of this domains 
have been described (reviewed by (Hurley and Meyer 2001; Xu et al. 2001; Itoh and 
Takenawa 2002; DiNitto et al. 2003; Lemmon 2003). Table 4 summarises lipid-
binding domains and their lipid-binding specificities. Figure 5 shows representative 
lipid-binding domains structures. 
Phospholipid-binding domains serve both to concentrate signaling proteins at specific 
sub-regions of the plasma membrane, and to regulate the enzymatic activities of their 
host proteins, either directly or by co-recruitment of another regulatory protein. 
 
Domain 
 
Name 
 
Examples 
 
Lipid binding 
 
PH Pleckstrin Homology PLC-δ PI(4,5)P2 
  Btk PI(3,4,5)P3 
  Dapp1, PKB PI(3,4)P2, PI(3,4,5)P3 
  3G Grp1, 3G ARNO, 3G Cyt PI(4,5)P2, PI(3,4,5)P3 
  2G Grp1, 2G ARNO, 2G Cyt PI(3,4,5)P3 
  Tapp1, Tapp2 PI(3,4)P2 
  Centaurin b2 PI(3,5)P2 
  PEPP1 PI(3)P 
  FAPP1 PI(4)P 
AP2-α 
 
AP2-α adaptor 
complex 
AP2-α1-80 
 
PI(4,5)P2 
 
FYVE 
 
Fab1p YOTB Vac1p 
EEA1 
Vps27, EEA1, Hrs 
 
PI(3)P 
 
PHD Plant Homeo Domain ACF, MLZF PI(5)P 
  ING1, ING2,WSTF PI(5)P, PI(3)P 
PX 
 
Phox Homology 
 
p40phox, 
yeast PX domains 
PI(3)P 
 
  p47 PI(3,4)P2, PS, PA 
  
 
CISK 
 
PI(3,5,) P2, PI(4,5,)P2 , 
PI(3,4,5,)P3                  
  CPK ,PI3K,TCGAP PI(4,5)P2 
ANTH 
 
AP180  N-Terminal 
Homology 
AP180 
 
PI(4,5)P2 
 
C2  Syt1, PKC-α, PTEN PS, anionic membranes 
  cPLA2 neutral membranes 
FERM 4.1-Ezrin Radixin 
Moesin 
Ezrin, Radixin, PTPL1 PI(4,5)P2 
ENTH 
 
Epsin N-Terminal 
Homology 
Epsin1 
 
PI(4,5)P2 
  Ent3p, Ent5p PI(3,5)P2 
Others  MARCKS PI(4,5)P2, PI(3,4)P2, PS 
  Tubby PI(3,4)P2, PI(4,5)P2 
 
Table 4:  Lipid-binding domains 
Lipid-binding domains and lipid-binding specificities of some examples.  
PS: Phosphatidyl Serine, PA: Phosphatidic Acid. (Proteins in bold: structure shown in Fig. 5). 
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B         AP2-α1-80   FYVE A        PH 
PI(,4,5)P2
PI(3,4,5)P3   
E           ANTH D            PX 
 
 
 
 
 
PI(,4,5)P2
PI(,4,5)P2
 
PI(3)P
G C2 
Phosp tidyl ha
Serine   
 
 
Figure 5: Representative structures of lipid-binding domains 
A: PH domain of Grp1, B: AP2-α1-80  of AP2-α, C: FYVE domain o
ANTH domain of AP180, F: Tubby domain of Tubby, G: C2 doma
Radixin, I: ENTH domain of Epsin1 
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The PX domain 
 
The PX domain has only recently been shown to be a novel PI (phosphoinositide)-
binding domain. PX domains have been originally identified as a common motif of 
about 120 amino acids in the subunits p40phox and p47phox of the neutrophil NADPH 
oxidase (Phox) complex (Ponting 1996), (Fig. 8). This domain is conserved from 
yeast to man and more than 400 domain family members have been annotated in 
sequence databases (e.g. SMART, (Letunic et al. 2004).  
 
Functions of PX domain containing proteins 
 
PX proteins have been implicated in highly diverse functions such as cell signalling, 
vesicular trafficking, protein sorting and lipid modification (reviewed in (Odorizzi et al. 
2000; Xu et al. 2001; Worby and Dixon 2002), (Fig. 6).  
 
 
SNXs 
Vesicle Grd19p 
Protein 
Sorting 
Signalling 
& Traffic 
Mvp1p Docking /fusionVps5p PLD1
 
                                                         Xu et al. 2001 
Figure 6: Diverse cellular functions regulated by interactions of PtdIns with PX domain- 
                containing proteins 
 
PX domain structure and PI binding affinities 
PX domains show surprisingly little sequence conservation (Fig.7 A) yet their 
structure appears to be highly conserved based on several available crystal 
structures (Bravo et al. 2001; Hiroaki et al. 2001; Lu et al. 2002; Zhou et al. 2003; 
Xing et al. 2004) (Fig.7 B). All published crystal structures exhibit a clearly defined PI-
binding pocket and in at least one case a second binding pocket has been found to 
bind phosphatidic acid (Kanai et al. 2001; Karathanassis et al. 2002). 
PX domains represent distinct PI binding specificities. For example, the PX domains 
of p40phox and Snx3 bind to PtdIns(3)P (Ago et al. 2001; Kanai et al. 2001; Song et al. 
2001; Xu et al. 2001; Karathanassis et al. 2002), while the PX domain of p47phox 
binds to PtdIns(3,4)P2 and phosphatidic acid (Kanai et al. 2001; Karathanassis et al. 
2002),(Table 4). 
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HS1BP3 
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PXK? 
P40 phox 
P47phox 
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Yeast PX domain containing proteins  
The yeast genome encodes 15 PX domain containing proteins involved in vesicular 
trafficking (Grd19p, Mvp1p, Snx4p/Cvt13p, Snx41p, Snx42p/Cvt20p/Atg20p, Vps5p, 
Vps17p, Vam7p), cell signalling (Spo14p), control of bud emergence and cell polarity 
(Bem1p, Bem3p, Mdm1p) and several proteins of largely unknown function (Ypt35p, 
Ykr078p, Ypr097p) (Table 5). It has been shown that all yeast PX proteins (except for 
the sequence outlier Ypr097p) bind specifically to PtdIns(3)P with different affinities 
(Yu and Lemmon 2001).  
 
PX domain and protein-protein interactions  
Although most PX domains contain additional domains or at least additional protein 
sequences, two yeast proteins, Grd19p and Ypt35p, consist almost exclusively of the 
PX domain (Table 5). The assumption that a signaling protein does not only bind to a 
membrane for its own sake suggested that the PX-only proteins are involved in 
protein-protein interactions in order to transduce a signal from the membrane to 
some effector. This is supported by several genetic observations in mutant PX 
proteins. For example, yeast strains with a deletion of their GRD19 gene missort the 
TGN membrane proteins A-ALP, Pep12p and Kex2p to the vacuole (Voos and 
Stevens 1998; Hettema et al. 2003). A direct involvement of the PX domain in 
protein-protein interactions has been observed in the subunit p47phox of the neutrophil 
NADPH oxidase complex. p47phox is held in an inactive state by an intramolecular 
interaction between its C-terminal SH3 domain and its PX domain. Upon activation 
by invading microorganisms p47phox becomes phosphorylated and the PX-SH3 
interaction is disrupted (Leto et al. 1994; Sumimoto et al. 1994). The C-terminal SH3 
domain interacts with a proline-rich region of the p47phox-PX domain (Hiroaki et al. 
2001), (Fig. 8). 
Another PX-domain mediated protein interaction may involve the PX-only protein 
Grd19p. It was shown to bind to the cytosolic domain of DPAP A. However, this study 
used yeast extracts containing a His-tagged DPAP A fusion protein (Voos and 
Stevens 1998). Hence it is possible that Grd19p did not interact directly with DPAP A 
but rather bound via some other protein such as Vps35p (Nothwehr et al. 2000). 
Finally, a recent large-scale two-hybrid screen has shown that both PX-only proteins 
from yeast, Grd19p and Ypt35p (YHR105W) interact with a number of other proteins 
(Uetz et al. 2000). Nevertheless, as these proteins also contain small N-terminal 
extensions it could not be ruled out rigorously that these sequences were actually 
mediating the observed interactions.        
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               (Wishart et al. 2001)  
TPR 
TPR 
TPR 
TPR 
 
Figure 8: Model of Phosphoinositide and SH3:PxxP Interactions for PX Domain-Containing 
Proteins Involved in Targeted Membrane Assembly of the Phagocyte NADPH Oxidase  
Selected regions of NADPH oxidase subunits gp91phox, p22phox, p40phox, p67phox, p47phox, and 
p21Rac1/2 are schematically represented as follows: phox domain, PX (red); src-homology 3 domain, 
SH3; proline-rich motif, PxxP (yellow); tetratricopeptide repeat, TPR; phosphorylation site, P. Specific 
phosphoinositides (orange) are depicted within a lipid bilayer. Dark arrows denote SH3:PxxP 
interactions previously identified for p47phox. Red and yellow arrows indicate lipid and protein 
interactions involving p40phox- and p47phox-PX domains.   
 
 
Lipid binding domains and protein-protein interactions   
Protein interaction additionally to lipid binding seems to be a common phenomenon 
for PI binding domains. Analysis of PH domains, identified further unknown 
components (possibly connected by protein-protein interactions) besides their 
phospholipid-interaction which may play a role in their localisation to certain 
organelles (Levine and Munro 1998; Levine and Munro 2001; Levine and Munro 
2002). For several PH domains interacting partners have been described although up 
to date, no physiological relevance has been reported (Cozier et al. 2004). Recently 
De Matteis and co-workers have demonstrated a direct interaction of the PH domains 
of FAPP1 and FAPP2 (four-phosphate-adaptor protein) with the small GTPase ADP-
ribosylation factor (ARF) in mammalian cells. Both proteins localize to the trans-Golgi 
network (TGN) on nascent carriers. Additionally they were able to prove that a 
displacement or knockdown of FAPPs inhibits cargo transfer to the plasma 
membrane and overexpression of FAPP-PH impairs carrier fission (Godi et al. 2004).  
Protein-protein interactions have also been found in FYVE domains. Corvera and co-
workers were able to demonstrate that the integrity of the FYVE domain of EEA1 
(early endosome antigen 1) in conjunction with a N-terminal stretch of 30 amino acids 
are essential for Rab5 association (Lawe et al. 2000).    
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The PX-only proteins Grd19p and Ypt35p and their phenotypes   
 
Grd19p and Ypt35p consist almost exclusively of the PX domain. Therefore, their 
mutant phenotypes are of particular interest with respect to the function of their PX 
domains.  
Grd19p was identified by Voos and Stevens (Voos and Stevens 1998) in the course 
of  a Golgi retention defective (Grd) screen (Nothwehr et al. 1996). This screen used 
A-ALP (a model late-Golgi membrane protein consisting of the cytosolic domain of 
DPAP-A = dipeptidyl amino peptidase A) fused to the transmembrane and luminal 
domains of ALP [Alkaline phosphatase]) as an assay for loss of retention of late-
Golgi membrane proteins. The yeast mutants with mislocalization of A-ALP (from the 
late Golgi to the vacuole) were classified into different Grd complementation groups.  
Further proteins found in the yeast TGN are the integral membrane proteins Kex1p 
and Kex2p, which are involved in the proteolytic processing of the secreted mating α-
factor. The carboxy peptidase Y (CPY) sorting receptor (Vps10p), also predominantly 
localizes to the yeast TGN. Kex2p was also found missorted from the TGN to the 
vacuole in GRD19 deletion strains. This was not the case for CPY and its receptor 
Vps10p which were sorted normally (Voos and Stevens 1998). Therefore, mutations  
in GRD19 do not affect the general vesicle traffic between the yeast Golgi and 
vacuole, but rather specific sorting processes involving the resident late-Golgi 
membrane proteins DPAP A and Kex2p.   
Voos and Stevens were also able to demonstrate the mechanism of correct 
localization of A-ALP, which is due to retrieval of the protein from the late endosomes 
rather than its static retention at the TGN (Voos and Stevens 1998).   
Hettema and co-workers (Hettema et al. 2003) described missorting of Pep12p, a 
TGN SNARE protein (soluble N-ethyl-maleimide-sensitive fusion protein attachment 
protein receptor, mediator of fusion of vesicles from the TGN to the late endosomes) 
to the vacuole in GRD19 deletion strains. Contrary to the SNAREs Snc1p, Tgl1p and 
Tgl2p, which are normally distributed at the early endomosmes when GRD19 is 
deleted (Hettema et al. 2003).   The knock-out of GRD19 did not result in any growth 
defects nor any perturbation of vacuolar morphology or vacuolar biogenesis (Voos 
and Stevens 1998).   
Based on the sequence homology within the PX domain, Voos and Stevens analysed 
possible genetic interactions between the GRD19, VPS5, YPT35 and MVP1 genes. 
The Golgi localization defects of grd19∆ cells could not be suppressed by 
overexpression of VPS5 or MVP1. Additionally, analysis of the double deletion 
mutants grd19∆ vps5∆ and grd19∆ mvp1∆ did not reveal any synthetic phenotypes 
concerning growth, CPY secretion, or A-ALP localization. A double deletion of 
grd19∆ and ypt35∆ (gene with the greatest sequence homology, 26% identity, 48% 
similarity) did not amplify or suppress any of the phenotypes due to the grd19∆ 
mutation.   
Analysing the sorting of Snc1p (a SNARE localized at early endosomes) Hettema 
and co-workers were not able to find an interaction between Grd19p and Snx4p, 
Snx41p and Snx42p.   
Summarizing this data, the precise mechanistic role of Grd19p remains uncertain. 
Grd19p is required for the retrieval of Kex2p, A-ALP and Pep12p, all of which also 
require the retromer complex (Reddy and Seaman 2001). This suggests that Grd19p 
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may associate with the retromer complex, improving the recruitment of some but not 
all cargo molecules. Such an association has not been demonstrated, and whether 
Grd19p directly recognizes cargo is also unclear. Hettema and co-workers have not 
observed binding of Grd19p to Pep12p, either by cross-linking or by affinity 
chromatography. Although Grd19p has been reported to bind the cytoplasmic tail of 
A-ALP (Voos and Stevens 1998), there is also evidence that recognition of A-ALP is 
mediated by the retromer subunit Vps35p (Nothwehr et al. 1999; Nothwehr et al. 
2000). Grd19p may therefore act indirectly, by modulating retromer binding.   
Ypt35p deletion shows no obvious growth defect as the double mutant 
grd19∆/ypt35∆ did not amplify or suppress any of the phenotypes of the grd19∆ 
mutation (Voos and Stevens 1998). Further, no misslocalization of Pep12p, Tgl1p, 
Tgl2p and Snc1p was observed (Hettema et al. 2003). Additionally CPY, PrA and 
ALP processing was normal in grd19∆ strains  (Bonangelino et al. 2002). Up to now 
no phenotype could be observed by the deletion of YPT35. Analysis of large scale 
two-hybrid data predicted this protein to be involved in protein modification and being 
a oxidoreductase (Hishigaki et al. 2001). This is in contrast to a possible function in 
Golgi to vacuolar transport, as suggested by network-based statistical analysis 
(Samanta and Liang 2003).  An analysis of interacting partners could shed light on 
the function of this protein.   
 
Aim of my PhD work   
 
The aim of this PhD work was to investigate the role of the PX domain as a bona fide 
protein interaction module. This would open a new perspective on lipid binding 
domains and their regulation. 
 
Project outline 
 
Searching for interacting partners   
In order to identify interacting partners of the PX-domain in yeast, my starting point 
was to perform genome-wide two-hybrid screens. The 15 PX domain containing 
proteins in yeast and their isolated domains (except for Ypt35p and Grd19p which 
are composed almost exclusively of their PX domain) were constructed and used as 
baits (see below for definition of two-hybrid terms). 
Confirmation of obtained interactions via a second independent method   
In a second step the two-hybrid interactions should be confirmed by an alternative 
technique.  This was done in vitro by means of GST pulldowns.   
 
Mapping the interacting region    
In a third step the exact binding region for the PX domains should be mapped. This 
was done by means of prey fragmentation, point mutation on the lipid binding pocket 
and peptide arrays.   
 
This work shows that the PX domain is a protein-protein interaction module binding 
predominantly to membrane proteins that are involved in vesicular transport (Vollert 
and Uetz 2004) 
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The Two-Hybrid System  
  
Definition  
The two-hybrid technique is an experimental procedure to detect protein-protein 
interactions that uses two fusion proteins (“hybrids”) which reconstitute an active 
transcription factor when the two fusion proteins interact (Fig. 9). The technique was 
developed by (Fields and Song 1989). It has been estimated that more than 50% of 
all protein interactions described in the literature have been detected using the yeast-
two hybrid system.  
( 
Basic Principle of the classical Yeast-Two Hybrid System  
In order to test if two proteins X and Y interact, they are expressed as fusion proteins 
with a transcriptional activating domain (AD, prey), and a DNA-binding domain (DBD, 
bait), respectively. The term “two-hybrid” derives from these two chimeric proteins.  
The bait and prey fusions are co-expressed in yeast where a physical interaction 
between X and Y leads to the reconstitution of a functional transcription factor that 
binds to the promoter of a reporter gene (Fig. 9). Consequently, transcription of the 
reporter gene is switched on. A protein-protein interaction is therefore translated into 
reporter gene activity which can be detected or measured. The interaction must take 
place in the nucleus for the subsequent activation of the reporter gene. For this 
purpose non-nuclear proteins are targeted to the nucleus. The two-hybrid system can 
be used for the detection of essentially any protein-protein interaction, independent of 
the function of the corresponding proteins.  
 
   
   
Mating type a Mating type α Mating type aα 
   
 
 
Figure 9: Classical Yeast Two-Hybrid System  
A protein of interest Y is expressed in yeast as a fusion to a DNA-binding domain (DBD, “bait”; circles 
denote expression plasmids). Another protein of interest X is fused to a transcriptional activation 
domain (AD, “prey”). The two yeast strains are mated to combine the two fusion proteins in one cell. If 
proteins Y and X interact in the resulting diploids cells, they reconstitute a transcription factor which 
activates a reporter gene (here: HIS3) and therefore allows the cell to grow on selective media (here: 
media lacking histidine).   
 
 
 
 
HIS3
ADX
HIS 3 x 
A D X   
HIS3
D B D 
Y 
D B D 
Y 
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Peptide Synthesis   
SPOT synthesis which was originally introduced by (Frank 1992) is an easy and 
flexible technique for simultaneous and parallel chemical synthesis of peptides at 
distinct positions on a membrane support. The SPOT method has opened up 
unlimited opportunities to synthesize and subsequently screen large arrays of 
synthetic peptides (eg., (Otte et al. 2003; Landgraf et al. 2004). Peptide arrays 
prepared by SPOT synthesis can be used to study molecular recognition events, 
such as epitope mapping, the analysis of protein-protein and protein-nucleic acid 
interactions, and identification of biologically active peptides. Peptide arrays can be 
applied to precisely depict molecular recognition events on the single amino acid 
level.    
(
SPOT synthesis technique  
Figure 10 illustrates of SPOT synthesis method on cellulose. A commercially 
available filter paper (e.g. Whatman) with hydroxyl functional groups can be uniformly 
converted to amino functions through coupling with activated Fmoc-ß-Ala-OH and the 
subsequent removal of the Fmoc-group (I). The spots are then predefined by 
dispensing small droplet of Fmoc-ß-Ala-pentafluorophenyl ester solution onto the 
distinct sites on the membrane (II). This process can be done either by a pipetting 
robot (Intavis Bioanalytical Instruments  AG, Bergisch Gladbach, Germany) or 
manually. After the removal of the Fmoc group, Fmoc-ß-Ala active ester or other 
activated building blocks can be coupled to the defined spots as spacer/linker (III). 
The following peptide chain elongation steps are conventional solid phase peptide 
synthesis (Merrifield 1963). It is a repetitive procedure, each cycle starting with 
removal of N-terminal protecting group of the immobilized peptide chain on cellulose 
(IV), followed by coupling of the pre-activated amino  acids with N-terminal and side 
chain suitably protected (V). The peptide chain is growing in the direction from 
carboxyl to amino-terminal (C->N). In between each step, the washing step is carried 
out by using respective reagents and solvents (VI). Finally, the peptide is generated 
by the removal of all side chain protecting groups (VII), which is ready for subsequent 
chemical or biological screening directly on the cellulose membrane.  
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Figure 10: Scheme of SPOT synthesis method in the application of synthesizing peptides on   
                  cellulose. Steps I-VII, see text.     
 
Analysis of protein- peptide contact sites based on SPOT synthesis   
Protein interactions can be studied at amino acid level since the use of protein-
derived scans of overlapping peptides (Geysen et al. 1984). SPOT technology allows 
the analysis and mapping of interaction sites of protein complexes in a rapid and 
straightforward way.   Proteins interact via surface-accessible interaction sites which 
involve amino acid residues and backbone contacts along a continuous segment of 
the protein chain (linear epitopes) or involve amino acid residues from at least two 
segments close in space by the folded conformation (conformational or discontinuous 
epitopes) but separated in the primary sequence (Fig. 11). The term “epitopes” 
mentioned here is defined as the contact sites of a protein that interacts with its 
binding partner. In linear epitopes, the key amino acids mediating the contacts with 
the binding partner are located within one part of the primary structure and comprise 
no more than 15 amino acids in length, usually 8-12 amino acids. Peptides covering 
such epitopes are usually able to compete with the protein-protein interaction and 
have similar affinities as the intact protein from which they are derived (Reineke et al. 
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1999). The mapping of linear epitopes by standard SPOT method using overlapping 
peptides derived from the entire primary sequence of a protein is an easy and 
efficient approach. The whole protein sequence is fragmented and synthesized on 
cellulose with short overlapping peptides (normally 13-15 amino acids in length and 
shifted by 3 amino acids), the so called peptide scan, which is subsequently probed for 
binding to the respective partner protein. The binding assay is either performed 
directly on the peptide membrane through immunodetection of bound probe protein 
or autoradiography of radiolabeled probe protein, or after transfer to a nitrocellulose 
membrane. The mapping of a linear epitope is shown in Figure 11(A). The 
sequences colored red are the linear contact site with detectable signals in binding 
assay.    
    
Figure 11:  Scheme of mapping linear (A) and discontinuous (B) protein-protein interaction epitopes   
 
Since protein-protein interactions are usually mediated by relatively large contact 
interfaces (Jones and Thornton 1996), in most cases proteins have more than one 
binding site to interact with their binding partners. In such discontinuous 
(conformational) binding sites the key residues contributing to the binding affinity are 
normally separated in the primary structure, but closer in the conformation on the 
surface of a folded protein to form a conjunct binding epitope (Fig. 11, B). The 
mapping of discontinuous epitopes using fragments of protein either generated 
chemically or biologically suffers from the drawback that peptides comprising only a 
single binding region of a discontinuous binding site generally have very low affinities 
for the binding partner in solution, even if the complete binding site mediates a high 
affinity interaction. Thus, the mapping of discontinuous epitopes with overlapping 
peptides on cellulose might be very difficult. However, the SPOT approach has the 
unique advantage that the density of the immobilized peptides on membranes can be 
as high as 50 nmol/cm2 or even higher, which corresponds to a high local peptide 
concentration (mM level or higher, estimated) and thus increases the screening 
sensitivity. In this way, the inherent defect that peptides comprising only the 
individual binding regions normally having low affinities for the binding partner can be 
overcome to a great extent by the SPOT method. The scheme of mapping 
discontinuous epitopes is shown in Figure 11 (B), where the sequences coloured red 
and green are separated in primary protein sequence individually with detectable 
signals in the binding assay. 
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Experimental procedures 
 
Yeast two-hybrid assay high-throughput screening 
 
Schematic overview: 
 
 
 
A strain expressing a Gal4 DNA-binding domain-ORF fusion protein (top row) is 
mated to 6000 different yeast strains of the opposite mating type that expresses one 
of the yeast ORFs fused to the Gal4 activation domain (second row). If the hybrid 
proteins interact, a transcriptional activator is reconstituted and a reporter gene 
(HIS3) is expressed. This expression allows the diploid cell to grow on selective 
media lacking histidine. Each column represents one individual two-hybrid test. 
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Interaction mating using robotic procedures (Cagney et al. 2000) 
 
Methodical Scheme: 
 
- Leu -Trp 
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1. Haploid yeast expressing the DNA-binding domain-ORF fusion protein is 
transferred from a liquid culture to solid medium. 
2. Haploid cells from the activation domain array are transferred with the same tool 
onto the DBD-ORF fusion-expressing cells for mating.  
3. After 2 days of growth, the colonies are transferred to –Leu-Trp medium to allow 
growth of diploids.  
4. After 2 days the diploid cells are transferred in step to two-hybrid selective 
plates  (-Trp –Leu –His), on which visible colonies start to grow after a few days. 
Weak two-hybrid positives may, however, take up to 3 weeks or more to form 
colonies. 
 
Required material: 
 
• Yeast synthetic media lacking appropriate nutrients 
• 384-pin replicating tool: Biomek 2000 Laboratory Automation Workstation 
(Beckman-Coulter)  
• Yeast strains expressing Gal4p AD-ORF fusion proteins arrayed in 384-colony 
format (Prey) 
• Yeast strain expressing Gal4p DBD-ORF fusion (Bait) 
 
Procedure: 
 
• Inoculate 20ml of complete yeast medium (YEPD) with a 0.3ml liquid pre-
culture of the strain expressing Gal4p DBD-ORF fusion into a 250ml conical 
flask. The culture is suitable for use for several days if stored at 4°C. 
• Grow overnight at 30°C. 
• Transfer the DBD-ORF culture onto OmniTrays containing solid YEPD medium 
using a 384-pin replicating tool. Allow the yeast to dry onto the plates for 10-20 
minutes. 
•  Transfer the yeast AD-ORF array elements directly onto the dry DBD-ORF 
cultures using the same tool. 
•  Incubate for 1-2 days at 30°C to allow mating of the strains. 
• Transfer the colonies to OmniTrays containing medium lacking leucine and 
tryptophane. 
•  Incubate for 2-4 days at 30°C to allow diploid cells to grow. 
• Transfer the colonies to OmniTrays containing selective media lacking leucine, 
tryptophane and histidine, which had been supplemented with an appropriate 
amount of 3AT (for nonactivating DBD-ORF strains routinely 3mM 3AT is used). 
•  Incubate for 1-3 weeks at 30°C. Score and document the screen (take photos 
and Filemaker Database). 
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Bait and Prey construction 
 
Strategy: 
 
 
 
Yeast ORFs are amplified (first PCR) with specific primers that generated products 
with common 5’ and common 3’ 20-nucleotide tails. A second PCR generates 
products with common 5’ and common 3’ ~70-nucleotide tails. The common ~70-
nucleotide ends allow cloning into linearized two-hybrid expression vectors by 
recombination. 
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Vectors 
 
              Low copy prey vector: pOAD (Cagney et al. 2000) 
 
 
 
Sequence features: 
 
• LEU2 (leucine auxotrophy): 4045-2954 
• bla: beta-lactamase (ampicillin resistance): 4673-5527 
• CEN4 (centromere element for stable maintenance of the plasmid): 866-1719 
• ARS1: 1748-1964 (corresponds to sequence between TRP1 and GAL3 on yeast 
chromosome 4) 
• GAL4-AD (activation domain): 7996-8429 (first 66 bp not from Gal4) 
 
Cloning site (position 8358-8370): 
 
C TAT CTA TTC GAT GAT GAA GAT ACC CCA CCA AAC CCA AAA AAA GAG 
ATC GAA TTC CAG CTG ACC ACC ATG GCA ATT CCC GGG GAT CCG TCG 
ACC TGC AGA GAT CTA TGA ATC GTA GAT ACT GAA AAA C[CC CGC AAG] 
 
This sequence corresponds to the two re-PCR primers (green + blue = forward 
primer, pink + black = reverse primer) except for the very 5' 8 bp of the reverse 
primer which are shown in brackets. The two restriction sites for linearizing pOAD 
(PvuII = CAGCTG and NcoI = CCATGG) are underlined. In the 4 bp-region of mixed 
color (blue and pink) the two primer sequences overlap). The primers and vectors are 
designed in a way that a single re-PCR product can be used for both the bait 
(pOBD2) and prey (pOAD) clones. 
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            Low copy bait vector 1: pOBD-2 (Cagney et al. 2000) 
 
 
 
Sequence features: 
 
• ADH1 (alcohol dehydrogenase 1) promoter: 1-298 (at least; region of homology 
when searched against SGD) 
• GAL4-DBD: 434-982 
• ADH1 terminator: 1221-1687 (at least; region of homology to SGD genom. seq.) 
• beta lactamase (ampicillin resistance): 4363-5220 
• TRP1 (tryptophane auxotrophy): 3379-4050 
• CEN4 (centromere element for stable maintenance of the plasmid):: 1814-2667 
 
 
Cloning site (position 877-1012): 
 
C TAT CTA TTC GAT GAT GAA GAT ACC CCA CCA AAC CCA AAA AAA GAG 
ATC GAA TTC CAG CTG ACC ACC ATG GCA ATT CCC GGG GAT CCG TCG 
ACC TGC AGA GAT CTA TGA ATC GTA GAT ACT GAA AAA CCC CGC AAG 
 
 
This sequence corresponds exactly to the two re-PCR primers (green + blue = 
forward primer, pink + black = reverse primer). The two restriction sites for linearizing 
pOBD2 (PvuII = CAGCTG and NcoI = CCATGG) are underlined. In the 4 bp-region of 
mixed color (blue and pink) the two primer sequences overlap). 
 
                        
 
 
- 26 - 
                                                                 EXPERIMENTAL PROCEDURES                                  
 
High copy bait vector : pGBD  (James et al. 1996) 
  
 
 
Sequence features: 
 
Stippled regions indicate the ADH1 (alcohol dehydrogenase) promoter (P) and 
transcription termination (T) elements.  
GAL4 BD (DNA binding domain) encodes amino acids 1-147  
2µ: High copy yeast plasmid 
TRP1: Tryptophane auxotrophy 
Amp: Ampicillin resistance 
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1st Round PCR: 
 
PCR conditions for amplification of ORFs from Genomic DNA 
  1     µl  genomic DNA 
  1     µl  dNTP mix (each 10 mM) 
10     µl  5x Pfu Polymerase Buffer 
  1,5  µl MgCl2 (50mM) 
  1     µl F Primer (10 pmol) 
  1     µl R Primer 
  1     µl Taq Polymerase 
  0,4  µl  Pfu Polymerase 
33,1  µl  Water 
50     µl  total  
 
1st Round PCR programm: 
 
5 min 95°C 
40 sec 94°C 
 1  min 54°C      x 30  
 2  min 72°C 
10 min 72°C 
Hold on 4°C 
 
2nd Round PCR: 
 
  1     µl  1st round PCR product 
  1     µl  dNTP mix (each 10 mM) 
10     µl  5x Pfu Polymerase Buffer 
  1,5  µl MgCl2 (50mM) 
  1     µl F Primer (10 pmol) 
  1     µl R Primer 
  1     µl Pfu Polymerase 
33,5  µl  Water 
50     µl  total  
 
2nd Round PCR programm: 
 
5 min 95°C 
40 sec 94°C 
 1 min 54°C      x 30  
 2 min 72°C 
10 min 72°C 
Hold on 4°C 
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Primers: 
 
First round PCR 
 
Forward primer:  
5' AA TTC CAG CTG ACC ACC ATG xxx xxx xxx xxx xxx xxx xxx 3' 
where the xxx's represent the ORF-specific sequences and the ATG represents the 
actual start codon of the yeast ORF. 
Reverse primer: 
3' xxx xxx xxx xxx xxx xxx *** GTA CCG TTA AGG GCC CCT AG 5' 
where the ***'s represent one of the 3 stop codons. 
 
Second round PCR 
 
Forward primer: 
5' C TAT CTA TTC GAT GAT GAA GAT ACC CCA CCA AAC CCA AAA AAA GAG 
ATC 
GAA TTC CAG CTG ACC ACC ATG 3' 
 
Reverse primer: 
5’ GTA CCG TTA AGG GCC CCT AGG CAG CTG GAC GTC TCT AGA TAC TTA 
GCA 
TCT ATG ACT TTT TGG GGC GTT C 5' 
 
 
Scoring of yeast two-hybrid high-throughput PX interactions 
 
• Positive prey clones from a first-round screen were re-arrayed as 
quadruplicate copies and tested again for reproducibility.  
• All retests were carried out at least 8 times and their results were used to 
assign “quality” scores to obtained positives:  
Score 3: Positives which were reproducible in at least 8 out of 12 or more 
tests  
Score 2: Positives which were found at least 4 times out of 12 (or more) tests  
Score 1: Postitives that were found two to three times. Some highly 
reproducible positives were classified as “1” if the results were difficult to 
interpret due to high background or other reasons.  
• Two-hybrid positives were classified by Gene Ontology descriptors as 
provided by the Saccharomyces Genome Database 
(http://www.yeastgenome.org). 
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Yeast genomic DNA preparation 
 
Required material: 
• Lysis Buffer 
• Phenol 
• Chloroform and chlorform/Isoamylalcohol 
• Tris-EDTA (TE), pH 7.6 
• 100% ethanol 
• 70% ethanol 
• Glass beads (acid glas beads 425-600 µm, Sigma G-9268) 
 
Lysis Buffer 
  1    %  SDS 
  2    %  Triton X-100 
  0.1 M NaCl 
10    mM Tris-HCl, pH 8.0 
  1    mM EDTA 
 
Procedure: 
 
• Centrifuge at 3500 rpm for 3 min 2ml of an over night yeast culture in complete 
yeast medium (YEPD) 
•  Wash the pellet with 1ml of  water and centrifuge 3 min at 3500 rpm 
• Add 200µl lysis buffer and 0,3g of glass beads 
• Add 200µl of phenol and vortex shortly 
• Add 200µl of chloroform and vortex shortly 
• Add 200µl TE buffer, vortex and centrifuge 5 min at 8000 rpm 
• In the meantime prepare 400µl chlorform/Isoamylalcohol in microfuge tubes 
• Add the supernatant to the chlorform/Isoamylalcohol and vortex 
• Centrifuge 5 min at 8000 rpm 
• In the meantime prepare microfuge tubes with 800µl abs. ethanol 
• Add the supernatant to the ethanol and vortex 
• Centrifuge 15 min at 13000 rpm 
• Discard the supernatant 
• Wash the pellet with 70% ethanol 
• Let the DNA pellet dry at RT 
• Solve the pellet in 50µl TE buffer 
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Yeast Strains 
 
We use two strains which are identical except for being of opposite mating type: 
 
Bait: 
PJ69-4α (James et al. 1996) MATα, trp1-901, leu2–3, ura3–52, his3–200, gal4∆, 
gal80∆, GAL2-ADE2, 
LYS::GAL1-HIS3, met2::GAL7-lacZ 
 
Prey: 
PJ69-4a (Hudson et al. 1997) MAT a, trp1-901, leu2–3, ura3–52, his3–200, gal4∆, 
gal80∆, GAL2-ADE2, LYS::GAL1-HIS3, met2::GAL7-lacZ 
  
 
 
 
Cloning by recombination (Ma et al. 1987) and Yeast transformation 
(Ito et al. 1983) 
 
Required material: 
 
• Host strains: PJ69-4a or PJ69-4α 
• Yeast synthetic media lacking appropriate nutrients 
• AD Vector DNA 200ng of NcoI- and PvuII-linearized pOAD 
• DBD Vector DNA 200ng of NcoI- and PvuI-Iinearized pOBD2 
• Insert DNA 3µl of Second Round PCR products 
• Carrier DNA: Dissolve 7.75mg/ml salmon sperm DNA (Sigma Cat. No. D1626) 
in water and store at –20°C following a 15 min 121°C autoclave cycle 
• DMSO 
• 0.1M Lithium acetate (LiOAc) 
• ‘96PEG’ solution:  45.6   g    PEG (Sigma P3640) make up to 94,8 ml with 
water 
  6.1   ml  2M LiOAc  
  1.14 ml  1M Tris.HCl pH 7.5 
  232  µl   0.5M EDTA. 
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Procedure: 
 
• Inoculate 50ml of complete yeast medium (YEPD) with 0.3ml of host strain (for 
activation-domain fusions we use a and alpha for baits) liquid pre-culture in a 
250ml conical flask and grow overnight at 30°C (minimum 15 h max. 24h). 
• Harvest the yeast by centrifugation (3500 rpm, 3 min, RT), pour off the 
supernatant, resuspend the yeast in 2ml of 0.1M LiOAc and transfer into 2 
microfuge tubes. Spin out yeast and resuspend all this yeast in a total volume 
of 1,8ml (incl. yeast)  
• Boil 0.58ml of carrier DNA for 5min, and plunge it into ice water. 
• Add the following reagents in order to a 50ml tube and immediately shake for 
30s followed by vortexing for 1min:  20.73 ml of ‘96PEG’ 
  0.58 ml carrier DNA 
                                                                   200 ng vector DNA   
  2.62 ml DMSO 
• Add the 1,8ml yeast suspension to the mixture and mix well by hand for 1 min 
• Prepare 96 well plates or individual microfuge tubes with 3µl rePCR (2nd 
Round PCR) products or 1µl control plasmid (e.g. pOAD) 
• Add to each tube/well 245µl of the mixture and vortex for 4 min 
• Incubate for 30 min at 42°C 
• Recover the yeast by centrifugation (2000 rpm, 7min, room temperature on a 
benchtop centrifuge) and aspirate the supernatant  
• Add 220µl of water to each well and resuspend the yeast 
• Plate the yeast suspensions singly on to 35mm –Leu or (–Trp) plates and 
allow to grow for 2-3 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 32 - 
                                                                 EXPERIMENTAL PROCEDURES                                  
Yeast Media 
 
YEPD-Medium 
For liquid medium: 
10g  Yeast extract 
20g  Bactopepton 
20g  Glucose 
Add to 1 liter and autoclave 
Store up to 3 months at RT  
For solid medium: 
Add 16g agar before autoclaving. 
Cool to 45°C and pour into appropriate plates. Wrap plates and store up to 6 month 
at 4°C 
YEPD+Ade medium 
Prepare solid medium and add after autoclaving 4ml sterile filtered 1% adenine 
solution in 0,1M NaOH 
 
 
Selective media 
 
For 1 Liter: 
 
Autoclave 16g agar in 800ml dest. water  
After autoclaving add 200ml sterile filtered medium concentrate 
According to the wished selective media you have to add the missing amino acids or 
3AT (3-amino-1,2,4-triazol): 
 
- T Plates:   8,3 ml Leucine solution (7,2 g/l sterile filtered) 
        8,3 ml Histidine solution (2,4 g/l sterile filtered)  
- L Plates:  8,3 ml Tryptophane solution (4,8 g/l sterile filtered) 
   8,3 ml Histidine solution (2,4 g/l sterile filtered)   
- LT Plates:  8,3 ml Histidine solution (2,4 g/l sterile filtered) 
- LTH plates:   6    ml 3AT- Solution (0,5M, sterile filtered) 
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Medium concentrate 
 
For 1 Liter 
 
    8,5 g  Yeast Nitrogen Base  
  25    g Ammoniumsulfate 
100    g  Glucose 
    7    g  Dropout Powder 
  
Fill up to 1l with dest. water and sterile filter 
 
 
Droput powder 
 
Methionine     1    g 
Arginine    1    g 
Phenylalanine    2,5 g 
Lysine    3    g 
Tyrosine     3    g 
Isoleucine     4    g 
Glutamic acid    5    g 
Aspartic acid    5    g 
Valine     7,5 g 
Threonine  10    g 
Serine   20    g 
Adenine     1    g 
Uracil      1    g 
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GST-PX Domain fusion proteins  
 
 
All PX domains were cloned at the BamHI and HindIII sites of the MCS (multiple 
cloning site) (Yu and Lemmon 2001) of the plasmid pGSTag (Ron and Dressler 
1992): 
 
 
 
 
 
 
 
Map of the pGSTag plasmid. The sequence of the high affinity PK-A site follows the 
thrombin cleavage site and is followed by a polylinker. The restriction sites present in 
the map are unique to the polylinker. 
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GST-Fusion Proteins Expression 
 
Required material: 
• BL21 E.coli cells containing the respective cloned pGSTag plasmid 
• Ampicillin  (Stock solution 100 mg/ml dH2O) 
• IPTG (Stock solution : 1M in dH2O)  
• Reduced Glutathione (10mM in 50mM Tris-HCl pH8.0) 
• Glutathion Sepharose (GS) 4 Fast Flow (Amersham Biosciences) 
50% slurry preparation: 
1 Gently shake the bottle of GS to resuspend the mix 
2 Use a pipet to remove sufficient slurry 
3 Dispense 1,33ml of the original GS slurry per ml of bed volume 
required 
4 Wash the GS by adding 10ml of cold (4°C) 1x PBS per 1,33ml of 
the orifinal slurry. Invert to mix 
5 Sediment the matrix by centrifugation at 500 x g for 5 min 
6 Decant the supernatant 
7 For each 1,33ml of the original slurry of GS add 1 ml of 1xPBS 
(50% slurry) 
8 Mix well prior to subsequent pipetting steps 
 
PBS 
NaH2PO  40.23   g  
Na2HPO  41.15  g 
NaCl      8.75  g 
 
Add dH2O to 900ml 
Adjust pH to between 7.2 and 7.4 using 1M NaOH or 1M HCl 
Adjust volume to 1 liter with dH2O 
 
LB Media 
Bacto Tryptone 10.0 g 
Yeast Extract   5.0 g 
NaCl     5.0 g 
Bacto Agar  15.0 g 
Add to 1 liter dH20 
 
Lysis Buffer 
  50 mM Tris pH 7.6 
150 mM NaCl  
    3 mM EDTA 
Proteinase Inhibitor  
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Procedure: 
 
• Add 20ml overnight culture to 1 liter of LB +Ampicillin (100mg/l final 
concentration) 
• Shake at 37°C approx. 2 hrs until they grow at  a OD600 of ~0,6 
• Induce fusion protein expression by adding 0,5mM IPTG 
• Continue growth by shaking 4 hrs at 37° C 
• Centrifuge bacteria at 3500 rpm  for 10 min (pellet can be frozen at -20) 
• For 1l probe  resuspend Pellets in ice cold 50ml lysis buffer 
• Lyse cells  on ice using a probe sonicator: (2 x 15 pulses hold 4, 40 volts)  
• Add 1 % Triton x-100 and incubate 10 min on ice 
• Centrifuge at 10 000 rpm at 4 °C for  10 min  
• To the 50ml probe  add 2-4 ml of  50% slurry sepharose beads  
• Rotate 1 h at 4°C 
• Wash beads 3x with PBS 
• Freeze beads at –20°C with 10% Triton/ or elute with 10mM reduced 
glutathione 
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Preparation and Transformation of “Ultra Competent” E.coli Cells 
 
This protocol reproducibly generates competent cultures of E.coli that yield 1x108 to 
3x108 transformed colonies/mg of plasmid DNA. The protocol works optimally when 
the bacterial culture is grown at 18°C. 
 
 
Required material: 
 
• DMSO 
• Plasmid DNA  
• Inoue transformation buffer: 
A) Prepare 0,5M pipes (pH6.7) (piperazine-1,2-bis[ethanesulfonic acid]) 
Dissolve 15,1g of PIPES in 80ml dH2O 
Adjust the pH to 6.7 with %M KOH 
Add to 100ml and sterile filter 
Divide into aliquots and store at -20°C 
     B)  MnCl2.4H2O  10,88  g   (55 mM) 
           CaCl2.2H2O    2,20  g (15 mM) 
           KCl   18,65  g (250 mM) 
           PIPES  20       ml (10 mM) 
Sterile filter 
 
• LB Media 
Bacto Tryptone 10 g 
Yeast Extract   5 g 
NaCl   10 g 
Bacto Agar  16 g 
Add to 1 liter dH20 
 
• LB plates with appropriate antibiotic  
 
 
Procedure: 
Preparation 
• Pick a single bacterial colony from a plate that has been incubated for 16-20 
hrs. at 37°C and transfer it to 25ml of LB media 
• Incubate the culture for 6-8 hrs at 37°C with vigorous shaking (250-300 rpm) 
• At about 6 am use this starter culture to inoculate 3 1-liter flasks, each 
containing 250ml of LB. The first flask receives 10ml of starter culture, the 
second 4ml and the third 2ml. 
• Incubate all 3 flasks overnight at 18-22°C with moderate shaking 
• The following morning, read the OD600 of all 3 cultures. Continue to monitor 
every 45 min 
• When the OD600 of one of the cultures reaches 0,55, transfer the culture 
vessel to an ice-water bath for 10 min. Discard the other 2 cultures. 
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• Harvest the cells by centrifugation at 2500 g (3900 rpm in a Sorvall GSA rotor) 
for 10 min at 4°C 
• Pour off the medium and store the open centrifuge tube on a stack of paper 
towels for 2 min. Use  a vacuum aspirator to remove any drops of remaining 
medium adhering to the walls of the centrifuge tube 
• Resuspend the cells gently in 20ml of ice-cold Inoue buffer 
• Add 1,5ml of DMSO 
• Mix the bacterial suspension by swirling and store it on ice for 10 min 
• Working quickly, dispense the aliquots of the suspensions into chilled, sterile 
microfuge tubes. Immediately snap-freeze the competent cells by immersing 
the tubes in a bath of liquid nitrogen 
• Store tubes at -70 °C until needed 
 
Transformation 
• Remove a tube of competent cells form the -70 °C freezer 
• Thaw the cells by holding the tube in the palm of the hand and transfer after 
thaw on ice  
• Add the transforming DNA (up to 25ng per 50µl competent cells), swirl to mix 
and incubate on ice for 30 min. 
• Transfer the tubes into a 42°C heat block for exactly 90 sec. 
• Rapidly transfer the tubes to ice for 1-2 min 
• Add 800µl of LB medium and shake the cultures at 37°C for 1 h 
• Centrifuge the cells at 13000 rpm for 1 min and resuspend in 200µl H2O 
• Transfer the suspension on to a LB plate with appropriate antibiotic 
• Let the plates dry at RT and incubate them at 37°C 
• Colonies should appear in 12-16 hrs 
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SDS PAGE 
 
Acrylamide Gels (for 2 gels 10cm x 8cm with 1mm spacers)  
 
Required material: 
 
•   1    M Tris-HCl pH 8.8 (Roth 3029.1) 
•   1    M Tris-HCl pH 6.8 
•   0,5 M EDTA 
• 20    % SDS 
• 30    % Acrylamid solution 
• 10    % Ammonium persulfate (APS) 
• TEMED 
• Gel Chambers (2 gels 10 cm x 8cm with 1mm spacers)  
 
• 2X protein sample buffer 
For 100ml 
Glycerol (20%)   20    ml 
SDS (20%)   20    ml 
β-mercaptoethanol (10%) 10    ml 
1M Tris-HCl pH 6.8  12,5 ml 
H2O      5    ml 
Bromphenol blue  a small spatula tip 
• Molecular weight marker 
 
Procedure:  
 
Resolution Gel (15% acrylamid) 
 
H2O   3,33 ml 
Tris-HCl pH 8.8 2,53 ml 
Acrylamid   4      ml    
SDS 20%         50       µl 
Temed         13,33  µl 
APS (10%)         50       µl 
• Pour into Gel chamber (so that it fills up 2/3 of the chamber) and cover with 
water using a Pasteur pipette (for the removal of air bubbles) and let solidify 
Stacking Gel 
 
H2O       4,35  ml 
Tris-HCl pH 6.8 750       µl 
Acrylamid  900       µl 
SDS 20%    30       µl 
Temed    11, 25 µl 
APS (10%)    30       µl 
• Remove water and pour stacking. Insert immediately the combs and let solidify  
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10 x SDS-Running Buffer 
 
Glycin          150.17 g 
Tris base 60.57 g 
SDS (20%) 50      ml 
 
Add to 1 liter 
 
 
Coomassie Blue Staining of Acrylamide Gels 
 
Required Material: 
 
Coomassie Blue stain: 
 
Methanol    50    % 
Acetic acid    10    % 
Coomassie Brilliant blue R250   0.2 % 
 
Destain: 
 
Methanol   30 % 
Acetic acid   10 % 
 
Procedure: 
 
• Incubate on a shaker with an appropriate amount of coomassie blue stain for 
30 min 
• Recover Coomassie stain (can be used several times) 
• Incubate in destain (change several times the solution) until the background is 
sufficiently reduced 
• Rinse in water  and dry the gel  
 
 
 
 
 
 
 
 
 
 
 
 
- 41 - 
                                                                 EXPERIMENTAL PROCEDURES                                  
In vitro transcription and translation using the TNT T7 Quick for 
PCR DNA (promega) 
 
1-TNT PCR 
 
Primer design: 
 
Forward Primer 
5´                         
3´ 
GGATCC  TAATACGACTCACTATAGGG  AACAG  CCACCATG  gene sequence 
(18bp) 
 
   Spacer  T7 promoter        Spacer Start codon 
 
Reverse Primer 
 
5´ TAA (stop codon) - gene sequence (20bp) 3´ 
 
Primers used: 
Yip1p-forward: GGA TCC TAA TAC GAC TCA CTA TAG GGA ACA GCC ACC ATG 
TCT TTC TAC AAT ACT AGT 
Yip1p-reverse: TCA GAC AAA AAT TAC CAT GAG 
Yip1p-N-Terminus-reverse: GAT CCC CGG GAA TTG CCA TGC CCA GCC AAA TCT 
GAA TCG TT 
Yif1p-forward: GGA TCC TAA TAC GAC TCA CTA TAG GGA ACA GCC ACC ATG 
TCT TAT AAT CCG TAC GCA,  
Yif1p-reverse: TCA ACC CAT TAA CCA CAT TAG 
Yif1p-N-Terminus-reverse: GAT CCC CGG GAA TTG CCA TGG TCC ATA ATT CGT 
TGC CAG TT 
Yip4p-forward: GGA TCC TAA TAC GAC TCA CTA TAG GGA ACA GCC ACC ATG 
TCA TAC GGA AGA GAA GAC 
 Yip4p-reverse: TCA GAA CTT TCT GCC GTG GCT 
 
PCR conditions for TNT PCR 
 
  1 µl  plasmid DNA encoding appropriate gene 
  1 µl  dNTP mix (each 10 mM) 
10 µl  5x Pfu Polymerase Buffer 
  1 µl F Primer (10 pmol) 
  1 µl R Primer (10 pmol) 
  1 µl Pfu Polymerase 
35 µl  Water 
 
50 µl  total  
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TNT PCR programm: 
 
5 min 95°C 
 
40 sec 94°C 
1 min 54°C      x 30  
4 min 72°C 
 
10 min 72°C 
 
Hold on 4°C 
 
 
2- In vitro transcription and translation 
 
• Remove the reagents from -70°C. Rapidly thaw the TnT T7 PCR Quick Master 
Mix by hand-warming and place on ice. The other components can be thawed 
at room temperature. 
• Freeze immediately with liquid nitrogen unused Master Mix  to minimize loss of 
translational activity 
• Assemble the reaction components in a 1,5 ml microcentrifuge tube (safe 
lock): 
• TNT T7 PCR Quick Master Mix    40 µl 
• [35S] methionine (1,000Ci/mmol at 10mCi/ml)    4 µl 
• PCR-generated DNA template      5 µl 
• Nuclease-free water       1 µl 
Total Volume      50 µl 
• After addition of all the components, gently mix by pipetting 
• Centrifuge briefly and incubate the reaction at 30°C for 60-90 min 
• Analyze translation results by means of SDS-PAGE and autoradiography 
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GST Pull-Down 
 
Required material: 
 
• GST-fusion protein bound to sepharose beads 
 
• Pull-Down (PD) Buffer 
 
  20 mM Tris pH 7,5-8.0 
    1 mM ß-mercaptoethanol 
    3 mM EDTA 
150 mM Na2Cl 
    1 % NP40 (leave also one fraction without detergent!) 
 
Procedure: 
 
• Take between 10-100µl GST-protein (according to the amount of protein) 
bound to the slurry sepharose beads 
• Add 200µl PD buffer + 4-8µl  radioactive labelled in vitro translation product  
• Rotate for 2 hrs at 4°C 
 
Wash 
• 1 x PD buffer  
• 4 x PD buffer with 0,1% NP40 
• 1 x PD buffer with no detergent 
• Between each step rotate 10 min at 4°C and centrifuge at 1500 rpm at 4°C 
• Add 40µl of 1x protein sample buffer 
• Freeze at -20 °C or load 10-20µl on a SDS PAGE 
• Analyze with autoradiography 
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Site directed mutagenesis using the QuickChange Method 
(Statagene) 
 
Methodical Scheme: 
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Primer Design: 
 
The mutagenic oligonucleotide primers for use in this protocol must be designed 
individually according to the desired mutation. The following considerations should be 
made for designing mutagenic primers: 
 
• Both of the mutagenic primers must contain the desired mutation and anneal 
to the same sequence on opposite strands of the plasmid. 
• Primers should be between 25 and 45 bases in length, with a melting 
temperature (Tm) of ≥78°C. Primers longer than 45 bases may be used, but 
using longer primers increases the likelihood of secondary structure formation, 
which may affect the efficiency of the mutagenesis reaction. 
The following formula is commonly used for estimating the Tm of primers: 
 
     Tm =m 81.5 +0. 41(%GC) -  675/ N -% mismatch 
 
• N is the primer length in bases 
• values for %GC and % mismatch are whole numbers 
 
• The desired mutation (deletion or insertion) should be in the middle of the 
primer with ~10–15 bases of correct sequence on both sides. 
• The primers optimally should have a minimum GC content of 40% and should 
terminate in one or more C or G bases. 
 
Primers used: 
 
Ypt35-PX Y123G mutation: 
Forward : 
CCA AAC CTA TAA ACG AGC CTC CGA TTT CGT CAG  
Tm=81,5 + 0,41 * 48,5%GC-675/33 -6% mismatch = 74,9°C 
Reverse : 
CTG ACG AAA TCG GAG GCT CGT TTA TAG GTT TGG 
Tm=81,5 + 0,41 * 48,5%GC-675/33 -6% mismatch = 74,9°C 
Yip11-2 mutation: 
Forward : 
5’ CAG CGT CCA TCT TAG AAT ACT GCT TTT TGC C 3’ 
Tm=81,5 + 0,41 * 45%GC-675/31 -3,2% mismatch = 75°C 
Reverse : 
5’G GCA AAA AGC AGT ATT CTA AGA TGG ACG CTG 3’ 
Tm=81,5 + 0,41 * 45%GC-675/31 -3,2% mismatch = 75°C 
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Yip1 K87A T88A K89A mutation: 
Forward : 
5´C GAT CAT ATC ATA ACG GCA GCT GCA ATG GTT CTT ATA CC 3´ 
Tm= 81,5 + 0.41 * 43,6% GC -675/39- 12,8% mismatch = 69,27 
Reverse : 
5 CG TAT TGG TAT AAG AAC CAT TGC AGC TGC CGT TAT GAT ATG ATC 3  
Tm= 81,5 + 0.41 * 42.2% GC -675/45- 11,1% mismatch = 72.8 
 
Æ mutated bases shown in bold 
 
       PCR 
 
       Cycling Parameters : 
 
Segment Cycles Temperature Time 
1 1 95°C 30 seconds 
2 12–18 95°C 30 seconds 
  55°C 1 minute 
  68°C 1 minute/kb of plasmid length 
 
Type of mutation  desired Number of cycles 
Point mutations 12 
Single amino acid changes  16 
Multiple amino acid deletions or insertions  18 
 
 
Procedure: 
 
• Add 1µl of the Dpn I restriction enzyme (10 U/µl) directly to each amplification 
reaction 
• Gently and thoroughly mix each reaction mixture by pipetting the solution up 
and down several times. Spin down the reaction mixtures in a microcentrifuge 
for 1 minute and immediately incubate each reaction at 37°C for 1 h to digest 
the parental (i.e., the nonmutated) supercoiled dsDNA 
• Transformation of XL1-Blue Supercompetent Cells (see protocol Preparation 
and Transformation of “Ultra Competent” E.coli Cells) 
• Gently thaw the XL1-Blue 50µl aliquots of supercompetent cells on ice. For 
each sample reaction to be transformed add1µl of the Dpn I-treated DNA from 
each sample reaction 
• Swirl the transformation reactions gently to mix and incubate the reactions on 
ice for 30 min 
• Heat pulse the transformation reactions for 90 sec at 42°C and then place the 
reactions on ice for 2 min 
• Add 0.5ml LB media preheated to 42°C and incubate the transformation 
reactions at 37°C for 1 h with shaking at 225–250 rpm. 
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• Centrifuge at 13 000 rpm for 1 min 
• Resuspend the cells in 200µl H2O and spread cells on LB plates containing 
the appropriate antibiotic 
• Incubate the transformation plates at 37°C for >16 hrs 
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Lipid overlay assay 
 
Required Material: 
 
Phospholipids (Cell Signals) 
Hybond-C extra membrane (Amersham Biosciences) 
Fatty acid-free BSA 
Eluted GST-fusion protein 
Chloroform 
Methanol 
 
TBS 20x Æ + 0,1%Tween 20  = TBST 
 
Tris   60 g 
NaCl 160 g 
KCl     4 g 
pH   7,4 (HCl) 
 
Æ add to 1 L 
 
 
• Spot 1µl of lipid solution (containing 200, 100, 50, 25, 12,5 and 6,25 pmol of 
phospholipids) in a mixture of chloroform/methanol/water (1:2:0.8) on to a 
Hybond-C extra membrane (only this type of membrane works!) and allow to 
dry at RT for 1 h  
 
• Block the membrane in TBST containing 3% (w/v) fatty acid-free BSA for 1h 
 
• Incubate the membrane overnight at 4 °C with gentle stirring in the same 
solution (blocking solution) containing 2µg of the indicated GST-fusion protein  
 
• Wash the membranes six times over 30 min in TBST 
 
• Incubate for 1h the 1st antibody (mouse anti-GST 1:1000) in blocking solution 
 
• Wash the membranes as before and then incubate for 1h with the 2nd 
antibody-HRP (goat anti-mouse 1: 5000) in blocking solution 
 
• Wash the membranes 12 times for 5 min in TBST 
 
• ECL:  - Mix 1 vol. of solution A and 1 vol. of solution B 
- Pipette the mixture on to the blot and let activate for 1 min 
- Put between blot and film a cling film and expose 
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Peptide Synthesis 
 
Required Materials: 
 
Whatman paper (hardened low ash Nr. 1450 917) 
DMF (Dimethylfromamide) 
NMP (N-methyl pyrrolidone) 
DIC (Diisopropyl carbodiimide) 
Piperidine (20% in DMF) 
HOBt (Hydroxy Benzotriazole) 
Fmoc-AA-OH 
Fmoc-β−Ala-Opfp  
Acetic Anhydride 
TFA (Trifluoroacetic acid) 
Ethanol 
TIBS (Triisobutylsilane) 
dH2O 
NMI (1-Methylimidazole) 
Triisoporpylsilan 
 
β−Alanine membranes 
 
• Cut 10x15 cm Whatman paper 
• Incubate in a metal dish following solution: 
β-alanine OH      2,56 g 
DMF      40      ml 
DIC   1496     µl 
NMI   1270     µl 
 
• Incubate 20ml pro membrane overnight shaking gently 
• Wash 3 x with DMF 
• Incubate membranes 20 min with 20% piperidine (removal of F-moc group) 
• Wash 5 x in DMF 
• Wash 2 x in EtOH 
• Let dry overnight 
 
Amino Acids (AA) Aliquots 
 
• Weigh 0,5mmol AA  
• Add for each AA 1ml of HOBt (2.3 g in 20 ml NMP) 
• Solve AA and fill up to 1.5ml with NMP  
• Store at -20°C 
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Peptide Synthesis 
 
Day 1 
 
• Thaw AA overnight at RT 
 
Day2 
• Activate AA with 240µl Activation Stock Solution: 
       0.4 ml DIC 
       2.0 ml NMP 
       2.8 ml DMF 
 
• Mix AA and activate for 30 min at RT 
• Centrifuge 3 min at 4000 rpm 
• Pipet solution (avoiding precipitated AA) to the synthesizer vials in correct 
order 
• Fill up: 
DMF 
Ethanol 
20% Piperidine solution 
Capping solution: 0.3ml Acetic Anhydride in 15ml DMF 
• Activate membrane in DMF 
• Start Program 
• For β-alanine membranes spacer spotting solve 0,0573g Fmoc.β.Ala-Opfp in 
400µl DMSO 
• Thaw ON AA aliquots 
Day 3 
• Activate AA 
• Discard old vials and pipet AA into new ones 
• Fill up Capping and Piperidine solutions 
• Thaw AA overnight at RT 
Day 4 
• Activate AA 
• Discard old vials and pipet AA into new ones 
• Fill up Capping and Piperidine solutions 
• Thaw AA overnight at RT 
• Let membrane dry overnight 
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TFA removal of all side chain protecting groups (for β-Alanine membranes) 
 
• Incubate the membranes without shaking in 90% TFA solution 
         0.5 g Phenol 
         1    ml dH2O 
         1.5 ml TIBS 
         2.5 ml DCM 
       45    ml TFA 
• Wash 4x 3 min with DCM 
• Wash 3x 3 min with DMF 
• Wash 3x 3 min with EtOH 
• Let Dry 
 
• Incubate the membranes without shaking in 50% TFA solution 
         0.5 g Phenol 
         1    ml dH2O 
         1.5 ml TIBS 
       22.5 ml DCM 
       25    ml TFA 
• Wash 4x 3 min with DCM 
• Wash 3x 3 min with DMF 
• Wash 3x 3 min with EtOH 
• Let Dry 
 
 
TFA removal of all side chain protecting groups (for PEG membranes = Intavis 
membranes) 
 
 
• Pro membrane:  9    mlTFA 
0.5 ml Triisoporpylsilan 
0.5 ml dH2O 
• Incubate for 1 h in the mixed solution, shake gently in between 
 
• Wash 4x 3 min with DCM 
• Wash 3x 3 min with DMF 
• Wash 3x 3 min with EtOH 
• Let Dry 
 
Positive control peptides 
 
• Three control peptides that bind to the anti-GST antibody were used: 
1. QRALAKDLIVPRRP 
2. LAKDLIVPRRPEWN 
3. DLVIRPPRPPKVLGL 
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Protein Incubation 
 
• Activate the membrane 10 min with methanol 
• Wash 3 x 5 minwith 1x TBS 
10x TBS 
    Tris base   24.2 g 
    NaCl  292.2 g 
    pH to 7.5 with HCl 
 
• Block 3 hrs with  Blocking Solution 
       1 g skim powder milk 
    2.5 g Saccharose 
    In 50ml 1 x TBS 
 
• Incubate protein 10 µg/ml in blocking solution (- Tween) overnight rotating at 
4°C 
• Wash 3 x 5 min with 1x TBS 
• Incubate 3 hrs at RT with 1st antibody in blocking solution + 0.05% Tween 
• Wash 3 x 5 min with 1x TBS 
• Incubate 1.5 hrs at RT with 2nd antibody in blocking solution + 0.05% Tween 
• Wash 3 x 5 min with 1x TBS 
• ECL:  - Mix 1 vol. of solution A and 1 vol. of solution B 
- Pipete the mixture on to the blot and let activate for 1 min 
- Put between blot and film a cling film and expose 
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Pulse + Chase Immunoprecipitation  
 
Required Material: 
 
 50x Chase Mix 
50 mM Methionine 
  5 mM Cysteine 
in dH2O 
Filter sterilize and store up to 1 year at -20°C in small aliquots 
 
Detergent IP buffer 
  50    mM Tris-HCl, pH7.5 
    0.1 mM EDTA 
150    mM NaCl 
    0.5 % (w/v) Tween 20 (polyoxyehtylenesorbitan monolaurate) 
Store up to 3 months at 4°C 
 
Detergent/Urea Buffer 
100    mM Tris-HCl, pH7.5 
200    mM NaCl 
    0.5 % (w/v) Tween 20 (polyoxyehtylenesorbitan monolaurate) 
    2     M Urea 
Store up to 3 months at 4°C 
 
SDS/Urea Buffer 
50 mM Tris-HCl, pH7.5 
  1 mM EDTA 
  1 % SDS 
  6 M Urea 
Store up to 1 month at RT 
 
Procedure: 
 
• Grow strains overnight in 5ml YEPD at 30°C. In the morning back-dilute 
cultures to ~0.25ODs/ml in 5ml media and again place at 30°C until cells 
reach an OD600 of ~1.0ODs/ml 
• Harvest cell (~1.5 ODs for each time point of chase) and wash 1 time with 5ml 
sterile dH2O  
• Resuspend in enough SC-Methionine media so that you have 1ml for each 
time point 
• Place at 30°C for 20 min 
• Add ~10µl per ml of 32S-Methionine. Place at 30°C for 5 min (a short pulse in 
necessary) 
• After 5 min pulse, add 20µl per ml of 50X Chase Mix to each tube 
• Immediately transfer 1ml of each to tubes containing 250µl 50% TCA 
(trichloroacetic acid) and keep on ice (this is the 0 time point) 
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• Place the remaining culture at 30°C for desired time (CPY is maturated by 10 
min in a WT strain). At each desired time point transfer 1ml of each to tubes 
containing 250µl of 50% TCA and keep on ice 
• Incubate TCA mixtures on ice for at least 20 min 
• Centrifuge at 14000 rpm for 10 min 
• Aspirate supernatants into radioactive waste trap and wash pellets 1x with 1ml 
ice cold acetone 
• Centrifuge 14000, 10 min 
• Aspirate supernatants and allow pellets to air dry (~5 min) 
• Resuspend the pellets in 100µl SDS Urea Buffer and incubate at RT for 15 
min 
• Add glas beads (0.1- 0.25 mm) to 80%-90% (v/v) of the sample volume 
• Vortex samples for 1min 
• Heat at 95°C for 5 min and vortex again for 30 sec 
• Add 900µl detergent IP buffer, vortex and put samples on ice for minimum 20 
min 
• Centrifuge samples at 14 000 rpm for 15 min and transfer ~850µl of the 
supernatants 8lysate) to fresh tubes being careful not to disturb the glass 
beads or any insoluble material pelleted. 
• Add 2µl of CPY/Kex2 or any other antibody to each sample and incubate at 
4°C with rocking overnight 
• Add 30µl Protein-G-Sepharose (protein G has much higher affinity to mouse 
IgG monoclonal antibodies than protein A) to each and incubate at 4°C for 2 
hrs 
• Pellet immune complexes by centrifuging at 14 000 rpm 
• Transfer the supernatant to new labelled tubes (these supernatants can be 
used to immunoprecipitate a different protein, for eg. ALP, PrA etc) 
• Wash the pellets (beads) 2 x with 1ml detergent/urea buffer and 1x with 
detergent IP buffer 
• Resuspend the beads in 50µl 1x SDS sample buffer and heat at 95°C for 10 
min  
• Load half the sample on to a 10% SDS-PAGE gel (run the gels as usual). 
• Save the remainder of the samples at 20°C in case the electrophoresis has to 
be done again 
• Soak the gels for 20 min in 1M Salicylic Acid with 2% glycerol 
• Dry gels at 80°C for 2 hrs 
• Expose gels to film. Usually a ~3 day exposure is sufficient for a nice signal 
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Yeast protein extracts 
 
Required material: 
• Yeast overnight culture 
• Liquid nitrogen 
• 2X protein sample buffer 
 
For 100ml 
Glycerol (20%)   20    ml 
SDS (20%)   20    ml 
β-mercaptoethanol (10%) 10    ml 
1M Tris-HCl pH 6.8  12,5 ml 
H2O      5    ml 
Bromphenol blue  a small spatula tip 
 
Procedure: 
• Collect 4ml of yeast overnight culture (in YEPD) at 3500 rpm for 5 min 
• Wash the cells with 1ml H2O 
• Resuspend the cells in 200µl 2x protein sample buffer 
 
• Heat resuspended cells for 3 min at 95°C 
• Vortex 45 sec      Repeat procedure 4 
times 
• Freeze immediately in liquid nitrogen  
 
 
• Load 5µl on a SDS-PAGE or store at -70°C 
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Western Blot Transfer (semi-dry) 
 
Required material: 
 
• Transfer buffer 
 
Tris Base     3.03 g 
Glycine   14.27 g 
Methanol 200      ml 
 
Æ add to 1 l with dH20 
 
• Ponceau S (commercial) 
• Blot Chamber 
• Whatman paper 
• Nitrocellulose membrane (Immobilon-P, Millipore) 
 
Procedure: 
 
• Cut blot paper (8 sheets of Whatman paper per gel) and to the size of your gel 
and equilibrate in transfer buffer 
• Cut blotting membrane to the size of your gel,shortly activate in methanol and 
equilibrate in transfer buffer 
• Disassemble electrophoresis chamber, lift short plate form saucer plate and 
carefully transger gel (cut off stacking gel) into a tray with transfer buffer, 
shortly equilibrate 
• Build up blot:  To bottom platinum anode of Trans-Blot-Semi-Dry-place: 
Pre-wet filter paper (4 sheets of Whatman paper) 
Pre-wet membrane 
Gel 
Pre-wet filter paper (4 sheets of Whatman paper) 
Roll out air bubbles 
• Secure safety cover and connect to power supply 
• Run 1 gel at 15V for 45 min, 2 gels at 20 V for 45 min 
• Stop transfer, discard filter paper and briefly wash blot in dH2O  
• Check transfer by staining blot in Ponceau S solution and destain in dH2O 
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Western Blot Detection 
 
Required material: 
 
10x TBS 
Tris base   24.2 g 
NaCl  292.2 g 
 
pH to 7.5 with HCl 
 
Æ add to 1 liter dH2O and autoclave 
 
TBST 
1xTBS with 0,05% Tween-20 
1%-, 2%,-3% TBSTM 
Dissolve skim milk powder to 1%,2% and 3% in TBST, prepare fresh 
 
• Block the membrane (in a Falcon tube and roll, or in a dish and shake gently) 
in 10ml 3%TBSTM for 30 min at RT 
• Wash 3 times with 1%TBSTM for 5 min each wash 
• Replace 1%TBSTM with 2%-TBSTM and add primary antibody  
• Incubate the membrane overnight at 4 °C with gentle shaking  
• Wash the blot once with 1%TBSTM for 10 min 
• Wash 2 times with 1%TBSTM for 5 min each wash 
• Replace 1%TBSTM with 2%-TBSTM and add secondary antibody 
• Incubate for 1h at RT (rolling or gently shaking) 
• Wash 3 times in 10ml TBST for 10 min each wash 
• ECL:  - Mix 1 vol. of solution A and 1 vol. of solution B 
- Pipete the mixture on to the blot and let activate for 1 min 
- Put between blot and film a cling film and expose 
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Lucifer yellow assay 
 
Required materials: 
 
• Lucifer Yellow CH Dilithium salt (Fluka 62642) 
• Low melting agarose 
• Succinate Buffer 
50 mM succinate-NaOH, pH 5.0 
20 mM NaN3 
 
Procedure: 
• Grow yeast cell to stationary phase on YEPD media at 30°C during 2 days 
• Inoculate 5-10µl of this overnight culture to 50 ml YEPD and shake at 30°C 
• After ~15 hrs they should have reached an OD of 1.5  
• Collect 1ml of cell suspension (3 min at 3500 rpm) and resuspend in 80µl 
YEPD 
• Add 20 µl of Lucifer Yellow solution (8 mg/100µl H2O solved 5 min at 30°C) 
• Incubate at 30 °C for 1 hr 
• Wash the cells 3 x in 1ml ice-cold succinate buffer 
• An equal volume of cells (usually 3-4µl) is mixed with a 1.6% low melt agarose 
(precooled to 45°C) on a microscope slide that can be kept on ice until 
observation under the microscope 
• Lucifer Yellow CH can be visualized by fluorescence microscopy using FITC 
optics 
• Filters: exitation 450-490nm, FT510, LP520 
• A defect in accumulation of LY in the vacuole can only be proven in cells that 
contain vacuoles visualized by Nomarski optics 
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Results 
 
Yeast two-hybrid data 
Previous two-hybrid data (Uetz et al. 2000) suggested that PX domains may act as 
protein interaction domains, although it should be noted that even the yeast ‘PX 
domain only’ proteins Grd19p and Ypt35p contain some additional sequences in 
addition to the PX domain itself. To extend previous findings and to investigate a 
possible role of the PX domain as a bona fide interaction module, all yeast PX domain-
containing proteins and their isolated PX domains were screened against a S. 
cerevisiae whole-genome two-hybrid array which contains most yeast open reading 
frames as Gal4 activation domain fusions (Uetz et al. 2000).  Since two-hybrid 
interactions often suffer from low reproducibility all screens were performed twice and 
only double positives were considered as positive interactions. Double positive 
interactions and selected single interactions of interesting candidates were reanalyzed 
several times in a retest plate, and finally quadruplicate colonies were screened to 
ensure that none of them had arisen by random activation events. Representative 
results of these screens are shown in Figures 13 and 14 for the baits Ypt35p and 
Grd19p respectively. A summary of all interactions is shown in Figure 15 and Tables 6 
and 7. In order to reflect various degrees of reproducibility, one of three scores (S) was 
assigned to the interactions in our datasets (Table 6, see Experimental Procedures for 
details). We found 27 highly reproducible interactions, denoted by S values of 3 in 
Table 2, 18 well-reproducible interactions (S=2), and 30 interactions that were 
reproduced several times but not consistently (S=1). This classification serves as a 
rough indication for the reliability of our interactions and may roughly correlate with the 
strength of the interactions. A representative result of this classification is shown in 
Figure 12. 
Bait: Ypt35p 
 
Prey  Score 
 
Rbd2p     3 
Yor292p    2 
Tvp23p     2 
Ktr3p     1 
Spsp18p    1 
Figure 12: Quadruplicate retest plate with Ypt35p as a bait  
Representative result for the reliability and possible interaction strength correlation of obtained 
interactions. Rbd2p (S=3), Yor292p (S=2), Tvp23 (S=2), Ktr3p (S=1) and Sps18p (S=1). See text for 
details. 
 
Out of the 75 interactions listed in Table 6, 17 have been published before (Table 6). 
The majority of those, 14, belong to scores 2 and 3, which confirms their validity. 
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 Prey S GO keyword R 
Bem1p 
 Cdc24p 2 cell polarity * I 
Grd19p 
 Adh1p 1 fermentation  
 Akr2p 1 unknown  
 Apg17p 1 autophagy  
 Rbd2p 3 unknown  
 Rvs167 1 endocytosis*  
 Sec15p 1 cell polarity*  
 Yif1p 3 ER-Golgi transport  
 Yip1p 3 vesicular transport  
 Yip5p 3 vesicular transport  
 Ylr031p 1 unknown  
 Ylr424p 1 splicing  
 Ypt53p 2 vacuolar targeting*  
Mvp1p 
p Std1p 1 Pol II transcript.*  
p Yra2p 2 mRNA export  
Snx42p 
p Rrn10p 2 Pol I transcription U 
 Snx4p 3 Vesicular transport* U 
 Yip1p 1 Vesicular transport  
Snx4p 
 Apg17p 1 autophagy I 
 Ask10p 2 transcription  
 Cog2p 3 ER to Golgi transport*  
 Cog6p 3 intra-Golgi transport  
 Dam1p 1 spindle assembly   
 Ecm11p 3 cell wall biogenesis  
 Lcp5p 1 rRNA modification*  
 Nip100p 3 mitotic anaphase B  
 Sds3p 3 histone deacetylation*  
 Sec15p 3 cell polarity *  
 Sgt1p 1 complex assembly*  
 Snx41p 3 protein transport I 
 Snx42p 3 vacuolar targeting*  
 Swf3p 1 mitochondria  
 Vma8p 1 vacuolar acidification  
 Vps17p 3 Endosome-Golgi tr.  
 Ylr031p 3 unknown  
 Ylr424p 1 mRNA splicing  
 Ynl086p 3 unknown  
 Ypl201p 1 unknown  
P Prey S GO keyword R 
Vam7p 
o Akr2p 1 unknown  
 Avt2p 2 transport  
o Bsp1p 3 actin cytoskeleton*  
 Ecm11p 2 cell wall biogenesis  
o Rbd2p 1 unknown U 
 Rpt5p 2 protein catabolism  
 Spc72p 2 Chromos. 
ti *
U 
 Vps21p 1 vacuolar targeting*  
 Ygr223p 3 unknown  
o Yif1p 3 ER to Golgi transport U 
o Yip1p 3 vesicular transport  
 Yip5p 2 vesicular transport U 
Vps17p 
p Akr2p 1 unknown  
p Bsp1p 1 actin cytoskeleton*  
 Vps5p 3 Golgi retention* U 
p Yif1p 2 ER to Golgi transport  
p Yip1p 2 vesicular transport  
p Ypt53p 1 vacuolar targeting*  
Vps5p 
 Bub1p 1 Protein phosphoryl.*  
 Vps17p 2 endosome -> Golgi U 
 Vps35p 2 Golgi retention* S 
 Ynl086p 1 unknown  
Ypt35p 
 Akr2p 3 unknown U 
 Atr1p 1 multidrug transport  
 Bet1p 1 ER to Golgi transport*  
 Bos1p 2 ER to Golgi transport  
 Ktr3p 1 cell wall biogenesis* U 
 Pep12p 1 Golgi-vacuole 
t t
 
 Rbd2p 3 unknown U 
 Sps18p 1 sporulation  
 Tvp23p 2 unknown  
 Yif1p 3 ER to Golgi transport U 
 Yip1p 3 vesicular transport  
 Yip4p 3 vesicular transport  
 Yip5p 3 vesicular transport U 
 
  
Table 6:  
Two-hybrid interactions of the yeast PX proteins 
P = PX domain, [no symbol]: interaction has been obtained only with the full length protein but note 
that Grd19p and Ypt35p are essentially PX-only proteins, [o]: interaction obtained with both full length 
protein and its PX domain, [px]: interaction has been obtained only with its PX domain. S = two-hybrid 
quality score: [3] highly reproducible with strong signal, [2] reproducible, [1] reproduced several times 
but not consistently. Asterisks (*) indicate proteins with multiple functions. R: Published interactions 
and their references [I =(Ito et al. 2001), U = (Uetz et al. 2000), S = (Seaman et al. 1998)].          
 Ymd8p 2 nucleotide-sugar 
t Yor292p 2 unknown 
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Preys Baits 
 Bem1 Grd19 Mvp1 Snx4p Snx42 Vam7 Vps5p Vps17 Ypt35
Adh1p  1        
Akr2p  1    1-1  0-1 3 
Apg17p  1  1-0      
Ask10p    2-0      
Atr1p         1 
Avt2p      2-0    
Bet1p         1 
Bos1p         2 
Bsp1p      3-1  0-1  
Bub1p       1-0   
Cdc24p 2-0         
Cog2p    3-0      
Cog6p    3-0      
Dam1p    1-0      
Ecm11    3-0  2-0    
Ktr3p         1 
Lcp5p    1-0      
Nip100    3-0      
Pep12p         1 
Rbd2p  3    1-1   3 
Rpt5p      2-0    
Rrn10p     2-0     
Rvs167  1        
Sds3p    3-0      
Sec15p  1  3-0      
Sgt1p    1-0      
Snx41p    3-0      
Snx42p    3-0      
Snx4p     3-0     
Spc72p      2-0    
Sps18p         1 
Std1p   0-1       
Swf3p    1-0      
Tvp23p         2 
Vma8p    1-0      
Vps17p    3-0   2-0   
Vps21p      1-0    
Vps35p       2-0   
Vps5p        3-0  
Ygr223      3-0    
Yif1p  3    3-3  0-2 3 
Yip1p  3   1-0 3-3  0-2 3 
Yip4p         3 
Yip5p  3    2-0   3 
Ylr031p  1  3-0      
Ylr424p  1  1-0      
Ymd8p         2 
Ynl086    3-0   1-0   
Yor292         2 
Ypl201    1-0      
Ypt53p  2      0-1  
Yra2p   0-2       
  
 
Table 7:  All PX protein interactions in a matrix format
Numbers indicate involvement of the PX domain in interactions; e.g. 3-0 = score 3 with full length protein 
and score 0 (= no interaction) with PX domain; only one number is provided for PX-only proteins 
(Grd19p and Ypt35p).                                          -65-
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Further comparison of obtained interactions were done by looking at the several 
large-scale projects which have attempted the systematic isolation and identification 
of protein complexes in yeast (Gavin et al. 2002; Ho et al. 2002; Hazbun et al. 2003). 
Surprisingly few of them recovered any PX domain proteins (see appendix Table I) 
and their interactions did not turn out to be very informative for those complexes of 
which PX proteins have been demonstrated to be involved in, such as Vps17p and 
Vps5p which form part of the retromere complex (Fig.52), were not isolated by these 
methods. 
A number of interactions have been reported for PX proteins that we failed to identify 
(false negatives, see appendix Table II). It is difficult to explain this discrepancy but it 
has been shown that differences in strains, plasmids, or reporter genes may account 
for these results. 
 
More detailed information on baits and preys with localization and GO (Gene 
Ontology) annotations, links to SGD, Interpro, and PDB are provided at 
http://itgmv1.fzk.de/www/itg/uetz/domains/PX/. 
 
 
Full-length vs. domain interactions 
Of the 15 PX domain proteins in yeast, 9 showed a total of 67 two-hybrid interactions 
when they were screened as full-length proteins (Table 6). No reproducible 
interactions were found for 5 proteins (Bem3p, Mdm1p, Spo14p, Ykr078p, and 
Ypr097p). Snx41p was not investigated further because it turned out to be a very 
strong transcriptional activator, even under high 3AT concentrations. 3-aminotriazole 
(3AT) acts as a competitive inhibitor of the HIS3 encoded gene (the reporter gene 
used in our two-hybrid system) and can be used to increase the growth threshold of 
the host strain. Under these conditions it is expected that even if the bait (DBD-ORF) 
activates HIS3 to some extend, the interaction with a prey (AD-ORF) leads to more 
expression to overcome the growth threshold imposed by 3AT. This strategy is not 
always successful, especially for strong self-activators. 
When the isolated PX domains were used as bait, only those from Mvp1p, Snx42p, 
Vam7p, and Vps17p showed a total of 13 reproducible interactions (Table 6). 
Bem1p, Snx4p, and Vps5p interacted in the assays only as full-length proteins, that 
is, their PX domain did not interact with any other protein in my two-hybrid array. This 
indicates that other parts/domains of these proteins mediate their interaction.  
Grd19p and Ypt35p were tested only as full-length proteins as they consist almost 
exclusively of their PX domains. However, their two-hybrid interactions were 
confirmed with PX-only constructs in vitro (see below). In case of Mvp1p no 
interactions were found for the full-length protein, while its PX domain surprisingly 
interacted with two nuclear proteins, Std1p and Yra2p. 
Finally, for Snx42p, Vam7p, and Vps17p different, but specific, interactions with both 
the full-length protein and the isolated domain were obtained. Interestingly, only 
Vam7p yielded interactions that were found with both the full-length protein and its 
PX domain. 
Since only 8 interactions were found with the PX domain but not the corresponding 
full-length protein, I conclude that full-length proteins often prevent interactions, 
possibly due to their fusion with the Gal4 domain. Whatever the mechanistic reason 
may be, this indicates that I may have missed a significant number of interactions 
despite my comprehensive approach. Such false negatives may be prevented by 
more extensive usage of domains as baits. 
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The nature of PX protein interactors 
As expected from the role of many PX domain-containing proteins such as sorting 
nexins, the identified preys were enriched in proteins known to be involved in 
vesicular transport (36% of preys as opposed to 5% in the whole genome).  
Interestingly, a relatively large fraction of interactors were uncharacterized proteins 
(20% vs. 30.5%). All other functional classes combined made up 44% of all preys 
(whole genome: 64%) (Fig.16). 
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 Figure 16: Gene Ontology distribution of interacting partners vs. whole yeast genome  
GO (biological function) terms provided from SGD (Dwight et al. 2004). 
 
ilarly, when localization data was analyzed in contrast to functional annotation, 
majority (50%) of preys has been localized to the secretory or endocytic pathway, 
is, to the ER, Golgi, endosomes, or the vacuole. Hence 53% of preys 
esented membrane or membrane-associated proteins which was somewhat 
pected because membrane proteins are often said to resist detection in two-
id screens. Another unexpected finding was that Snx4p, Snx42p, and Mvp1p all 
acted with a significant number of nuclear proteins. 
ingle domain or motif was common among our preys. However, some domains 
 significantly enriched. Four PX domain-containing proteins bind to another PX 
ain protein, resulting in 4 pairs: Vps17p-Vps5p, Vps17p-Snx4p, Snx4p-Snx42p, 
Snx42p-Snx41p. However, since the PX domain-only baits do not reproduce 
e interactions, this reflects characteristics of other parts of these sorting nexins - 
icularly their coiled-coil regions, which have been shown to drive homo- and 
ro-oligomerization in other studies. This finding has been confirmed 
pendently in a study of the Vps17p-Vps5p interaction (Seaman and Williams 
). 
table class of preys consists of the Yip1 family of proteins (Calero et al. 2002). 
 out of the 9 productive PX proteins (Ypt35p, Vam7p, Grd19p, Vps17p, Snx42p) 
acted with at least one member of the Yip1 family, and these interactions were 
ed by the PX domain as assessed using PX domain-only baits and/or by in vitro 
action studies (see below). 
r domains that were found repeatedly among PX protein interactors were the 
RE domain (in Ypt35p interactions with Bet1p, Bos1p, and Pep12p), the Rab 
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domain (Vps17p-Ypt53p, Grd19p-Ypt53p, Vam7p-Vps21p), and PH domains (Snx4p-
Ask10p, Bem1p-Cdc24p). However, none of these interactions seems to involve the 
PX domain as only the full-length baits but not the PX-only baits detect those preys. 
 
In vitro data 
 
PX domains interact with members of the Yip1 family in vitro 
Given the surprisingly strong interactions of PX domains with the highly hydrophobic 
Yip1 family members in the two-hybrid screens, I wanted to verify these results by in 
vitro binding assays. All yeast PX domains that were positive in the two-hybrid 
screens were expressed as GST fusion proteins in E. coli and purified on 
Glutathione-Sepharose beads. Note that the Mvp1p and Vam7p PX domains could 
not be tested because they were either unstable or insoluble. Yip1p, Yip4p, and Yif1p 
were translated and 35S-labelled in vitro, and incubated with the GST-PX fusion 
proteins. Yip5p could not be tested because its in vitro translation repeatedly failed. 
The in vitro binding assays clearly show that Yip1 family members bind specifically to 
certain PX domains (Fig. 17). The strongest interaction was shown for Ypt35-PX 
which interacted strongly with Yif1p, and somewhat less with Yip1p and Yip4p. 
Vps17-PX showed a similar binding pattern, although the overall binding strength 
appears to be weaker. Snx4-PX only bound significantly to Yip4p. The PX domains 
from Snx42p preferred Yip1p over Yif1p, while the Vps5p PX domain appeared to 
bind most strongly to Yif1p. The in vitro interactions of isolated PX domains with Yip1 
family members are summarized in Table 8. 
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Figure 17: PX domains bind to Yip family members in vitro 
Various GST-PX domain fusion proteins were tested for Yip1p, Yif1p and Yip4p binding in vitro. 
Pictures on top of each panel show Coomassie Blue-stained GST fusion proteins while bottom rows 
show autoradiography of bound Yip proteins (see Experimental Procedures for details). Yip1p and 
Yif1p bound equally strong to the Ypt35-PX domain while Yip4p bound only weakly. Yif1p and Yip1p 
were also bound by Vps17p and Vps5p PX domains and weakly by Snx42 PX domain. Yip4p was 
additionally bound by the PX domains Snx4p and Vps17p. I: Input (1µl of in vitro translated protein), L: 
Ladder (molecular mass marker). Only ¼ of each pull-down probe was loaded on to the gel. 
 
  Preys  
GST Yip1p Yip4p Yif1p 
Ypt35-PX ++ + ++ 
Vps17-PX + (+) + 
Snx4-PX - ++  * - 
Mdm1-PX - - - 
Grd19p -  2H - (-/+) 2H
Snx42-PX + ** - (+)  *
Vps5-PX (+) - + 
Bem1-PX - - - 
Bem3-PX - - - 
Table 8: Results of GST-pull-down experiments 
++: Very strong interaction; +: Strong interaction; 
(+): Weak interaction; -: no interaction 
2H: Two-hybrid positive interaction; *: No two-
hybrid interaction; **: No two-hybrid interaction with 
PX bait. 
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Comparison of two-hybrid and in vitro binding data 
The in vitro binding data presented in Figure 17 largely supported our two-hybrid 
results. However, there were a few notable differences: Yif1p clearly bound to Vps5-
PX in vitro, whereas our two-hybrid screens did not identify any Yip1 family 
interactions with Vps5p as bait. Similarly, Snx4-PX appeared to interact with Yip4 in 
vitro, but not in our two-hybrid screen. 
By contrast, Grd19p interacted strongly with Yif1p, Yip1p, and Yip5p in a two-hybrid 
assay, but binding was not detectable in vitro (except perhaps Yif1p). 
Finally, we observed one two-hybrid interaction, Snx42p-Yip1p, only with the full-
length bait (but not the PX-only bait), although Snx42-PX interacted weakly with 
Yip1p and Yif1p in vitro (Fig. 17, Table 8). 
 
Mapping of the interacting regions 
Ypt35-PX binds to Yip1 and Yif1 N-Terminus 
Yip1 family members are extremely hydrophobic proteins with 2-5 predicted 
transmembrane domains. The only significant cytoplasmic part is an N-terminal 
domain of approximately 100-150 amino acids that is conserved among Yip proteins 
(Calero et al. 2002), (Fig.18).  
 
 
Hydrophobic 
Hydrophillic 
Yip1p 
Yif1p 
Yip4p 
Yip5p 
 
 
Figure 18: Prediction of m
       Yip4p and Yip5
TMpred plots were genera
maximal length of the hy
relative location of the hy
cytoplasmically oriented N
membrane-spanning/inser
 0        50      100      150     200     250     300  Æ amino acids 
embrane spanning regions and their orientations for Yip1p, Yif1p,  
p 
ted using the program TMpred with a 17 residue minimal and 33 residue 
drophobic part of the transmembrane helix. The TMpred plot shows the 
drophobic/hydrophilic segments of the protein Sequence data indicate a 
-terminus and a hydrophobic C-terminal domain with several potential 
tion segments (Calero et al. 2002). 
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Since the N-Terminal domain of Yip1p and Yif1p is facing the cytosol (Yang et al. 
1998; Matern et al. 2000) and therefore accessible to the PX-domain, I wondered if it 
interacts with PX domains. In vitro translated Yif1p and Yip1p N-terminus indeed 
bound to GST-Ypt35-PX (Fig. 19). Binding assays with the remaining C-terminal half 
of Yip1p also showed some weak binding (Fig. 20). It may be possible that the small 
cytoplasmic loops in the C-terminus of Yip1p contribute to PX binding. 
 
 
 
             Yif1p FL         Yif1p-N-Term                 Yip1p FL           Yip1p-N-T
 
Figure 19: Yip1p and Yif1p N-Terminal fragments bind in vitro to Ypt35-PX 
Ypt35p binds in vitro to the N-Terminal domains of Yip1p (1-112aa) and Yif1p (1-138aa). I: Inp
Ladder (molecular mass marker), FL: Full-length protein, N-Term: N-terminal fragment. <: N-te
fragment. *: Full-length protein which was additionally (to the N-terminal PCR fragment) in
translated due to some remaining contaminating full-length PCR products. 
 
 
 
                                      Yif1p-N-Term             Yip1p-C-Term 
 
Figure 20:  Ypt35-PX binds in vitro to Yip1p N-terminus and weakly to Yip1p C-Terminus 
Ypt35p binds in vitro to the N-Terminal domain of Yip1p (1-112aa) and weakly to its C-terminus
248aa). I: Input, L: Ladder (molecular mass marker), N-Term: N-terminal fragment, C-Ter
terminal fragment. 
 
 
PI-binding site is different from putative protein-protein interaction sites 
The observation that PX domains are involved in protein-protein interactions pos
the question if the PtdIns(3)P binding site also contributes to these interactions
lipids and proteins compete for binding to the same sites in PX domains? I addre
this possibility by introducing a point mutation (Y123A) into the lipid-binding pock
Ypt35-PX which I predicted should impair PtdIns(3)P-binding based on results
an analogous mutation in Vam7p, Snx3p, Cvt20p and Cvt13p (Sato et al. 1
Cheever et al. 2001; Xu et al. 2001; Nice et al. 2002). As shown by the cr
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structure of Grd19p´s PX domain (Fig 21 A), this strongly conserved residue forms 
the floor of the phospholipid binding pocket (Zhou et al. 2003). The Y123A mutation 
did not completely abolish PtdIns(3)P binding by Ypt35p as shown by a protein-lipid 
overlay assay, although its  binding affinity was significantly reduced (Fig. 21 B).  
Importantly, this mutation did not prevent in vitro binding of Ypt35-PX to any of the 
Yip1 family members (Fig. 21 C), although the amount of bound protein appeared to 
be slightly reduced compared with that seen for wild-type protein. Thus, lipid binding 
does probably not interfere with protein-protein interactions in PX domains (although 
the two ligands may cooperate). In addition, this suggests that interacting proteins 
also use a different interaction surface than lipids or at least do not require the critical 
Tyrosine-123 that is involved in binding the phosphate head group of 
phosphoinositides. 
 
A) 
 
Lipid bilayer 
PI(3)P 
R118 
S83 1 3 
K112 
R127 
Y82 R81 
= Y123 in Ypt35 PX 
 
 B) 
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C) 
 
 
 
Figure 21: Protein-protein interaction is independent of PX-domain phospholipid binding 
(A) Crystal Structure of the PX domain of Grd19p. Important conserved residues for lipid binding 
pocket formation are shown in ball and stick display:  R81 (arginine 81:main specific interaction with 
the 3-phosphate group), Y82 (tyrosine 82: floor of the pocket, the face of the inositol ring rests on it, 
analogous to mutation Y127A in Ypt35-PX),  S83 (serine 83: stabilizes hydrogen bond of 3-phosphate 
group), R118 (arginine 118: forms a second salt bridge with the 3-phosphate group), R127 (arginine 
127: forms hydrogen bonds with the 4- and 5-OH groups of PI(3)P ), K112 (lysine 112: close to the 
non-bridging oxygen of the 1-phosphate group) (Zhou et al. 2003). Cartoon represented with the 
Rasmol program (Sayle and Milner-White 1995). 
(B) The affinity of Ypt35-PX and its mutant Ypt35pY123A-PX for PtdIns(3)P were assessed by a protein-
lipid overlay assay. PtdIns were spotted onto a nitrocellulose membrane at different concentrations 
and incubated with 5µg of GST-fusion protein as well as GST alone (data not shown). Binding of the 
proteins was detected with anti-GST antibodies. The Ypt35pY123A-PX mutant exhibits significantly 
reduced binding affinity as no binding was detected at a lipid concentration of 12.5 pmol when 
compared to the wild-type protein which still bound at a concentration of 6.25 pmol. The overall 
binding to PtdIns(3)P of the mutant was therefore reduced by about 3-fold. 
(C) Mutant GST-Ypt35pY123A-PX with partially abolished PtdIns(3)P binding still interacts with Yip1p, 
Yif1p and Yip4p. I: Input, L: Ladder (molecular mass marker). 
 
 
Peptide arrays 
 
To narrow down the interacting region of the Yip1 family members with the PX- only 
protein Grd19p and the PX domain of Ypt35p to the level of the single amino acid, 
peptide arrays have been used. Additionally, other PX domains and non Yip1p family 
members were analysed in order to compare and depict an interacting motif.  
For this purpose peptides were synthesised on cellulose membranes either coupled 
with β-alanine OH as spacer or directly on to commercially available membranes 
from Intavis Bioanalytical Instruments AG (Germany) with incorporated spacer (see 
experimental procedures). Peptides were synthesized with 3 amino acids offsets 
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along the sequence. The membranes were then incubated over night with eluted 
GST-PX fusion proteins or GST alone, and binding was detected via α−GST 
antibodies and chemiluminescence (see experimental procedures). 
  
Yip1 family members 
 
Experimental setup 
To test the reproducibility and reliability of this method we synthesised peptides of all 
Yip1 family members on different membranes. We started to test those two PX 
domains which interacted either with all family members (Ypt35-PX) or with 3 of them 
(Grd19p). We repeated these experiments 3 times for each protein and all family 
members. GST was used as a negative control. These membranes are represented 
in figures 22, 24, 26 and 28. Membranes are positioned on a grid were positive 
peptides are identified by their position.  
 
Recognizing interacting regions 
To have a clear representation of the distribution of positive interacting peptides on 
the predicted structure of Yip1 family members, spots representing the peptides were 
positioned on a schematic representation of Yip1 family proteins (Figures 23, 25, 27 
and 29). The different colours identify the different PX-domains fused to GST. As 
expected from my in vitro results, I find binding peptides on the cytosolic N-termiuns 
of Yip1 family members but also at the C-terminal loops. Yip1p shows the clearest 
binding pattern concentrating its binding at the N-terminal motifs PVGILHALSTKG 
and ITK.  It is possible to restrict this interacting motif to 3 amino acids which are 
shared by all 5 positive peptides (Fig. 22 23). I also observe binding at the loop 
between TM1 and TM2 (Spots B23, 24) which according to the prediction, should not 
be accessible to PX domains for they are facing the Golgi lumen (Fig. 23). Further, 
the binding peptide C24 positioned at the C-terminus of Yip1p should be facing the 
cytosol. It should be kept in mind that the spots B23, 24 and C24 showed also strong 
binding to GST and may be therefore unspecific binding motifs due to the GST fusion 
of PX domains. 
To verify these binding motifs and those of Yif1p, Yip4p, and Yip5p, alanine scanning 
of selected peptides was performed (see mapping to the single amino acid with 
alanine scans). 
PX domain binding peptides of Yif1p, Yip4p and Yip5p are more promiscuous and 
distributed quite uniformly throughout the whole protein. It is therefore more difficult 
to assign a particular PX domain binding motif for those proteins (Figures 25, 27, 29). 
  
Mapping to the single amino acid with alanine scans 
For the analysis of the amino acid residues which are essential for PX domain 
binding, selected peptides were subjected to mutational anlysis by successively 
replacing all 15 amino acids by alanine (alanine walk), (Liu et al. 1999; Bluthner et al. 
2000), (Fig. 23).  
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Figure 23: Schematic representation of PX domain binding sequences on Yip1p  
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  C 23 24    
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Grd19p 
Grd19p 
A18 B3 
INFDHIITKTKMVLI
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INFDHIATKTKMVLI 
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INFDHIITKAKMVLI 
INFDHIITKTAMVLI 
INFDHIITKTKAVLI 
INFDHIITKTKMALI 
INFDHIITKTKMVAI 
INFDHIITKTKMVLA 
 
 
VAPDPLPVGILHALSTKGYPHEPPLLEEIGINFDHIITKTKMVLIPIRFGS
ITKTK
DPLPVGILHALSTKG 
APLPVGILHALSTKG 
DALPVGILHALSTKG 
DPAPVGILHALSTKG 
DPLAVGILHALSTKG 
DPLPAGILHALSTKG 
DPLPVAILHALSTKG 
DPLPVGALHALSTKG 
DPLPVGIAHALSTKG 
DPLPVGILAALSTKG 
DPLPVGILHALSTKG 
DPLPVGILHAASTKG 
DPLPVGILHALATKG 
DPLPVGILHALSAKG 
DPLPVGILHALSTAG 
DPLPVGILHALSTKA 
 
KG 
B) 
A) 
 
K 
G 
Cytosol 
TM1 TM2 
Yip1p 
Golgi lumen 
K
T 
K
A) Amino acid sequence of Yip1p represented as a rectangle (TM: predicted transmembrane 
domains). Coloured spots represent positive interaction of distinct PX domains (see legend) with 
particular peptides (peptides are indicated above, eg. A18 etc). AS: Indicates peptides were alanine 
scans were performed. Box: zoom in section with amino acid sequence. Bars represent peptides 
shifted by 3 amino acids. Thick bars represent positive interactions. Rows of interacting peptides 
indicate interacting region (represented in coloured boxes). Alanine scan information of Yip1p peptides 
A18 and B3 for Grd19p. Replacement for KG with alanine at peptide A18 abolished the interaction. 
For peptide B3 replacement of amino acids KTK abolished Grd19p interaction. This region does not 
overlap exactly with the one obtained from the 5 in a row positive shifted spots (ITK).  
B) Schematic presentation of Yip1p at the membrane with two predicted transmembrane domains. 
The N-terminus has been shown to face the cytosol (Yang et al. 1998). Accordingly the loop between 
TM1 and TM2 would be facing the lumen of the Golgi and therefore not accessible to the PX domain.  
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Figure 24:  PX-Domain mapping on Yif1p peptides 
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Yif1p peptide arrays (118 15meres covering the complete sequence of Yif1p synthesized 
acid offsets) were incubated overnight with GST-PX fusion protein or GST alone resp
right margin). Positive interactions were visualized using α-GST antibodies and chemilu
(see experimental procedures). Different types of membranes are indicated in parenth
right margin. 
Yif1p 
Here alanine scans of several peptides were performed (Fig. 25) wi
contradictory results (Table 9, Fig. 25). As an example, the alanine scans o
B24 and C4, which overlap only by 3 amino acids, are shown in Fig. 25. B
abolishment of the interaction upon mutation of the last two lysines. These
overlap at the beginning of the C4 peptide (shown in green) but the inte
takes place when replaced with alanine. The spatial position of the peptide
the membrane may be responsible for these discrepancies. C4 on the o
loses its interaction with both Ypt35-PX and Grd19p upon replacement 
lysine. This motif can be narrowed down to 6 amino acids (blue rectangle
B) by means of the four positive peptides obtained peptide arrays (C4 to C
The E10 peptide shows a strong binding and a clear alanine scan with th
lysines being important for interaction (Fig. 25 B) although it should be 
lumen of the Golgi according to the predicted topology (Fig. 25 A) and
should not be accessible to the PX domain. 
  
- 78 - Ypt35-PX
(β-Alanine) Ypt35-PX
(Intavis) rYpt35-PX 
(Intavis) Grd19p 
(Intavis) 
Grd19p 
(Intavis) 
Grd19p 
(β-Alanine) 
Gst 
(Intavis) 
with 3 amnio 
ectively (see 
minescence 
eses on the 
th relative 
f peptides 
24 shows 
 two lysins 
action still 
 relative to 
ther hand, 
of the last 
 in Fig. 25 
7, Fig 24).  
e last two 
facing the 
 therefore 
                                                                             RESULTS                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
AS 
Ypt35-PX 
 
Grd19p 
 
GST 
 
A15   20   B 5  6  12 14  15  16 17  22  24 C4   5   6    7  19 22 23       D4     7    8     12 13        E 2   3   4  5     8   9   10  11
TM 2 TM 1 TM 3 Yif1p 
AS AS AS 
AS 
AS 
AS 
RSGAEDDDIHVSISKSTVKKCNYF 
9 
1 E10
8 
D
D
I
H
V
S
I
S
K
S
T
V
K
K
C
Cytosol 
Golgi lumen 
TM1 TM2 TM3 
A) 
B) 
T
Yif1p 
Ypt35-PX  TYFQVSTRYVINKLKLILVPFLNGTKNWQRIMDSGNFLPPRDDVNSPDMYMPIMGLVTYILIWNTQQGLKGSFNPEDLYYKLSS
 C23 B24  
 
 
 
 
  
 
 
S 
Ypt35-PX 
C19  C5 
 Y F Q V S T
Figure 25
A) Schem
N-terminu
facing the
represent
positive i
indicated 
Boxes: zo
acids. Thi
interacting
Peptides 
alanine re
alanine.  
 
 C4 
      
Q G L K G S F N P E D L Y Y K
AS 
Ypt35-PX Ypt35-PX 
C7 
C6 
 K L K L I L V P F L N G T K N
 R Y V I N K L K 
: Schematic representation of PX domain binding sequences on Yif1p  
atic figure of Yif1p at the membrane according to its predicted transmembrane domains. The 
s has been shown to face the cytosol (Matern et al. 2000). Only the 2nd loop would be 
 cytosol and therefore be accessible to the PX domain.  B) Amino acid sequence of Yip1p 
ed as a rectangle (TM: predicted transmembrane domains). Coloured spots represent 
nteractions of distinct PX domains (see legend) with particular peptides (peptides are 
above, eg. A15 etc). AS: Indicates peptides were alanine scans were performed.  
om in sections with amino acid sequences. Bars represent peptides shifted by 3 amino 
ck bars represent positive interactions, peptide numbers are on the side of the bars. Rows of 
 peptides indicate interacting region (represented in coloured boxes).  
marked in red: alanine scan with amino acids in red where interaction has been abolished by 
placement. Peptides in green, expected abolishment of interaction by replacement with 
 
- 79 - C22E
EE1 AS
                                                                             RESULTS                                   
 
Yip4p  
 
1  2 3 4 5 6 7 8 9 10 11 12 13 14  15 16 17 18 19 20 21 22 23 24
 
 
 
 
 
 
 
 
 
 
 
Figure 26:  PX-Domain mapping on Yip4p peptides  
Yip4p peptide arrays (the complete sequence of Yip4p synthesized as 78 15me
offsets) were incubated overnight with GST-PX fusion protein or GST alone r
margin). Positive interactions were visualized using α-GST antibodies and che
experimental procedures). Different types of membranes are indicated in par
margin. 
 
Yip4p 
Yip4p peptides exhibit similar discrepancies as Yif1p (Fig. 26, 
overlap by 3 amino acids and notably in B4, arginine replacem
domain interaction not in B8 (Fig. 27 A). Instead, B8 showed loss
mutated C-terminal lysine, but this amino acid does not affect bind
in an N-terminal positon of peptide B12. The positioning of basic 
terminal seems to play a role. 
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Figure 28: PX-Domain mapping on Yip5p peptides 
Yip5p peptide arrays (116 15meres covering the complete sequence of Yif1p s
amnio acid offsets) were incubated overnight with GST-PX fusion protein or GST 
(see right margin). Positive interactions were visualized using α-GST 
chemiluminescence (see experimental procedures). Different types of membrane
parentheses on the right margin 
 
Yip5p 
Yip5p is a case where overlapping amino acids such as in B10 and B
of the interaction when mutated (C-terminal K in B10 and N-terminal K
A). Clear alanine scans are also obtained at the C-terminus of the pr
loops between the hydrophobic regions.  
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Figure 29: Schematic representation of PX domain binding sequences on Yip5p 
A) Amino acid sequence of Yip5p represented as a rectangle (TM: predicted transmembr
domains). Coloured spots represent positive interaction of distinct PX domains (see legend) w
particular peptides (peptides are indicated above, eg. B4 etc). AS: Indicates peptides were alan
scans were performed. Red amin oacids indicate were the interaction has been abolished thro
alanine replacements. B) Schematic figure of Yip5p at the membrane according to its predic
transmembrane domains. The N-terminus is predicted to face the cytosol based on homology to Yi
and Yif1p (Matern et al. 2000; Calero et al. 2002). Loops 2 and 4 would be facing the cytosol 
therefore be accessible to the PX domain.   
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Figure 30: Peptide array information on yeast Yip1 family multiple alignment 
 
 
      C24:  Peptide position 
           Surrounding  peptide sequence 
Surrounding amino acids whose replacement by alanine abolished the interaction with 
Grd19p and Ypt35-PX 
Transmembrane domain 
 
 
 
  
 
 
 
  
- 84 - 
                                                                             RESULTS                                   
 
       Yip1            Rrn10 
A18  DPLPVGILHALSTKG  2  IPFKTREEIDADVEK 
B3   INFDHIITKTKMVLI         Rbd2 
C24  SGFLNSLLQLQNARL  1 LREDLSLAPESLFKL 
      Yif1      4 YYSFKESQIRPRTRI 
B24  TYFQVSTRYVINKLK  9 DGLIRLIPWGIKYYR 
C4   KLKLILVPFLNGTKN       Ylr031w 
C22  QGLKGSFNPEDLYYK  3 RVRESIKRRQDLEKK 
E4   FLLRSVKFNLLSRSG  6 LFLMLENERRKKSSV 
E10  DDIHVSISKSTVKKC       Ynl086w 
      Yip4      2  ESQALLILMLRKVRD 
B4  ADNIGGTMQNSGSRG  4 KPTMDKLADLSARVR 
B8  SRGTLDETVLQTLKR 
B12  LKRDVVEINSRLKQV 
C4    AFIILYSLFVSHARS 
C12  WFILLVMALHLRLTK Non-polar 
Acidic 
Basic 
Uncharged polar 
D4  LAYHIGKQNRWIVRV 
D13  MWSVAAVSWVTKSK 
      Yip5     
B10  PDSPNMNNSTAGKGS 
C7  YSKYFQIDLTQFKKR 
D7  EDIDRASQFKKLLHS 
D18  LNRDEHSERNRSFKS 
 
Figure 31: PX domains bind peptides with basic C-termini of Yip1 family members 
Peptides which interacted several times with different PX domains (incl. alanine scans in table 9) have 
been selected. Amino acids were coloured according to their properties, red: acidic, green: uncharged 
polar, blue: basic and black: non-polar. Amino acids bigger in size are essential for binding: when 
changed to alanine the interaction is lost. When Yip1 family peptides are compared to non-Yip1 family 
peptides (these only reproduced once) we clearly see a preference for peptides with basic residues at 
their C-terminus. The peptides additionally contain few acidic residues or none at all. 
 
      A              Aligment      B      Motif 
 
 Yip1p  A18   DPLPVGILHALSTKG  
 Yip1p  B3      INFDHIITKTKMVLI 
K 
β 
γ  
ε 
    β  
 ε γ ε 
 γ ε γ
  
 Yif1p  B24    TYFQVSTRYVINKLK 
 Yif1p C4   KLKLILVPFLNGTKN 
 Yif1p  C22   QGLKGSFNPEDLYYK  
 Yif1p E10   DDIHVSISKSTVKKC 
 Yip4p  B8   SRGTLDETVLQTLKR 
 Yip4p  B12    LKRDVVEINSRLKQV 
 Yip5p  B10    PDSPNMNNSTAGKGS 
 Yip5p  D7       EDIDRASQFKKLLHS 
 Yip5p  D18    LNRDEHSERNRSFKS 
 
Figure 32: Aligment of essential K´s depicting an interacting motif Depiction of the general context in which the essential K´s are embeded (A) defining it as in (B) were β
represents any basic residue, ε any hydrophobic residue and γ any uncharged polar residue.  
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PX domains bind to basic peptides at the N-terminus of Yip1 family members 
and their intermembrane loops. 
Reproducibly interacting peptides as well as reproducible alanine scans were 
selected (Table 9 and Fig. 31). Amino acids of these peptides were coloured 
according to their properties (acidic, basic etc., Fig. 31). As already observed from 
the alanine scans, we clearly see a tendency for binding peptides which are 
composed of basic residues at their C-terminus. Compared to those of non-Yip1 
family members (although these were not reproduced several times) they also 
contain a reduced number of acidic residues or none at all. These peptides are 
concentrated at the N-terminus of Yip1 family members but are also located at their 
hydrophobic C-terminal half which may contribute to PX binding. 
When I aligned the peptides that carry the essential lysines for binding, that is, those 
that were indispensable for the interaction according to the alanine scan, I was able 
to observe general context in which the positive lysines are embedded (Fig. 32). I 
defined the binding motif as follows:                                                                                                     
 
 
where β represents any basic residue, ε any hydrophobic residue and γ an 
uncharged polar residue.  
K
β 
γ  
ε 
    β  
 ε γ ε 
 γ ε γ
  
 
 
Binding site conservation among Yip1 family members 
I wondered if Yip1 family interacting peptides have conserved amino acids (Fig. 30). 
For this purpose, reproducible peptides are shown (boxes) in an alignment adapted 
from Calero et al. (2002). I do observe some overlap but not between all members of 
the family. The strongest conservation is observed for the peptides B3 for Yip1p and 
B24 for Yif1p. Here the lysins at positions K87, K89 and K118, K120 respectively, 
which were identified in alanine scans and considered as important for interaction, 
are conserved within these two members. Yip4p and Yip5p may have other 
interacting regions.  
 
Differences between PX domains 
To test if we are able to see the same difference between the PX domains in the 
spot-array as in the two-hybrid analysis (i.e. PX domains that interact with Yip1 family 
members and those which do not) peptide arrays of Yip1p were incubated with Yip1p 
binding PX domain Vps17p (additionally from Grd19p and Ypt35-PX) and the non-
Yip1p-binding Snx4-PX domain. Vps17-PX and Snx4-PX showed binding at the 
expected interacting peptides at positions B1-5. Snx4-PX shows only 2 interactions 
of the 5 expected peptides were as Vps17-PX only 3, but these variations were also 
obtained when incubating  β−ala membranes with Ypt35-PX (Fig.22). Snx4 had 
additional interacting peptides not found with other PX-domains but these were single 
spots and possible false positive interactions. I was not able to observe the expected 
differences from the two-hybrid results which may be due to structural differences 
which are lost when using this method. We must also consider that peptide arrays of 
Vps17-PX and Snx4-PX were only performed once and on β-ala membranes which 
seem to exhibit stronger spot pattern variations than the commercially available 
Intavis membranes.  
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Peptide 
Position 
Sequence Protein: 
positves/total 
Protein: 
Alanine scan 
Result 
Alanine scan 
  Yip1p  Figures 22-23  
A1 MSFYNTSNNANNGGG Snx4-PX:    1/1 -- -- 
A17 VAPDPLPVGILHALS Snx4-PX:    1/1 -- -- 
A18 DPLPVGILHALSTKG 
 
Grd19p:      3/3 
Ypt35-PX:  2/3 
Grd19:       2/2 
Ypt35-PX: 2/3 
Grd19: KG/ K 
Ypt35-PX: KG 
A19 PVGILHALSTKGYPH Ypt35-PX:  1/3 -- -- 
A23 YPHEPPLLEEIGINF Ypt35-PX:  1/3 -- -- 
 
B1 
 
LLEEIGINFDHIITK 
Grd19p:      2/3 
Ypt35-PX:  2/3 
Vps17-PX:  1/1 
Snx4-PX:    1/1 
 
-- 
 
-- 
 
B2 
 
EIGINFDHIITKTKM 
Grd19p:      3/3 
Ypt35-PX:  3/3 
Snx4-PX:    1/1 
-- -- 
 
B3 
 
INFDHIITKTKMVLI 
Grd19p:      3/3 
Ypt35-PX:  2/3 
Vps17-PX:  1/1 
Grd19:       3/4 
Ypt35-PX: 1/4 
Grd19:      KTK 
Ypt35-PX:  -- 
 
B4 
 
DHIITKTKMVLIPIR 
Grd19p:      3/3 
Ypt35-PX:  3/3 
Vps17-PX:  1/1 
-- -- 
B5 ITKTKMVLIPIRFGS Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
B14 AGPLIFFLLFGLFLL Snx4-PX:    1/1 -- -- 
B16 FLLFGLFLLMAGKVH Grd19p:      3/3 
Ypt35-PX:  1/3 
-- -- 
B18 FLLMAGKVHFGYIYG Vps17-PX:  1/1 -- -- 
B23 VALFGTISLHNLSKL Grd19p:      2/3 
Ypt35-PX:  2/3 
-- -- 
 
B24 
 
FGTISLHNLSKLMSN 
 
Grd19p:      2/3 
Ypt35-PX:  2/3 
Vps17-PX:  1/1 
GST:            1/1 
Grd19:       0/1 
Ypt35-PX: 0/2 
Grd19:       -- 
Ypt35-PX: -- 
C23 WTSSGFLNSLLQLQN Vps17-PX:  1/1 
Snx4-PX:    1/1 
-- -- 
 
C24 
 
SGFLNSLLQLQNARL 
 
Grd19p:      2/3 
Ypt35-PX:  1/3 
Vps17-PX:  1/1 
Grd19:       0/1 
Ypt35-PX: 1/2 
Grd19:       -- 
Ypt35-PX: R 
  Yif1p Figures 24-25  
 
A15 
 
AYATSEQNGVNDRFS 
Grd19p:      2/3 
Ypt35-PX:  2/3 
GST:           1/1 
-- -- 
 
A20 
 
HTPQQQRPMQIPRNT 
Grd19p:      2/3 
Ypt35-PX:  2/3 
GST:           1/1 
-- -- 
B5 NVNGSGGGFPFQDPR Ypt35-PX:  1/3 -- -- 
B6 GSGGGFPFQDPRGSM Ypt35-PX:  2/3 -- -- 
B6 GSGGGFPFQDPRGSM Ypt35-PX:  1/3 -- -- 
B12 LGQSAFSNFIGQDNF Ypt35-PX:  1/3 -- -- 
B14 SNFIGQDNFNQFQET Ypt35-PX:  1/3 -- -- 
B15 IGQDNFNQFQETVNK Grd19p:      2/3 
Ypt35-PX:  2/3 
Grd19:       0/1 
Ypt35-PX: 0/1 
Grd19:       -- 
Ypt35-PX: -- 
B16 DNFNQFQETVNKATA Grd19p:      1/3 
Ypt35-PX:  2/3 
-- -- 
B22 GSQQISTYFQVSTRY Ypt35-PX:  2/3 -- -- 
B24 TYFQVSTRYVINKLK Grd19p:      2/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:        K, K 
Ypt35-PX:  K, K 
C4 KLKLILVPFLNGTKN Grd19p:      2/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:        K 
Ypt35-PX:  K 
C5 LILVPFLNGTKNWQR Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
C6 VPFLNGTKNWQRIMD Ypt35-PX:  1/3 -- -- 
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Peptide 
Position 
Sequence Protein: 
positves/total 
Protein: 
Alanine scan 
Result 
Alanine scan 
C7 LNGTKNWQRIMDSGN Ypt35-PX:  1/3 -- -- 
C19  TYILIWNTQQGLKGS Grd19p:      1/3 
Ypt35-PX:  2/3 
-- -- 
 
C22 
 
QGLKGSFNPEDLYYK 
Grd19p:      2/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:        YYK 
Ypt35-PX:  YYK 
C23 KGSFNPEDLYYKLSS Grd19p:      1/3 
Ypt35-PX:  2/3 
-- -- 
D4  TLAFVCLDLLILKLG Grd19p:      1/3 
Ypt35-PX:  2/3 
Grd19:       0/1 
Ypt35-PX: 0/1 
Grd19:       -- 
Ypt35-PX: -- 
D7 LILKLGLYLLIDSKI Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
D8 KLGLYLLIDSKIPSF Ypt35-PX:  1/3 -- -- 
D12 PSFSLVELLCYVGYK Grd19p:      1/3 
Ypt35-PX:  2/3 
Grd19:       0/2 
Ypt35-PX: 0/1 
Grd19:       -- 
Ypt35-PX: -- 
D13 SLVELLCYVGYKFVP Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
E2  FIAFGVFLLRSVKFN Grd19p:      2/3 
Ypt35-PX:  1/3 
-- -- 
E3  FGVFLLRSVKFNLLS Ypt35-PX:  1/3 -- -- 
E4 FLLRSVKFNLLSRSG Grd19p:      2/3 
Ypt35-PX:  2/3 
-- -- 
E5 RSVKFNLLSRSGAED Ypt35-PX:  1/3 -- -- 
E8 RSGAEDDDIHVSISK Grd19p:      1/3 
Ypt35-PX:  2/3 
-- -- 
E10 DDIHVSISKSTVKKC Grd19p:      3/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:        KK 
Ypt35-PX:  KK 
E11 HVSISKSTVKKCNYF Ypt35-PX:   2/3 -- -- 
  Yip4p Figures 25-27  
B4 ADNIGGTMQNSGSRG Grd19p:      3/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       R 
Ypt35-PX: R 
B8 SRGTLDETVLQTLKR Grd19p:      2/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:      KR 
Ypt35-PX: KR 
B9 TLDETVLQTLKRDVV Ypt35-PX:  1/3 -- -- 
B10 ETVLQTLKRDVVEIN Ypt35-PX:  1/3 -- -- 
B11 LQTLKRDVVEINSRL Grd19p:      2/3 
Ypt35-PX:  2/3 
-- -- 
 
B12 
 
LKRDVVEINSRLKQV 
Grd19p:      2/3 
Ypt35-PX:  2/3 
GST:           1/1 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       KQ 
Ypt35-PX: KQ 
B13 DVVEINSRLKQVVYP Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
B15 SRLKQVVYPHFPSFF Ypt35-PX:  1/3 -- -- 
B16 KQVVYPHFPSFFSPS Ypt35-PX:  1/3 -- -- 
C4 AFIILYSLFVSHARS Grd19p:      3/3 
Ypt35-PX:  2/3 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       R 
Ypt35-PX: 
HARS 
C5 ILYSLFVSHARSLFS Ypt35-PX:  2/3 -- -- 
C7 VSHARSLFSSLFVSS Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
C11 VSSWFILLVMALHLR Grd19p:      2/3 
Ypt35-PX:  1/3 
-- -- 
C12 WFILLVMALHLRLTK Grd19p:      2/3 
Ypt35-PX:  3/3 
-- -- 
C13 LLVMALHLRLTKPHQ Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
C14 MALHLRLTKPHQRVS Grd19p:      2/3 -- -- 
D2 SQILLPLAYHIGKQN Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
D3 LLPLAYHIGKQNRWI Grd19p:      1/3 
Ypt35-PX:  3/3 
-- -- 
D4 LAYHIGKQNRWIVRV Grd19p:      3/3 
Ypt35-PX:  1/3 
-- -- 
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Peptide 
Position 
Sequence Protein: 
positves/total 
Protein: 
Alanine scan 
Result 
Alanine scan 
D13 LMWSVAAVSWVTKSK Grd19p:      2/3 
Ypt35-PX:  2/3 
-- -- 
D14 SVAAVSWVTKSKTII Grd19p:      1/3 
Ypt35-PX:  1/3 
-- -- 
  Yip5p Figures 28-29  
B4 EGVDDFGNEPNPFDD Grd19p:      1/3 
Ypt35-PX:  2/2 
Grd19:       0/1 
Ypt35-PX: 0/1 
Grd19:       -- 
Ypt35-PX: -- 
B6 GNEPNPFDDATVPDS Grd19p:      1/3   
B10 PDSPNMNNSTAGKGS Grd19p:      3/3 
Ypt35-PX:  1/1 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       K 
Ypt35-PX: K 
B12 NNSTAGKGSEFYNTT Grd19p:      1/3   
B13 TAGKGSEFYNTTGSK Grd19p:      1/3 
Ypt35-PX:  1/1 
Grd19:       1/1 
 
Grd19:       K,K 
 
 
B23 
 
DQVIGQNDNDGLGRN 
Grd19p:      2/3 
Ypt35-PX:  1/1 
GST:           1/1 
-- -- 
B24 IGQNDNDGLGRNGLR Grd19p:      2/3 
GST:           1/1 
-- -- 
C3 GRNGLRPGLINYYSK Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
C4 GLRPGLINYYSKYFQ Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
C5 PGLINYYSKYFQIDL Grd19p:      1/3 -- -- 
C6 INYYSKYFQIDLTQF Grd19p:      1/3 -- -- 
C7 YSKYFQIDLTQFKKR Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
 
C8 
 
YFQIDLTQFKKRLSA 
Grd19p:      2/3 
Ypt35-PX:  1/1 
GST:           1/1 
-- -- 
 
C9 
 
IDLTQFKKRLSAVLT 
Grd19p:      2/3 
Ypt35-PX:  1/1 
GST:           1/1 
-- -- 
C10 TQFKKRLSAVLTFRN Ypt35-PX:  1/1 -- -- 
C21  ITATVVMINFTMSRG Grd19p:      2/3 
Ypt35-PX:  1/1 
GST:           1/1 
-- -- 
D2 LNFIISDVIEGVKTG Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
D4 DVIEGVKTGEDIDRA Grd19p:      2/3 
Ypt35-PX:  1/1 
-- -- 
D5 EGVKTGEDIDRASQF Grd19p:      1/3 -- -- 
D6  KTGEDIDRASQFKKL Grd19p:      1/3   
D7 EDIDRASQFKKLLHS Grd19p:      2/3 
Ypt35-PX:  1/1 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       KKL 
Ypt35-PX: KKL 
D17 MQVLNRDEHSERNRS Grd19p:      2/3 
Ypt35-PX:  1/1 
-- -- 
D18 LNRDEHSERNRSFKS Grd19p:      3/3 
Ypt35-PX:  1/1 
Grd19:       1/1 
Ypt35-PX: 1/1 
Grd19:       K 
Ypt35-PX: K 
D19 DEHSERNRSFKSVPE Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
E4 IPVCVILNILDMSKR Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
E5 CVILNILDMSKRLRT Grd19p:      2/3 
Ypt35-PX:  1/1 
-- -- 
E18 SSNNNTETQSNGKFS Grd19p:      1/3 
Ypt35-PX:  1/1 
-- -- 
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Table 9:  Summary of peptide array results of Yip1 family member’s interaction data with PX domains 
Peptide position: spot position of incubated membrane according to the grid from figures 22, 24, 26 and 27. 
Sequence: sequence of peptides, in bold amino acids which seem to be relevant for protein interaction 
according to alanine scan data. Protein, positves/total: PX-GST fusion proteins which show interaction with 
this peptide and its reproducibility. Protein, Alascan: PX-GST fusion proteins with which an alanine scan of 
the selected peptide has been performed and its reproducibility (clear result obtained). Alacan, Results:
Amino acids which upon replacement with alanine cause abolishment of the interaction. 
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Non-Yip1 family members 
 
Based on the two-hybrid results I tested other interesting PX domain interactors via 
peptide arrays. For example, Rbd2p, a transmembrane protein of unknown function, 
which interacted with the two PX-only proteins Ypt35p and Grd19p (Fig. 34). 
Unfortunately the alanine scans of the selected peptides for this protein were not very 
clear (Fig. 34), but still we observe several binding peptides with C-terminal basic 
residues. This is not the case for the nuclear protein Rrn10. This protein is interacting 
with the PX domain of Snx42p and most of the obtained peptides contained several 
acidic and uncharged polar residues (Fig. 33).  
Peptides of the proteins of unknown function Ylr031w and Ynl086w were also probed 
with Grd19p. Here the obtained interacting peptides contain basic (Ylr031w) or non-
polar  (Ynl086w) amino acids in blocks (Figures 35, 36). 
 
 
Rrn10p peptides incubated with Snx42-PX GST fusion protein 
 
 
2
6 
 
 
Spot Sequence 
1    AVPIPFKTREEIDAD 
2       IPFKTREEIDADVEK 
3          KTREEIDADVEKDRN 
4    DLRVVHYYATQLCLN 
5       VVHYYATQLCLNKYP 
6 LLIEKWVKDYLTSIQ 
7              SIQTEQGRQSKVIG
8 GPCEFISKHIDYRHA 
 
 
Figure 33: Snx42-PX-Domain mapping on R
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RBD2p peptides incubated with Grd19p GST fusion protein 
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Ylr031w peptides incubated with Grd19p GST fusion protein 
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Yip1p HIITKTKM motif analysis on Ypt35-PX interaction 
When mapping the interacting region of Yip1 family members with peptide arrays the 
most promising result was obtained with Yip1p. We could clearly depict a motif on the 
cytosolic N-terminus of Yip1p which could be restricted to the amino acids ITK due to 
the 3 residue shift on the peptide arrays (Fig. 23 A). As mentioned before, the alanine 
scan diverged from the result obtained with the peptide arrays (Box in Fig. 23 A). To 
be able to specify wether these amino acids are truly essential for the interaction 
between Yip1p and Ypt35-PX, two strategies were chosen.  
 
1) Mutational analysis: 
3 amino acids of B3 Yip1p peptide, when replaced with alanine, abolished the 
interaction with Grd19p (KTK). These were also replaced by 3 alanines in the full 
length Yip1p in an in vitro translated protein. Subsequently, GST pulldowns with 
Ypt35-PX protein and this mutant were performed. 
 
 
   Yip1p wt  Yip1p mut 
 
 
Figure 37: Replacement of Yip1p N-terminal KTK with AAA does not abolish its interaction     
                  with Ypt35-PX 
Pictures on top of the panel shows Coomassie Blue-stained GST fusion proteins while bottom row 
shows autoradiography of bound Yip1p proteins (see Experimental Procedures for details). 
I: Input, L: Ladder (molecular mass marker), Yip1p mut: Yip1p full-length protein with K87, T88 and 
K89 replaced by alanine. 
 
I was not able to confirm by means of this method the data obtained from the alanine 
peptide scan for Grd19p (Fig. 23). I still obtained an in vitro interaction of mutated 
Yip1p (KTK Æ AAA) with the PX domain of Ypt35p (Fig. 37).  
 
2) Competition assay:  
 
An 8-mere peptide composed of the amino acids HIITKTKM was synthesized (NMI 
Peptides, Reutlingen, Germany) and added to the GST pulldowns of Ypt35-PX with 
in vitro translated Yip1p protein at different concentrations. This peptide contains the 
main binding sequence of Yip1p to Ypt35-PX as obtained from the arrays results 
(Figures 22, 23). I therefore expected a strong competition between the peptide and 
the in vitro translated full-length protein for the binding to Ypt35-PX.  
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KM peptide does not block Yip1p - Ypt35-PX interaction 
35-PX was incubated with in vitro translated Yip1p protein and synthetic peptide 
fferent concentrations. Subsequently GST pulldowns were performed (see 
edures). Picture on top of the panel shows Coomassie Blue-stained GST fusion 
om row shows autoradiography of bound Yip1p protein. 
 (molecular mass marker), 0-500: Different concentrations (in µM) of the synthetic 
ompetition was not observed in this experiment. The synthetic peptide 
 block the interaction even at a concentration of 500µM (Fig. 38).  
ensitive mutant Yip1-2 (G175E) is able to interact in vitro but not 
 proteins and domains 
s discovered (Yang et al. 1998) temperature sensitive mutants were 
ctional analysis of this essential gene. The mutant Yip1-2 showed a 
d maturation of CPY which was completely inhibited at 36°C. The ER 
s accumulated in Yip1-2 at 36°C as shown by electrophoretic mobility 
8).  These results suggested a transport defect at early stages in the 
thway due to Yip1 loss of function. I decided to look for PX domain 
 this temperature sensitive mutant and constructed a prey 
to Yip1-2 for yeast two-hybrid assay (see experimental procedures). 
s the interactions of Yip1p and Yip1-2 with PX proteins.   
perature-sensitive mutation prohibits the interactions with PX proteins 
hen performing yeast two-hybrid at 30°C (Fig. 39). An interaction may 
ed by destabilization of the protein due to the mutation. However, this 
is translated in vitro at 30°C and interacted with Ypt35-PX when 
-pull-downs at 4°C (Fig. 40).  With this experimental setup I am not 
any conclusions for it may be possible that protein stability is 
pendent. In this case I will perform a yeast two-hybrid assay as well 
wn assays at the permissive temperature of 25°C and observe if I 
 results. 
 
- 94 - 
                                                                             RESULTS                                   
 
 
 
 
 
  
 
 
 
Figure 39:   Yip1-2   temperature  sensitive  mutant  does   not  interact  with   PX   proteins  and  
                    domains via yeast two-hybrid at 30°C 
Diploids on selective media (without histidine) showing growth of colonies where interaction takes 
place. Yip1-2: (G175E) mutant; pOAD: empty prey vector; pOBD2: empty bait vector. 
  
 
 
    PREYS                 Yip1p    Yip1-2    Yif1p   pOAD      BAITS  
                                                 (G175E)  
Ypt35p 
 
 
Grd19p 
 
 
Vam7p 
 
 
Vam7-PX 
 
 
Vps17-PX 
 
 
pOBD2 
 
 Yip1p wt     Yip1-2 
 
Figure 40:  Yip1-2 temperature sensitive mutant interacted with Ypt35p PX domain                         
Pictures on top of the panel shows Coomassie Blue-stained GST fusion proteins while bottom row 
shows autoradiography of bound Yip1p proteins (see Experimental Procedures for details). 
I: Input, L: Ladder (molecular mass marker), Yip1-2: (G175E) mutant. 
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DISCUSSION 
PI binding domains as protein interaction domains 
I describe here the first systematic study of PX domain interactions with other 
proteins. My study identifies for the first time the PX domain as a bona-fide protein-
protein interaction module. This knowledge opens a new perspective on PX-
phospholipid binding domains as being bifunctional, i.e. participating in both protein 
and phospholipid recognition.   
The nature of PX protein interactors 
Although PX proteins in the yeast genome are diverse in function, most of the 15 
yeast PX domain-containing proteins are involved in vesicular transport. The over 
representation of proteins involved in vesicular transport among the interacting 
partners (36%, Fig. 16) was therefore expected. Unexpected was the large amount of 
transmembrane and membrane associated proteins detected with this method (53%).  
False negatives 
Detection of membrane proteins has been considered as being difficult with the yeast 
two-hybrid system. This is due to the hydrophobic transmembrane domains which 
may prevent the proteins from reaching the nucleus. Also unsuitable for analysis by 
the yeast two-hybrid method are transcriptional activators which may activate 
transcription without any interaction. Other unproductive baits may require 
modification by cytoplasmic or membrane associated enzymes in order to interact 
with binding partners. To overcome these limitations a considerable number of 
alternative systems have been developed (Vollert and Uetz in press). 
Localization of PX interactors 
The localization of the obtained interactions also validated the selected method for 
detecting of protein-interaction partners. 50% of the preys were localized to the ER, 
Golgi, endosomes or the vacuole where most of the PX proteins are situated 
(genome: 8,8%). 
 
Cytosol  11 % 
5 %
23% Nucleus  23 % 
11 % 
Unknown  
 
                                   Figure 41: Localization o
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Nuclear PX interactions 
I was surprised to find that several PX domain-containing proteins showed 
preferential interactions with nuclear proteins. Although this was initially unexpected, 
my findings can be rationalized by the known relationships between inositol 
phosphates and nuclear functions (reviewed in (Jones and Divecha 2004).  
Mvp1p, a protein required for sorting proteins to the vacuole, interacted weakly with 
Std1p, a suppressor of a TBP deletion. Std1p together with Mth1p is required for 
Rgt1p-mediated repression of transcription in the absence of glucose through 
interaction with Rgt1p (Lakshmanan et al. 2003).  
Mvp1p also interacted with Yra2p (Yeast RNA annealing), a protein that is involved in 
mRNA export from the nucleus and possesses a RNA recognition motif (RRM), 
(Letunic et al. 2004):  
Yra2p
 
 
 
Interestingly Yra2p has been isolated by systematic mass spectrometry with 34 
members named the Hap2p-associated complex. A member of this complex is 
Apg17p, a protein required for activation of Apg1 protein kinase, involved in 
autophagy and interacting partner of further two PX proteins: Cvt20p/Snx42p and 
Cvt13p/Snx4p. Although the significance of both interactions is unclear, it is notable 
that both of these Mvp1p interactors have been found both in the nucleus as well as 
in the cytoplasm (Habeler et al. 2002; Huh et al. 2003). Std1p has also been 
localized to the plasma membrane (Schmidt et al. 1999).  
Vps5p and Snx42p also have interactions with nuclear proteins of which Snx42p’s 
interaction with Rrn10p is remarkable because it appears to be specific for the PX 
domain of Snx42p. Rrn10 (Regulation of RNA polymerase I) is a component of the 
upstream activation factor (UAF) complex involved in activation of RNA polymerase 
(Siddiqi et al. 2001). The UAF motif has been recognized and described by the Pfam 
database (Bateman et al. 2004):  
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Rrn10 null mutants are hy
phosphoinositides  (PI) synthesis
PI turnover (PLCp: Phospholipase
The most remarkable example o
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remains obscure.  
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it is involved in silencing the HM
activity is also unknown but, int
vitro (Zhu et al. 2001). Rrn10 and
hypersensitivity to wortmannin b
(Zewail et al. 2003). 
 UAF Rrn10  
Rrn10p
-Rrn10p interaction comes from the observation that 
persensitive to wortmannin, an inhibitor of 
  (Stt4p: PI 4-kinase; Mss4p: PI(4)P 5-Kinase) and 
 C) (Zewail et al. 2003). 
f nuclear protein interactions was seen with Snx4p, 
lear proteins. Two of these were highly reproducible, 
ds3p.  
in that its mutants exhibit phenotypes related to 
h as zymolyase hypersensitivity. Nevertheless, the 
 nucleus (Huh et al. 2003). Its molecular function 
r, Sds3p, is a suppressor of defective silencing, i.e. 
R mating cassette locus. Its precise biochemical 
erestingly, it binds phosphoinositol 4-phosphate in 
 Sds3 are two of 38 genes whose deletion results in 
ut the mode of action remains to be determined 
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PX domain interaction map:  a pool of new information 
The obtained interaction map confirmed 17 published interactions (Table 6) 
belonging mainly to scores 2 and 3 which confirms their validity and my experimental 
setup. 
False negatives 
I also obtained several false negative interactions (see appendix: Table III), i.e. 
expected positive interactions not detected in my screens. Inefficient diploid 
formation, the use of different strains, plasmids or reporter genes and missfolding of 
proteins due to the GAL4 fusion may account for these results.  
New high confidence interactions 
Vam7p/Vam7 PX - Hsv2p 
Most important, the interaction map describes a pool of new and interesting 
interactions. For example, Vam7p interacted reproducibly (score 3) with Ygr223c 
now named Hsv2p (Homologous with Svp1p). This protein was detected as a Svp1p 
like protein belonging to a new family of phosphoinositide effectors (Dove et al. 
2004). The Svp1 itself is a specific PtdIns(3,5)P2-binding protein that participates in 
the recycling of membrane proteins from the vacuole to the late endosome. Hsv2p is 
likely to be PtdIns(3,5)P2 effector, but its loss causes none of the known 
FAB1/PtdIns(3,5)P2-dependent phenotypes. It is therefore likely that undiscovered 
PtdIns(3,5)P2-dependent cellular processes remain to be found (Dove et al. 2004). 
Interaction of Hsv2p with Vam7p a SNARE (protein which is required for vacuolar 
homotypic membrane fusion) may elucidate these undiscovered additional 
PtdIns(3,5)P2-dependent cellular process.  Hsv2p possesses two WD40 repeats 
which can act as a site for protein-protein interaction. Proteins containing WD40 
repeats are known to serve as platforms for the assembly of protein complexes or 
mediators of a transient interplay among other proteins. 
  Hsv2p 
 
Vam7p/Vam7 PX – Bsp1p 
A further novel reliable interesting interactor of Vam7p and its isolated PX domain is 
Bsp1p. Bsp1p (binding protein of synaptojanin PPIP domains) is proposed to 
function as an adapter that links the synaptojanins (inositol polyphosphate 5-
phosphatases) to the cortical actin cytoskeleton. An interaction with Vam7p (vacuolar 
SNARE) can be biologically meaningful as actin is required to produce fusion-
competent docked vacuoles and its reassembly is needed for yeast vacuole fusion 
(Eitzen et al. 2002). The interaction of Vam7p and its PX domain with Bsp1p was 
therefore particularly interesting. Vam7-PX domain GST fusion protein was hardly 
expressed or insoluble in E.coli cells. I decided therefore to use another strategy to 
characterize this interaction in cooperation with Birgit Singer-Krüger (University of 
Stuttgart, Germany). I TAP-tagged genomic VAM7 (Rigaut et al. 1999) and tested by 
means of the lucifer yellow assay (Singer and Riezman 1990) if the TAP tag 
influences the proteins function. Tap-Tagged yeast cells had normal vacuolar 
morphology like the wild type control. Birgit then crossed this haploid strain with a 
genomic HA- tagged BSP1 and selected double-tagged diploid cells. Currently I am 
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performing immunoprecipitations from yeast extracts of these diploids to verify this 
interaction. A positive interaction would link homotypic vacuolar fusion to the actin 
cytoskeleton.   
Rbd2p 
The predicted transmembrane protein of unknown function Rbd2p is also interesting 
as it interacted reproducibly (score 3) with the PX only proteins Grd19p and Ypt35p. 
These interactions may give clues about the function of this protein.  Rbd2p has been 
recently described as a member of the Rhomboid protein family for it shows relation 
to the rhomboid protein of Drosophila (RBD2 = RhomBoiD) (McQuibban et al. 2003). 
Analysis suggests that Rhomboid-1 is a novel intramembrane serine protease that 
directly cleaves the membrane-anchored TGF-α−like growth factor Spitz, allowing it 
to activate the Drosophila EGF receptor (Bier et al. 1990; Urban et al. 2001). Proteins 
of this family contain three strongly conserved histidines in the putative 
transmembrane regions that may be involved in the peptidase function.   
Yeast Rbd1p is localized in the inner mitochondrial membrane and mutant cells have 
disrupted mitochondria. Two substrates of this protein have been identified, c 
peroxidase and a dynamin-like GTPase (Mgm1p) which is involved in mitochondrial 
membrane fusion. Rbd2p has been predicted to be involved in cell wall synthesis, or 
protein-vacuolar targeting as suggested by network-based statistical analysis 
(Samanta and Liang 2003). Computational analysis additionally has predicted that 
this protein may be involved in vesicular transport (Brun et al. 2003).  It would be 
interesting to analyse different GTPases and interactors of this protein amongst those 
the PX proteins as putative substrates. 
 
Rbd2p 
Akr2p 
A further interesting candidate is Akr2p, an ankyrin repeat protein involved in 
constitutive endocytosis of yeast pheromone receptors (Givan and Sprague 1997). 
Akr2p also interacted with the PX-only proteins Ypt35p (score 3) and Grd19p (score 
1). Ankyrin repeats have been implicated in mediating protein-protein interactions 
although no common theme among the known ankyrin domain protein targets has 
been identified. The PX domain could be a possible target for this protein. An 
additional zf-DHHC motif has been found in Akr2p. This domain is predicted to be a 
zinc binding domain. The function of this domain is unknown, but it has been 
predicted to be involved in protein-protein or protein-DNA interactions (Putilina et al. 
1999), and palmitoyltransferase activity (Lobo et al. 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 T1Akr2p 
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I hope all the new information obtained from the PX interaction map will encourage 
further studies on these proteins which may be able to eventually reveal their 
biological function. 
 
Yip1 family members 
The most striking result of the PX domain two-hybrid screens was the repeated 
appearance of Yip1-family proteins (Table 6 and 7). Yif1p, Yip1p, and Yip5p were 
consistently found with the PX domain-only proteins Grd19p and Ypt35p as baits, 
with Vam7p (PX domain alone and full-length protein), and with the PX domain from 
Vps17p. Yip4p was found with Ypt35p. The verification of PX domain interaction with 
Yip1p family members in vitro was successful (Figure 17, Table 8) although I 
obtained some notable differences compared to the two-hybrid data. Some expected 
interactions from the two-hybrid assay were not obtained in vitro and vice versa. 
These differences may rely on the methods which are based on different principles. 
On the one hand, yeast-two hybrid assays involve the construction of a fusion protein 
which may inhibit or impair interaction. Associated yeast proteins may also mediate 
an indirect interaction described as bridging effect. On the other hand, in vitro 
analysis may be more sensitive due to a higher concentration of the interacting 
partner but improper prey folding in a non-yeast based system may be limiting for 
interaction detection in some cases. 
 
Yip1 family member’s localization and function 
Yif1p and Yip1p have been reported to be localized to the Golgi (Yang et al. 1998; 
Matern et al. 2000), and the two proteins have been postulated to be part of a 
complex (Matern et al. 2000). Recently, several studies showed that Yip1p/Yif1p 
proteins are necessary for COPII vesicle budding from the ER membrane (Heidtman 
et al. 2003) and for membrane fusion with the Golgi (Barrowman et al. 2003). Yip1p 
is thought to cycle between the ER and Golgi compartments (Heidtman et al. 2003), 
(Fig. 42) 
 
Yip1 family member’s interactors localization 
It was therefore surprising that the strongest and most consistent PX domain-
containing interactors of Yif1p/Yip1p were proteins that have been localized to the 
endocytic pathway. For example, Ypt35p is mainly found associated with endosomes 
(Huh et al. 2003), and Grd19p is localized to both the vacuolar membrane (Huh et al. 
2003) and the cytosol (Voos and Stevens 1998), although it becomes associated with 
the prevacuolar compartment in ∆vps27 null mutant cells (Voos and Stevens 1998). 
Vps17p also localizes to the endosome, as reported by a C-terminally tagged GFP 
fusion protein (Huh et al. 2003) as well as to the prevacuolar compartment (Burda et 
al. 2002). So do Snx42p (Cvt13p) and Snx4p (Cvt20p) which have additionally been 
localized to the post-Golgi endosomes and the pre-autophagosomes (Hettema et al. 
2003). Snx42p is also found at a perivacuolar structure (Nice et al. 2002). And finally, 
Vam7p is usually seen in association with vacuolar membranes (Sato et al. 1998; 
Boeddinghaus et al. 2002), (Fig. 42). 
There are three possible explanations for this finding that a group of ER/Golgi 
proteins (the Yip1 family) interact with endosomal/vacuolar proteins (the PX domain-
containing proteins).  
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First, a significant fraction of at least some PX proteins can be found in the 
cytoplasm, and could be recruited in small amounts to the ER membrane and act 
there during COPII vesicle formation. Although there is no direct evidence for this, 
while 5% of Vam7p associates with vacuolar membranes, the rest is soluble (Sato et 
al. 1998). Soluble and therefore diffusely stained cytoplasmic fractions of PX proteins 
could easily escape detection if there is at least one other membrane-related 
localization. In fact, sites of COPII vesicle formation are difficult to spot by light 
microscopy and neither are the proteins involved in such highly dynamic membrane 
spots.  
Second, it remains likely that Yif1/Yip1 proteins have other, yet unnoticed functions 
(independent of COPII vesicle formation) in post-Golgi sorting or endocytosis. This 
idea is supported by the requirement for the Yip1/Yif1p-binding Rab GTPases in 
docking and fusion of transport vesicles, but not for budding (Heidtman et al. 2003). 
Furthermore, Sivars et al. 2003 (Sivars et al. 2003) showed that Yip3, a mammalian 
Yip1 family member, can act as a GDI-displacement factor for Rab GTPases, 
particularly Rab 9, which is localized in the endocytic pathway.  
Third and last, I cannot completely rule out the possibility that at least some of the 
interactions are experimental artefacts with no physiological relevance. However, the 
specificity, apparent strengths of the interactions and confirmation by independent 
methods argue against this possibility. 
Interestingly, Yif1p has been shown to localize to the vacuole under certain 
circumstances, for example in a BTN2 null mutant. The BTN2 gene encodes for a 
novel nonessential coiled coil protein (Chattopadhyay et al. 2003). Btn2 (Batten 
disease) was originally identified by gene expression profiling as one of only two 
proteins up-regulated in yeast strain lacking Btn1p (Pearce et al. 1999). BTN1 
encodes for a non-essential gene that is 39% identical and 59% similar to human 
CLN3-protein (Pearce and Sherman 1997). Mutation of the human CLN3 gene 
results in the neurodegenerative disorder, Batten disease (1995). Btn2p has a role in 
trafficking Rsg1p to the cell periphery were it acts to down regulate arginine uptake 
through the Can1p permease (Chattopadhyay and Pearce 2002). Deletion of BTN2 
results in altered intracellular pH maintenance (Chattopadhyay and Pearce 2002). 
Both findings indicate that Btn2p may be involved in maintaining the homeostatic 
environment within the cell. The accumulation of Yif1p in the vacuole in the absence 
of Btn2p may indicate a connection between intracellular homeostasis and protein 
trafficking (Chattopadhyay et al. 2003).  
In addition, Yif1p was localized to the cytoplasm and may be free to diffuse to 
locations other than the ER (Kumar et al. 2002). 
Even if Yif1p and Yip1p do not have a role in endocytosis or post-Golgi sorting, such 
a function may have been taken over by Yip4p and Yip5p as their localization 
remains unclear. Yip5p localizes to the cytoplasm, as determined for a C-terminally 
tagged GFP fusion protein (Huh et al. 2003) while Yip4p could not be localized so far. 
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Figure 42: Primary localization of PX proteins and Yip1 family members in the cell 
        = PX proteins,          = Yip proteins 
CVT 
thPCvt13/20 
ALP 
C
Spo14, Mdm1, 
Ykr078w 
Snx4/41/42 
 
                       
PGE 
PVE/PVC 
Vacuole 
PAS 
Vps5/17, Ypt35
Grd19, Mvp1 
Vam7 
CPY 
CVT 
Autophagy 
Ypr097w? 
Mvp1
Mvp1
Yip1/Yif1
 
Yip1/Yif1
PE 
P
a
P
 
P
 
P
v
p
(w
s
V
th
(=
re
a
c
o
th
p
    GE: post- Golgi e
utophagosomal struct
hosphatase Pathway, 
X domain protein
hosphoinositides p
acuole targeting) 
roteins and other 
hich also contain
ynthesizes PtdIns(
ps34p creates the
e transport of the 
 Snx4p) and Cvt2
cruits the key reg
l. 2003) (Fig. 43). 
oil domains (see T
r any of their othe
ese proteins serv
art recruits the Apg  ndosom
ure, PE
CPY: C
s in th
lay a
pathw
compo
s Vps
3)P a
 PtdIns
vacuol
0p (= 
ulator 
Snx4p
able 5
r inter
es to 
17p/APYip4/5 ?e, PVE/PVC: pre-vacuolar endosome/compartment, PAS: pre-
: Peroxisome, CVT: Cytosol to valcuole targeting, ALP: Alkaline 
arboxy peptidase Y pathway 
e Cvt pathway 
n important role in autophagy and the Cvt (cytoplasm to 
ay, two pathways for the degradation and recycling of 
nents (Figures 43, 44). The Vps34 PI3 kinase complex 
15p, Vps30p/Apg6p and alternatively Vps38p or Apg14p) 
nd is required for both autophagy and the Cvt pathway. 
(3)P binding sites for two PX proteins that are required for 
ar hydrolase aminopeptidase I via the Cvt pathway, Cvt13p 
Snx42p). Both proteins interact with Apg17p which in turn 
Apg1 kinase to the forming autophagic vesicle (Hettema et 
 and Snx41p both have a PX domain and predicted coiled-
). Their PX domains do not appear to interact with Apg17p 
actors. I therefore suggest that the PX domain of each of 
anchor the protein in the membrane while the C-terminal 
pg1p complex and other binding partners (Fig. 44).  
 
- 103 - 
                                                                          DISCUSSION                                   
 
 
        (Khalfan and Klionsky 2002) 
 
Figure 43: Morphological events marking autophagy and Cvt trafficking.  
Autophagy is induced under starvation conditions. (a) A nucleation step initiates the formation of a 
sequestering vesicle. In autophagy, bulk cytoplasm is nonspecifically sequestered. The highly 
oligomerized precursor form of the resident vacuolar hydrolase aminopeptidase I (prApe1) can be 
selectively packaged into this isolation membrane. (b) This structure forms a closed double-membrane 
transport vesicle called the autophagosome. (c) The outer layer of the autophagosome membrane 
then fuses with the unit membrane of the vacuole. (d) The fusion event releases a subvacuolar 
vesicle, the autophagic body, which is degraded. During nutrient-rich conditions, the Cvt pathway 
transports prApe1 and the resident hydrolase α-mannosidase (not shown). The Cvt pathway is 
morphologically similar to autophagy, except that prApe1 is selectively targeted to double-membrane 
Cvt vesicles that exclude cytosol. Like autophagosomes, Cvt vesicles fuse with the vacuole and are 
subsequently degraded. Once exposed within the vacuole, the precursor form of Ape1 is 
proteolytically processed to yield the mature active enzyme (mApe1).   
 
Recent work of the group of P.J.Cullen demonstrated the presence of a BAR domain 
in Snx1 (previously described as coiled coil region) which is able to form dimers and 
to sense membrane curvature (Carlton et al. 2004). It seems that several sorting 
nexins (SNX´s) belong to the BAR-domain family (Habermann 2004) including the 
yeast SNX proteins (P.J.Cullen, personal communication). Data on Arfaptin2 and 
adaptor proteins APPL1 and 2 suggest that another function of the BAR domain is to 
bind to small GTPases. It would be interesting to determine the role of putative BAR 
domains in yeast SNX proteins. 
It is interesting that neither Snx4p nor Snx42p interacted with the Yip1 family in our 
two-hybrid tests, clearly separating them functionally from other PX domain 
containing proteins.   
Particular interesting was the interaction of Snx4p with Snx41p because it could 
indicate that Snx41p may also be involved in the Cvt pathway. Deletions of SNX41 
showed normal API maturation but the homologous gene in P.pastoris has deficient 
peroxisome degradation at a late stage when mutated (Michael Thumm personal 
communication). This could indicate a role of Snx41p in one of both pathways 
(autophagy or Cvt). 
  
- 104 - 
                                                                          DISCUSSION                                   
 
 
Cvt20 
Cvt13 
       Adapted from Khalfan and Klionsky 2002 
Figure 44: Proteins involved in autophagy and Cvt pathway 
Autophagy is induced through formation of an Apg1p kinase complex. During nutrient-rich conditions, 
Tor kinase is active, and Apg13p and Apg1p are part of two separate protein complexes that function 
in the Cvt pathway. Apg13p is a phosphorylated protein that physically interacts with Vac8p, a protein 
that is relatively specific for the Cvt pathway. Apg1p kinase is also a phosphoprotein that physically 
associates with Cvt9p and Apg17p, proteins that are required primarily for the Cvt pathway and 
autophagy, respectively. The PX proteins Cvt20p (Snx42p) and Cvt13p (Snx4p) physically interact 
with Apg17p and are exclusively essential for the Cvt pathway. Under these conditions, Apg1p kinase 
activity is low. During starvation, Tor kinase activity is inhibited, causing partial dephosphorylation of 
Apg13p. Dephosphorylated Apg13p shows enhanced binding affinity for Apg1p, driving formation of 
an Apgp1–Apg13p complex. Consequently, the kinase activity of Apg1p increases and autophagy is 
induced. The level of phosphorylated Apg1 decreases under starvation conditions, and this might be 
an important feature that also helps to promote autophagy. The specificity factors Vac8p, Cvt9p and 
Apg17p, might be able to modulate the activity of Apg1p and Apg13p in order to favour one of the two 
pathways.  
 
Mapping the interacting region on Yip1 family members 
Based on their predicted topology (Calero et al. 2002) I was able to narrow down the 
interacting region of Yip1p and Yif1p (with Ypt35-PX) to their cytosolic N-terminus 
(Fig. 19). For Yip1p, I was also able to detect a weak binding of Ypt35-PX to the 
Yip1p C-terminus. I therefore suggest that cytoplasmic loops contribute to binding.  It 
is possible that the PX-Yip1 interaction involves a discontinuous binding site, i.e. key 
residues contributing to the binding affinity are normally separated in the primary 
structure, but closer in the conformation on the surface of a folded protein to form a 
conjunct binding epitope (Fig. 11), Additional observations obtained from peptide 
arrays and competition assays confirm this hypothesis (see below). 
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The PI-binding site is different from the protein-protein interaction site 
If this dual binding to lipids and proteins is a general feature of PX domains several 
important questions can be raised. Can an individual PX domain bind both protein 
and lipid ligands simultaneously? Or do they use the same site for lipid binding and 
protein interaction? Linkage between protein interaction and phospholipid binding 
sites of PX domains could give rise to interesting forms of regulation. For example, 
PX domains could require coordinated presentation of both phospholipids and 
proteins for proper cooperative binding and localization. Alternatively, the domain 
could function as a switch excluding the simultaneous binding of the two ligand types. 
To be able to solve some of these questions I introduced a point mutation into the PX 
domain of Ypt35p which should impair PtdIns(3)P binding  (Sato et al. 1998; Cheever 
et al. 2001; Xu et al. 2001; Nice et al. 2002), (Fig. 21 A). For Ypt35-PX this mutation 
reduced lipid binding about 3 fold (Fig. 21 B). Importantly, the Y123A mutation did not 
prevent in vitro binding of Ypt35-PX to Yip1p, Yi1p and Yip4p (Fig. 21 C). This result 
suggests that interacting proteins use different surfaces than lipids or at least do not 
require the critical  tyrosine 123 that is involved in binding the phosphate head group 
of PtdIns(3)P (Fig. 21 A).   
Structural evidence for possible simultaneous binding of lipids and proteins 
The obtained data would argue for a simultaneous binding of both ligands. Is there 
any structural evidence for this? The solved structures of the Grd19p PX domain in a 
ligand-free and ligand bound (diC4PtdIns(3)P bound) state showed great similarity 
(Fig. 45). The position of the diC4PtdIns(3)P in the recognition site of Grd19p is very 
similar to its position in the complex with the p40phox PX domain.  
 
Figure 45: Global superposition of the free (pink) and ligand-bound (green) structures of  
                  Grd19p (Zhou et al. 2003) 
                  N: N-Terminus. diC4PtdIns(3)P bound to Grd19p is represented as “ball-stick” model 
The Grd19p inositol-binding site undergoes small but significant structural changes 
upon ligand binding (Fig. 45). This are restricted to two sites: the first region, situated 
close to the diC4PtdIns(3)P-binding site, is involved in dimer formation (at least in the 
crystal) and the second region provides one rim of the ligand-binding site (Zhou et al. 
2003). The authors of this study believe that dimerisation in the presence of the 
ligand is probably induced by the crystallization conditions as gel filtration studies 
showed that the protein elutes as a monomer in the absence of ligand. It seems that 
the conformational changes of the structure are restricted to the lipid binding region, 
suggesting no activating conformational change for protein binding at putative protein 
interaction site/sites. This leaves open the possibilities of a simultaneous ligand 
binding or individual binding of each ligand independent from each other.  
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Simultaneous lipid and protein binding and phospholipid distribution in the cell 
As shown in Figure 4, phospholipids are not distributed evenly throughout the cell but 
concentrate at distinct sub-cellular compartments.  
PX domain containing proteins such as Vam7p, Snx4p and Snx42p, bind 
phospholipids (via their PX domain), and at the same time recruit proteins via an 
additional contact site to their proper cellular localization (Cheever et al. 2001; 
Boeddinghaus et al. 2002; Hettema et al. 2003). Many PX proteins do contain 
additional coil-coiled regions that possibly drive protein-protein interactions too. In the 
case of the PX-only proteins Grd19p and Ypt35p I assume that the recruitment of 
other proteins has to be achieved by the PX domain itself. As expected, I was able to 
prove that both proteins are involved in protein-protein interactions. This is 
additionally supported by several genetic observations in mutant PX proteins such as 
yeast strains with a deleted GRD19 gene which missort the TGN membrane proteins 
A-ALP, Pep12p and Kex2p to the vacuole (Voos and Stevens 1998; Hettema et al. 
2003). Assuming that phospholipid binding happens simultaneously to protein-protein 
interaction, is PtdIns(3)P (the yeast PX domain´s main lipid target) (Yu and Lemmon 
2001), also present at the location of its interactors? As discussed before, the 
localization of Yip4p has not been studied, but Yip5p seems to localize to the 
cytoplasm although it is predicted to be a transmembrane protein. However, PX 
proteins may also cycle between membrane bound and cytosolic forms. Yip1p and 
Yif1p have been localized to the ER and Golgi (Yang et al. 1998; Matern et al. 2000), 
although Yif1p has been shown to localize to the vacuole under certain 
circumstances (Chattopadhyay et al. 2003).  Assuming that the interaction of the PX 
proteins with Yip1p and Yif1p take place at the ER and Golgi, is PtdIns(3)P present at 
these sites?    
Localization of phosphoinositides has been measured mainly by fusing lipid-binding 
protein modules to a green fluorescent protein to visualize these lipids and their 
changes within a single cell. Using this technique PtdIns(3)P could not be detected at 
the ER or Golgi. However, this technique has its limitations. It is quite possible that 
each of these lipid binding modules only recognizes the lipid in a very specific 
molecular context and, therefore, does not image all of the target inositides in every 
cellular compartment. It is not yet clear what fraction of the inositide pools are 
visualized by even the well-documented constructs. This aspect of inositide 
recognition by the domains is still being studied. Further, the amount of lipid that is 
produced and is available for binding by a fluorescent probe is limited. Therefore, in a 
cell that expresses a high concentration of the fusion protein, the membrane-bound 
fraction may not be distinguishable from the high cytosolic intensity of unlocalized 
fusion protein (Balla and Varnai 2002). I conclude that with the actual phospholipid 
localization detection methods, a failure to detect PtdIns(3)P in the Golgi and ER, 
does not mean that this lipid is absent in these membranes. The lipid concentration 
may be too low and the pools too short-lived to be detected by means of GFP-
coupled lipid binding modules.  
A possible experimental setup to distinguish between simultaneous or exclusive 
lipid/protein binding would be the use of PtdIns(3)P-loaded liposomes. These could 
be incubated with the PX domains of Grd19p or Ypt35p and the soluble N-terminal 
fraction of Yip1p. The liposomes are sedimented, washed and analysed for the 
presence of Yip1-N-terminus and PX domains. PtdIns(3)P binding specificity and 
strength of the PX domain of Ypt35p is enough to detect attachment of the domain to 
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the liposomes (Massimilano Mazza´s, personal communication). As comparison, the 
same experiment could be performed with PX domains containing a mutation in the 
PX lipid binding pocket.  
Peptide arrays 
Analysing different membranes 
To solve the interacting region of Yip1 family members to the single amino acid 
resolution peptide arrays have been performed (Figures 22-29, 33-37 and Table 9). 
To test the reproducibility and reliability of this method in our lab we synthesized the 
arrays several times. We also used two different membranes for comparison: namely 
β-alanine membranes which are cellulose membranes coupled with β-alanine OH as 
a spacer, and alternatively the commercially available membranes from Intavis 
Bioanalytical Instruments which are also cellulose based. In my experience the 
commercially available membrane had clearly less background and was more 
sensitive. This can be clearly observed for the interactions of Grd19p and Ypt35-PX 
with Yip1p (Fig. 22). With the commercially available membranes I was able to obtain 
up to 5 spots in a row at positions B1-5 which was not the case for the β-alanine 
membranes (only 3 spots in row). Different supports and spacers might influence the 
folding of attached peptides and thus influence the recognition process.  
Distribution of Yip1 family member binding peptides  
The majority of the interacting peptides in Yip1 localized to the cytosolic N-terminus 
of the protein (Fig. 23). This was expected from the fragmentation experiments (Fig. 
19). Additional binding to the luminal loop and C-terminus was also detected and 
expected from the pull-down experiments (Fig. 19). However, weak interacting 
signals were also detected in this region with GST alone. In the case of the other 
Yip1 family members interacting peptides were distributed quite evenly throughout 
the protein. This might indicate that not all proteins are suited for this analysis or point 
at a discontinuous interacting epitope (Fig. 11). Mapping this type of epitopes with 
overlapping peptide scans may be difficult as each of the single binding regions may 
contribute only with low binding affinity. Although the SPOT technology can 
immobilize peptides at a high density of up to 50 nmol/cm2 and therefore increase the 
screening sensitivity it may also result in a non-specific background that hide all 
signals which arise form weak but specific interactions. 
PX domain interacting motif on Yip1 family members 
From all Yip1 family member interacting peptides (Table 9) I decided to select a core 
of peptides which either interacted with several PX domains and/or gave clear results 
with the alanine scans. I then searched those sequences for a common motif (Fig. 
31). Indeed, I clearly observed a tendency for PX-binding peptides to have a 
concentration of basic residues at their C-terminus compared to non-Yip1 binding 
peptides which have a higher portion of acidic residues (Fig. 31). It should be kept in 
mind that non-Yip1 peptide arrays were only reproduced once. Based on the alanine 
scan results lysine seems to be essential for interaction with PX domains. I therefore 
aligned the essential lysines (Fig. 32) and defined according to this peptide set the 
following context in which these lysines are embedded: 
 β: Any basic residue    
ε: Any hydrophobic residue  
γ: Any uncharged polar residue 
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Only a subset of the possible variations was observed. For example no peptide 
composed of 3 hydrophobic residues N-terminal of the lysines was detected. With 
these criteria I decided to look whether lysines in this context are generally over-
represented in all proteins or enriched only in Yip1 proteins or PX interacting partner? 
I selected the four Yip1 family members, four PX interacting partners with scores 3 or 
2 and four random proteins (domain containing proteins and approximately the same 
size as Yip1 family proteins) for this study. Figure 46 shows various Yip proteins with 
the different K positions represented as circles. Red circles represent lysines which 
are surrounded by the selected motif, black circles those lysines with a different 
enviroment. Arrows show essential lysines as elucidated in my alanine scans. If 
these results did not show an abolishment of the interaction by replacing the lysine by 
alanine they were represented with an “x”.   
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Random Proteins 
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Figure 46: Lysine distribution throughout different protein groups 
On the x axes the amino acid position is shown. Lysines (circles) which are surroun
(εγ)(βγε)(εγ)K(βγε) are coloured red (  ), the remaining ones are in black (  ).     : 
regions. Domains and motifs are represented as coloured rectangles and label
Rvs167 SH3: Binding of the SH3 domain of Rvs167p to this peptide according to
2004) 
 
The results are preliminar so interpretation should be taken with caution
that Yip1 family members contain few lysines and those which are
surrounded mostly by the selected motif (65-100%). Non Yip PX intera
do vary in their number of lysines. In this group the lysine motif occurs
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values we can clearly classify Yip1 family members as proteins with a 
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                Figure 47: Average number of lysines per 100 amino acids in the yeast proteome 
Analysis of the HITKTKM Yip1 motif on Ypt35-PX interaction 
Using the peptide arrays I obtained the clearest binding motif (ITKTK) for the 
interactions of Ypt35-PX and Grd19p with Yip1p (Figures 22, 23, Table 9). The 
lysines of ITKTK are conserved in Yip1p and Yif1p (Fig. 30) and are essential for PX 
interaction (Figures 23, 25). I therefore chose this motif for further studies using 
mutational analysis and a competition assay (Figures 37, 38).  
Mutational analysis 
I decided to concentrate on the PX-domain of Ypt35p because I was able to detect 
clearly and reproducibly the interaction with Yip1p by means of GST pulldowns 
(Figures 17, 19). These experiments were repeated with a mutated version of the 
Yip1p protein. The mutation comprised the three amino acids which seemed to be 
essential for interaction according to the alanine scan results: K87, T88 and K89 (Fig. 
23). Each one was replaced by alanine (i.e. KTK was replaced by AAA). Suprisingly, 
the interaction still took place in vitro. In vivo (i.e. analysing this mutant by means of 
two-hybrid) the constructed preys seem to have a mating defect (Fig. 48).  
 
S   BAITS Ypt35   Grd19    Vam7   Vam7-PX  Vps17  Vps17-PX  Vps5-PX  pOBD2
 
 
Figure 48: Yeast two-hybrid diploids on selective media. Yip1-mut is no
Selective media (lacking leucine and tryptophane) for diploids growth. Yi
K89A) was not able to mate properly as no diploids were formed (no growth 
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The reason for this unexpected outcome is jet not understood. Further biochemical 
analyses have to be performed before a complete picture of this interaction will 
emerge 
 
Competition assay 
It is also possible that the amino acids surrounding the KTK motif (Fig. 32 B) play a 
role in the interaction. To test this possibility, GST pull-downs were performed with 
wild type Yip1p in the presence of different increasing concentrations of a synthetic 
peptide composed of HIKTKM (comprises the binding motif, Fig. 38). I expected that 
this peptide would compete for the interacting site and therefore (at least at an 
increased concentration) block the interaction between the full-length proteins. This 
was not observed. The peptide was used at a three fold higher concentration than 
the GST fusion protein. This concentration might not be sufficient to displace the 
interacting protein. This peptide may also have not been rightly folded or as indicated 
from several results (fragmentation, peptide arrays and mutational analysis) it may 
only be one of several interacting regions of a conformational discontinuous epitope 
(Fig. 11). In this case additional amino acid substitutions of putative additional 
binding sites could be performed. It would also be interesting to make systematic 
substitutions or deletions to see if only the interactions with particular proteins are 
lost. This would indicate that distinct interaction sites for different proteins are used. 
 
PX domain´s interaction site 
 
The alignment of the PX domains of Grd19p and Ypt35p (Fig.50) show few strictly 
conserved residues. Of particular interest are acidic residues which may represent 
putative sites for interaction with the basic motifs of Yip1 proteins.  
 
Grd19p      VHNPKTHIPN G.MDSKGMFT DYEIICRTNL PSFH.KRVSK VR...RRYSD  
Ypt35p      .HVSDCTIVN GDHGTKFAVW RITVFLEPNL KAFAAKRESY KIQTYKRYSD  
 
 
Grd19p      FEFFRKCLIK EISMLNHPKV ...MVPHLPG KILLSNRFSN EV.......I  
Ypt35p      FVRLRENLLT RIKTAKPEKL NCLQIPHLPP SVQWYSSWKY QEVNLNKDWL  
 
 
Grd19p      EERRQGLNTW MQSVA.GHPL LQSGSKVLVR FIEAEKFVG 
Ypt35p      AKRQRGLEYF LNHIILNSSL VEMTKDILIQ FLEPSKRVA 
 
 
Figure 50 : Alignment of Ypt35p and Grd19p PX domains 
The alignment was performed using the multiple alignment tool T-coffee (Notredame et al. 2000). 
Arrows: conserved acidic residues (D84 and E156 in the Grd19-PX domain). Amino acids were 
coloured according to their properties, red: acidic, green: uncharged polar, blue: basic and black non-
polar. 
When analysing the alignment, two acidic residues are strictly conserved: aspartic 
acid 84 (D84) and glutamic acid (E156). When represented in the crystal structure of 
Grd19-PX (Fig. 51) I can clearly observe that the D84 is too near to the lipid binding 
pocket to be a putative protein interaction site. On the other hand the glutamic acid at 
position 156 is nicely exposed and surrounded by basic residues from which K73 is 
also conserved in both domains. This region may be a putative protein interaction site 
and a good candidate for mutational studies to prove their role in the protein 
interaction. 
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R74 
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Figure 51: Grd19 PX domain structure and conserved charged residues 
H72 
Crystal structure of the PX domain of Grd19p. Acidic and basic conserved residues are shown in ball 
and stick display (see text for details). Green: acidic residues; blue: basic residues. Cartoon generated 
with the program Rasmol (Sayle and Milner-White 1995). 
 
 
The biological function of PX-Yip interactions 
As described in detail in the introduction (The PX-only proteins Grd19p and Ypt35p 
and their phenotypes), the precise mechanistic role of Grd19p in vesicular trafficking 
remains unclear. Grd19p is required for the retrieval of Kex2p, A-ALP and Pep12p. 
The retrieval of these proteins also requires the retromer complex (Fig. 52) 
suggesting that Grd19p may associate with the retromer and improve the recruitment 
of some but not all cargo molecules.   
 
 
                (Worby and Dixon 2002) 
Figure 52: Retromer complex in Saccharomyces cerevisiae  
This complex functions in the endosome-to-Golgi retrieval of the vacuolar protein sorting receptor 
Vps10p, as well as the Golgi-resident membrane protein A-ALP and the endopeptidases Kex2p and 
dipeptidyl amino peptidase (DPAP). The protein subcomplexes that are involved in cargo selection 
and vesicle formation are bracketed. Vps35p acts as a ‘receptor protein’ for cargo proteins, and 
recruits them into retrograde vesicles by direct interaction with (Y/F)XXΦmotifs (where Φ is 
hydrophobic).  PX: PX domain, cc: coiled coil motifs, arrows: cycling of retromer-complex proteins 
between cytoplasmic and membrane localization. 
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Pulse-Chase labelling of Kex2p 
For YPT35 deletion no mutant phenotype has been observed up to date. I therefore 
decided to look at the missorting of the TGN protease Kex2p to the vacuole in 
deletion strains of the YPT35 gene. For this purpose I performed a pulse-chase 
labelling and immuno-precipitation of Kex2p as described in (Voos and Stevens 
1998). The idea of this experiment is to mark all proteins radioactively with a short 
pulse and chase them at different time points. In this case I looked at the degradation 
of Kex2p through vacuolar proteases when the protein is misslocalized (to the 
vacuole). This is done by immuno-precipitating Kex2p from the radioactive labelled 
yeast extracts with a specific Kex2p antibody. The deletion of the GRD19 gene is 
known to cause the misslocalization of Kex2p to the vacuole were it is degraded after 
20 minutes (Voos and Stevens 1998). I took therefore this strain as a positive control. 
Unfortunately the antibody kindly provided by D.Gallwitz (polyclonal rabbit anti- 
Kex2p) was not specific enough. This resulted in the immuno-precipitation of several 
proteins from which it was difficult to clearly assign Kex2p (Fig. 53). I did not only 
perform this experiment for YPT35 but decided to look at several non-essential 
Grd19p interacting partners (RBD2, YIP4 and YIP5). Unfortunately the same 
unspecific results were obtained for these deletions (Fig. 53). The use of monoclonal 
antibodies may solve this problem. It is of particular interest to identify phenotypes of 
the selected interactors and therefore specify their role in endocytosis or post-Golgi 
sorting.  
(
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Based on the recent evidence that the mammalian Yip3 acts as a GDI-displacement 
factor (GDF) for Rab GTPases (Fig. 54) in the endosomal pathway (Sivars et al. 
2003), it may suggest a similar role of Yip1p at the ER.  
Rab/Ypt GTPases are present in two states, inactive (GDP bound) and localized in 
the cytosol or active (GTP bound) and associated to the membrane. These states are 
regulated by accessory factors such as Guanine nucleotide Exchange Factors 
(GEFs) and GTPase activating proteins (GAPs). Rabs attach to membranes by their 
post-translational prenylation modification. The GTPase can be removed from the 
membrane through the action of Rab-GDI (GDP dissociation inhibitor). GDI is a 
soluble protein whose recognition site consists of both the GDP-bound Rab and its 
prenylation moiety (Fig. 54).  
 
 (Barrowman and Novick 2003) 
 
 
Figure 54:  Membrane recruitment and retrieval of Rab GTPases 
 (a) Prenylated GDP-bound Rabs bound to GDI are recruited to membranes, where a membrane-
associated GDF catalyses release of GDI and insertion of the Rab into membranes. (b) After 
membrane recruitment, a GEF facilitates exchange of GDP for GTP. Activated Rabs can then interact 
with effector proteins. (c) Stimulation of the intrinsic GTP hydrolytic by a GAP converts the Rab into its 
GDP-bound form.GDI retrieves GDP-bound Rabs from membranes. 
The membrane recruitment reaction of Rabs is highly specific, as each organelle of 
the secretory and endocytic pathways is found to associate with particular Rab 
proteins (Segev 2001). In yeast only one GDI has been described meaning that the 
specificity of Rab localization must be achieved by the factor that mediates the GDI 
release and membrane attachment, termed GDI displacement factor (GDF). No GDF 
function has been assigned to any yeast protein yet. Yip1 family members are 
therefore interesting candidates for this task. In this context it may be interesting to 
determine the effect of PX proteins on the recruitment of GDFs, their activity, or some 
downstream event such as the recruitment of GEFs. An indication in this direction is 
given by the interaction of Grd19p with the GTPase Ypt53p (score 2) involved in 
endocytosis and transport of proteins to the vacuole. Regulation of Ypt GTPases by 
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PX proteins in addition to other functions (multiple functions) appears to be possible 
as two recent studies demonstrated two distinct functions for each of the proteins 
Snx4p (Cvt13p) and Snx42p (Cvt20p) which depended on their localiztation in the 
cell (Nice et al. 2002; Hettema et al. 2003). 
Against a role of Yip1p as a GDF for Ypt1p at the ER argues the fact that blocking of 
the Ypt1 GTPase function does not prevent COPII vesicle formation (Heidtman et al. 
2003) and the localization of Ypt1p does not change when Yip1p is depleted 
(Barrowman et al. 2003).  
Barrowman and co-workers assigned Yip1p/Yif1p a function in establishing fusion 
competence of ER derived vesicles. They were able to observe correct priming and 
tethering of ER derived vesicles to Golgi acceptor membranes but no fusion when 
Yip1p was depleted. This assay compared to the one of Heidtman and co-workers 
had a different outcome. Barrowman et al. 2003 were additionally able to prove an 
interaction of Yip1p with the ER to Golgi SNARES Bos1p and Sec22p. This is 
particularly interesting as Ypt35p interacted in my two-hybrid screens reproducibly 
(score 2) with Bos1p.  
Yip1p temperature sensitive mutant interacts with Ypt35-PX in vitro but not     
in vivo. 
The first functional studies of Yip1p (Yang et al. 1998) used the temperature sensitive 
mutant Yip1-2 which showed a slightly disturbed maturation of CPY at 25°C which 
was completely inhibited at 36°C. I decided to study this functional mutant and look at 
its interactions with PX proteins and domains. The mutant could be translated in vitro 
at 30°C although the permissive temperature studied by Yang and co-workers was 
25°C. The interaction took place when GST pull-downs were done although these 
were performed at 4°C (Fig. 40). In vivo (Fig. 39) interactions when performing yeast 
two-hybrid at 30°C were abolished. At this temperature I cannot make any statement 
about the protein stability which is an important issue, for the interpretation of these 
results. 
To rule out protein degradation I performed western blots of yeast extracts 
expressing the mutant in a prey vector (pOAD, see experimental procedures). I used 
the polyclonal GAL4 activation domain antibody (Sta. Cruz Biotechnology, sc-429) 
which revealed an extremely high background (Fig. 55). The fact that the pOAD 
vector is a low copy vector additionally complicated the detection.  
 
 
66 
45 
35 
25 
18 
14 
 pOAD   Yif1      L     Yip1     Yip1-mut      Yip1-2   
 
 
Figure 55: Western Blot of yeast extracts with antibodies against GAL4-AD 
Yeast extracts of PJ-69 a strains carrying the low copy prey plasmid pOAD coding respective proteins 
(Yip1p: 27 KDa and Yif1p: 35 KDa) as GAL4-AD (18 KDa) fusions. pOAD: negative control, empty 
vector. L: ladder (molecular mass marker, mass in KDa). Yip1-mut: K87A, T88A and K89A, Yip1-2: 
(G175E) mutant. 
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These contradictory results between both experiments can only be sorted out with 
further studies. A possibility would be to perform yeast two-hybrid assays as well as 
GST pull-down assays at the permissive temperature of 25°C and observe if I obtain 
the same results. 
 
In this work I have shown that PX domains can interact with a number of different 
proteins in biological meaningful contexts. Most striking was their preference for 
membrane proteins of the Yip1 family which could be confirmed by independent 
techniques. Given the much greater diversity of both Yip and PX proteins in 
vertebrate genomes (Fig. 56, Fig. 57), I hope that my findings will encourage further 
studies on these proteins and so improve the understanding of both their diversity, 
specificity and, eventually, biological function. 
 
 
 
 
Figure 56: PX-domain phylogenetic tree 
Phylogenetic clustering of PX domains in groups should give an overview of domain diversity. It is 
tempting to speculate that the SNXs that share conserved PX domains falling on the same branch of 
the phylogenetic tree might share common functions in the cell (Worby and Dixon 2002).  
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Figure 57: Phylogenetic-tree analysis of the Yip1 protein family 
Of the five species shown (yeast, Saccharomyces cerevisiae; worm, Caenorhabditis elegans; fly, 
Drosophila melanogaster; mouse, Mus musculus; and human, Homo sapiens), each has at least one 
representative Yip protein in each of the main branches, except for worm, which has no apparent Yip3 
orthologue, and yeast, which has no apparent Yip6 orthologue (Pfeffer and Aivazian 2004). 
 
 
Open questions, strategies, and future perspectives  
 
Results obtained during these 3 years opened new perspectives of the PX domain 
which entail several open questions: 
 
How do PX domains and proteins contribute to Yip1 family function? 
 
Yip1p/Yif1p 
 
The role of PX proteins in COPII vesicle formation could be tested by a tethering 
(Barrowman et al. 2003) and COPII cell-free transport assay (Heidtman et al. 2003) 
to which I would add PX fusion proteins or domains and test if any change in COPII 
vesicle formation or fusion of the ER-derived vesicles to the Golgi-donor membranes 
occurs.  
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Yip4p/Yip5p 
For these two Yip1 family members no mutant phenotype, function or localization in 
the cell is known. My first steps would be to look at some phenotypes which are 
observed in mutants/deletions their interacting partners, the PX only-proteins Grd19p 
and Ypt35p. As mentioned before (Biological function of PX-Yip interactions) I am 
planning to look at the missorting of the Golgi endopeptidase Kex2p in deletions of 
Yip4p and Yip5p by means of pulse and chase experiments (Voos and Stevens 
1998). Also interesting would be the analysis of missorting of Pep12p by 
immunoblotting Pep12p in p13 and p100 fractions (13,000 g pellet, 100,000 g pellet). 
In GRD19 and retromer mutants endogenous Pep12 shifts from p100 (endosomes) 
to p13 (vacuole) (Hettema et al. 2003). This experiment is semi-quantitative, 
unbiased, looks at an endogenous protein rather than an overexpressed mutant 
chimera and seems quite specific (Hugh Pelham, personal communication).  
Localization of these proteins can be performed by immunofluorescence or GFP/YFP 
constructs. It would be interesting to see if they are localized to the same membranes 
and form a complex.  An interesting observation was for PRA (prenylated Rab 
acceptor = Yip3) isoforms. These are targeted to distinct membrane compartments 
and this localization could be mapped to a particular signal localized at the C-
terminus of both isoforms (Abdul-Ghani et al. 2001). It would be interesting to analyse 
Yip4p and Yip5p for this type of localization signal.  
 
Can we find out more by about PX proteins looking at their genetic 
interactions? 
A future plan is to establish in our lab the Systematic Genetic Array (SGA), for we 
possess the knock-out library of all yeast non-essential genes and the robotic 
equipment. SGA analysis is an approach that automates the isolation of yeast double 
mutants and enables large-scale mapping of genetic interactions. In a typical SGA 
screen, a mutation in a query gene of interest is crossed into an array of viable gene 
deletion mutants to generate an output array of double mutants, which can then be 
scored for specific phenotypes. Synthetic interactions, in which the combination of 
mutations in two genes causes cell death or reduced fitness, respectively, are of 
particular interest because they can identify genes whose products buffer one 
another and impinge on the same essential biological process (Tong et al. 2001). I 
have performed GRD19 and YPT35 as query genes and tested a subset of deletions 
according to the SGA protocols. I was not able to efficiently obtain double deletion 
haploids though. This was probably due to inefficient sporulation, different media and 
other factors which have to be optimized. Looking at genetic interactions 
systematically for PX proteins would be the first direct comparison of the same set of 
proteins used for genome wide two-hybrid screens. 
 
Do PX domains bind simultaneously lipids and proteins? 
As suggested already (Possible simultaneous lipid and protein binding and 
phospholipid distribution in the cell), a liposome based assay may give insight into 
the possibilities of independent or simultaneous protein and lipid interaction of PX 
domains.   
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Which surfaces interact in Yip-PX interactions? 
The best way to map the interacting region of Yip1 family members is to crystallize 
the complex of Yip proteins with PX domains. Efforts are being made in this direction 
in cooperation with Alexey Rak (Max-Planck Institute for Molecular Physiology, 
Dortmund, Germany). This would give us insight into the protein interaction site/sites 
on the PX domain surface as well as on the Yip proteins.  
 
Further more, point mutations in the PX domain or putative interacting partners 
(Figures 50 and 51) or domain swap may allow us to map the protein interacting 
regions.  
The domain swap project consists of the following steps: The first step would be to 
divide the PX domains of Snx4p and Ypt35p into two parts, each containing only the 
N-terminal β-sheets or the C-Terminal α-helices (Fig. 7 A). Both parts would be then 
exchanged (domain swap) and GST pull downs of these chimeras would be 
performed. Snx4-PX interacts only with Yip4p in contrast to Ypt35-PX which interacts 
with Yip1p, Yif1p and Yip4p. After the domain swap it would be interesting to observe 
if the interacting partners have also been exchanged. In this way I would be able to 
map the interacting region and determine aspects about the differences between 
these two PX domains. 
 
I hope that future work and cooperation’s will able to answer some of these exciting 
open questions and we can so improve the understanding of the functions, diversity 
and specificity of these proteins.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
- 120 - 
                                                                               APPENDIX                    
                                                                                                                                                                                                                          
Appendix 
 
Systematic complex purifications 
Several large-scale projects have attempted the systematic isolation and identification of 
protein complexes in yeast (Gavin et al. 2002, Ho et al. 2002). Surprisingly few of them 
recovered any PX domain proteins and their interactions did not turn out to be very 
helpful for my discussion, so I did not discuss those results in detail. 
 
Protein complexes containing PX proteins or their interactors based on Gavin et al. 2002 
(G), Ho et al. 2002 (H) and Hazbun et al. 2003 (Ha); bait proteins are listed first. 
 
 
Table I a: PX proteins in systematic complex purifications 
 
 
 
 
 
 
 
 
 
 
 
BAIT ORF Complex Ref. 
Bem1p YBR200W Bem1 Boi2 Cdc24 Rsc2 G 
Bem3p YPL115C Dop1(cs), Yil055c, Yta7 H 
Grd19p YOR357C none  
Mdm1p YML101C none  
Mvp1p YMR004W none  
Spo14p YKR031C Mum2(tag) Mtc2 Spo14 G 
Snx4p YJL036W none  
Snx41p YDR425W none  
Snx42p YDL113C none  
Vam7p YGL212W none  
Vps17p YOR132W none  
 
Vps5p 
 
YOR069W 
Sup35 Sup45 Clu1 Crn1 Ecm29 Kap123 
Mec1 Mip6 Mis1 Mrpl23 Nab3 Nrd1 
Rom2 Rpa135 Sen54 Sui3 Tao3 Uso1 
Vps5 Ybl004w Yjl017w Ylr386w Yml117w 
G 
Ypt35p YHR105W Vps13 H 
Ykr078p YKR078W none  
Ypr097p YPR097W none  
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Table I b: PX interactors in systematic complex purifications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREY ORF Complex Ref. 
 
Adh1p 
 
YOL086C 
1. Aos1-Adh1 Aos1 Uba2 Yef3 
2. Ecm1-Adh1 Ecm1 Gcn1 Hsc82 Kap123 Lys2 Pse1 Sxm1 
3. Esa1-Act1 Adh1 Arp4 Eaf3 Epl1 Esa1 Tra1 Vid21 Yaf9 
Yap1 
4. Fth1-Adh1 Fet5 Fks1 Fth1 Gea2 Kap123 Rpn3 
5. Isw2-Adh1 Isw2 Itc1 
6. Leu1-Adh1 Leu1 
7. Med7-Ada2 Adh1 Cse2 Eno2 Fab1 Fba1 Med1 Med11 
Med4 Med6 Med7 Med8 Nut1 Pgk1 Rgr1 Sin4 Srb2 Srb4 
Srb5 Srb6 Srb7 Srb8 Srb9 Srp1 Taf60 Tif1 YIL077C 
8. Mot1-Adh1 Gcn1 Isw1 Mot1 Pdc1 Spt15 Vps1 Yef3 
9. Myo4-Act1 Adh1 Gcn1 Hsc82 Kap123 Mlc1 Myo4 Nip1 
She2 She3 YDR101C Yef3 
10. Nmr1-Adh1 Nmr1 Spo72 
11. Rad16-Adh1 Mir1 Pdc1 Pep4 Rad16 Rim1 Tdh3 Vma4 
Vps1 Wrs1 YMR315W 
12. Sec1-Adh1 Pgi1 Sec1 
13. Sec7-Adh1 Cse1 Dhh1 Fks1 Gcn20 Gfa1 Idh2 Kap123 
Ktr3 Mir1 Sam1 Sec7 YFR044C YHR020W 
14. Sir2-Adh1 Bgl2 Net1 Sir2 Sir4 Tdh3 Yef3 
15. Ubp14-Adh1 Ils1 Nip1 Ubp14 
16. YAL027W-Adh1 Gin4 Hmo1 Kcc4 Pdc1 Pgi1 Rad1 Rad10 
Yra1 [YAL027W] 
17. YAL034C-Adh1 Kap123 Sin3 Taf145 Taf90 YAL034C 
18. YNL127W-Adh1 Eno2 Far3 Fba1 Gpm1 Hfm1 Hsc82 
Pdc1 Rom2 Sse2 Tpi1 YGL131C YNL127W 
YOR056C-Adh1 Enp1 YDL060W YNL207W YOR056C 
 
G 
Adh1p YOL086C YKL195W YER110C (KAP123 YMR203W (TOM40) YOL086C (ADH1) H 
Bsp1p YPR171W Sla1-Bzz1 Ecm25 Inp52 Las17 Sla1 Stm1 YCR030C YFR024C-A YPR171W Ysc84 
G 
Bub1p YGR188C ARO9, ENO1, KAR2, PDC1, PGI1, VMA2 H 
Dam1p YGR113W 
Pse1-Dam1 Dbp9 Gfa1 Ino4 Kap95 Lys12 Mds3 Nud1 Pda1 
Pdb1 Pre10 Pre5 Pre6 Pre8 Pse1 Rpt3 Rpt5 Scl1 Spa2 Srp1 
Ulp1 YGR081C  
YMR310C YPL012W Yra1 
 
G 
Lcp5p YER127W YDR299W (BFR2), YDR365C, YER127W (LCP5), YGR145W, YHR196W (UTP9), YJL033W (HCA4), YOR310C (NOP58) H 
Rrn10p YBL025W PDA1 H 
Rvs167p YPR097W 
ALD6, ARG1, ARO8, ARO9, CDC33, CIT1, COR1, CYS4, 
GAL1, GDH1, GLK1, GND1, HXK1, HXK2, INO1, KGD2, KRS1,
LPD1, MET6, PDC1, PDI1, PGI1, PMI40, RSP5, RVB2, 
RVS161, SAH1, SES1, SSC1, TEF2, TIF2, TKL1, TRP5, TUB1, 
UGP1, VMA2 
H 
 
Protein complexes containing PX proteins or their interactors based on Gavin et al. 2002 
(G), Ho et al. 2002 (H) and Hazbun et al. 2003 (Ha); bait proteins are listed first. 
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 Table I b: PX interactors in systematic complex purifications 
 
PREY ORF Complex Ref. 
Sds3p YIL084C 1. Ecm16-Ecm16 Pho23 Sds3 Ume1 
2. Rpd3-Cka1 Ckb2 Dep1 Eaf3 Nrd1 Pho23 Rpd3 Sap30 
Sds3 Sin3 Sto1 Top1 Ume1 Vps1 YBR095C YMR075W 
YPL181W 
3. Sin3-Abf2 Cka1 Cka2 Ckb1 Eaf3 Hta2 Ioc3 Isw1 Pho23 
Rpd3 Rsc8 Sap30 Sds3 Sin3 Tup1 Ume1 YBR095C 
YDL076C YMR075W YPL181W 
4. YDL076C-Dot6 Med4 Nhp10 Rpd3 Sap30 Sds3 Sin3 
Ume1 Ume6 YDL076C YPL181W 
G 
Vma8p YEL051W 1. Vma7-Vma1 Vma10 Vma13 Vma4 Vma6 Vma7 Vma8 
Vph1 
2. Vma8-Vma1 Vma13 Vma4 Vma5 Vma7 Vma8 
G 
Vps21p YOR089C ACO1 ARO9, BMH1, BMH2, ENO1, GDH1, GDI1, HSC82, 
MET6, MRS6, PDC1, PYC1, RHR2, RPT3, SAH1, SSB1, 
STE11, TDH1, TDH2, TPS1, TSA1, VAS1, YPT52, YPT53 
H 
Ylr424p YLR424W 
1. Prp43-Asc1 Clf1 Nop1 Prp43 Prp46 Snu114  Sro9 
YGL128C YLR424W YNL224C 
2. Prp8-Aar2 Cef1 Clf1 Lsm2 Lsm6 Prp19 Prp3 Prp31 Prp4 
Prp43 Prp6 Prp9 Rse1 Smb1 Smd3 Snu114 Snu66 Syf1 
YCR063W YDL209C YGL128C YGR278W YHR156C 
YLR424W [Prp8] 
3. Smx2-Brr1 Clf1 Cus1 Dib1 Hsh155 Lea1 Lsm4 Luc7 
Mud1 Prp11 Prp19 Prp21 Prp3 Prp31 Prp4 Prp40 Prp46 
Prp6 Prp9 Rse1 Smb1 Smd1 Smd2 Smd3 Snp1 Snu114 
Snu56 Snu66 Snu71 Sto1 Yhc1 YJR084W YLR424W 
[Smx2] 
4. Smx3-Cus1 Dib1 Ecm2 Hsh155 Lea1 Luc7 Msl1 Prp19 
Prp31 Prp39 Prp4 Prp40 Prp42 Prp43 Prp46 Prp6 Prp9 
Rse1 Smb1 Smd3 Snt309 Snu114 Snu71 Sto1 YDL209C 
YJR084W YLR424W [Smx3] 
5. Yju2-Cdc40 Clf1 Lea1 Prp19 Prp43 Prp45 Prp46 Snt309 
Snu114 Sto1 Syf1 YDL209C YGR278W Yju2 YLR424 
 
G 
  1. YAL032C (PRP45) YBR065C (ECM2) *YDL209C (CWC2) 
YDR364C (CDC40) YDR416W (SYF1) YER029C (SMB1) 
YER172C (BRR2) YGL120C (PRP43) YGL128C 
(CWC23) YGR074W (SMD1), YGR129W (SYF2), 
YHR165C (PRP8), YJR050W (ISY1), YKL095W (YJU2), 
YKL173W (SNU114), YKR022C, YLL036C (PRP19), 
YLR117C (CLF1), YLR147C (SMD3), *YLR424W, 
YMR213W (CEF1), YPL151C (PRP46), YPL213W 
(LEA1), YPR101W (SNT309) 
2. YAL032C (PRP45), YBR065C (ECM2), *YDL209C 
(CWC2), YDR364C (CDC40), YDR416W (SYF1), 
YER029C (SMB1), YER172C (BRR2), YGL120C 
(PRP43), YGL128C (CWC23), YHR165C (PRP8), 
YKL173W (SNU114), YKR022C, YLL036C (PRP19), 
YLR117C (CLF1), YPL151C (PRP46), YPR101W 
(SNT309), YPR182W (SMX3) 
Ha 
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PREY ORF Complex Ref. 
Ypt53p YNL093W BCY1, CDC33, MRS6, PAB1, POR1,  THI21, TPK1, TPK3, VPS21, YNL227C, YPT52 H 
Yra2p YKL214C 
Brr1 Bur2 Cbc2 Hta1 Kap95 Luc7 Msh4 Mud1 Nab3 Nrd1  
Prp40 Prp42 Rlr1 Rse1 Scp160 Sen1 Sgv1 Smd1 Smd2 
Smd3 Snp1 Snu71 Sro9 Srp1 Sto1 Tif4631 Tif4632 YDL175C 
YKL214C 
G 
 
Table I b: PX interactors in systematic complex purifications 
 
Protein complexes containing PX proteins or their interactors based on Gavin et al. 2002 
(G), Ho et al. 2002 (H) and Hazbun et al. 2003 (Ha); bait proteins are listed first. 
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Table II: PX protein interactions not found in this work 
A number of interactions have been reported for PX proteins that we failed to identify. 
It is difficult to explain this discrepancy but it has been shown that differences in 
strains, plasmids, or reporter genes may account for these results. 
 
Bait Prey Method Refs. 
Bem1p Act1p  (1) 
 Boi1p 2-hybrid, affinity column (2) 
 Boi2p 2-hybrid, affinity column, coippt (3)(2)(4) 
 Cdc42p affinity column, coippt, 2-hybrid, in vitro binding (5)(4)(6) 
 Cla4p coippt, in vitro binding (6) 
 Far1p 2-hybrid  (7)(8)(4)(9) 
 Rsr1p affinity column (10) 
 Sec15p 2-hybrid (4) 
 Ste20p 2-hybrid, coippt, in vitro binding (1)(11)(4)(12) 
 Ste5p 2-hybrid, coippt, copurification (7)(1) 
 Swe1p 2-hybrid (4) 
Bem3p Bem4p 2-hybrid  (4) 
 Cdc42p 2-hybrid (13) 
 Cla4p 2-hybrid (4) 
 Lsm2p 2-hybrid (14) 
 Zds1p 2-hybrid (4) 
 Zds2p 2-hybrid (4) 
Grd19p Ste13p in vitro binding (15) 
Mdm1p Mdm1p in vitro binding (16)(17)(18) 
 Ypr099c 2-hybrid (18) 
Mvp1p Hxt10p 2-hybrid (18) 
 Ybr077c 2-hybrid (19) 
Snx4p Atg17p 2-hybrid (18) 
 Atg20p coippt, 2-hybrid (19)(20) 
 Snc1p crosslinking (20) 
 Snx41p coippt, 2-hybrid (18)(20) 
Snx41p Snx4p 2-hybrid (18) 
Snx41p Yip5p 2-hybrid (18) 
 Yip4p 2-hybrid (18) 
 Yip1p 2-hybrid (18) 
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Bait Prey Method Refs. 
Snx41p Yjr110w 2-hybrid (18) 
 Ypl280w 2-hybrid (18) 
 Ypt52p 2-hybrid (18) 
Snx42p Nip100p 2-hybrid (18) 
 Rrn10p 2-hybrid (19) 
 Snx4p coippt, 2-hybrid (19)(20) 
 Yhr022p (2-hybrid (21) 
 Ylr424p 2-hybrid (18) 
Spo14p Dcp2p 2-hybrid (14) 
Vam7p Apg17p 2-hybrid (19) 
 Ktr3p 2-hybrid (19) 
 Nyv1p in vitro binding, coippt, copurification (22)(23) 
 Vam3p in vitro binding, coippt, copurification, 2-hybrid,  
affinity column
(22)(23)(19)(24) 
 Vtip in vitro binding, coippt, copurification, affinity column (22)(23)(24) 
 Ykt6p coippt, copurification (23) 
 Rbd2p 2-hybrid (19) 
 Sec10p 2-hybrid (19) 
 Sna3p 2-hybrid (19) 
 Spc72p 2-hybrid (19) 
 Stb2p 2-hybrid (19) 
 Tvp18p 2-hybrid (19) 
 Vps68p 2-hybrid (19) 
 Vps73p 2-hybrid (19) 
 Yif1p 2-hybrid (19) 
 Yip5p 2-hybrid (19) 
 Yor292c 2-hybrid (19) 
 Ypt7p 2-hybrid (19) 
Vps5p Smf3p 2-hybrid (18) 
 Vps29p crosslinking (25) 
 Vps35p crosslinking (25) 
 Vps17p hybrid (19) 
Vps17p Vps29p crosslinking (25) 
 Vps35p crosslinking (25) 
Table II: PX protein interactions not found in this work 
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Abbreviations 
AA:   Amino acid 
A-ALP:  cytosolic domain of DPAP A fused to the transmembrane and  
lumenal domains of the alkaline phosphatase 
Amp:   Ampicillin 
bp:    Base pairs 
BSA:   Albumin bovine serum 
CPY:  Carboxypeptidase Y 
DMSO:   Dimethyl sulfoxide 
DNA:   Desoxy ribonucleic acid 
DPAP A:   dipeptidyl aminopeptidase A 
dNTP:   Desoxy nucleosid triphosphate 
E.coli:   Escherichia coli 
EDTA:   Ethylenediaminetetraacetic acid 
GAL4:   Yeast transcription factor of the galactose pathway  
GAL4-AD:   GAL4-Activation Domain 
GAL4-DBD:  GAL4-DNA Binding Domain 
HMM:  Hidden Markov Models 
HRP:  Horse radish peroxidase 
IPTG:  Isopropyl-β-D-thiogalactopyranoside 
KDa:   Kilo Dalton 
kb:    Kilo base  
MAT:   Mating type 
µl:    microliter 
µM:   micromolar 
M:    Molar 
mM:   milimolar 
ORF:   open reading frame 
PCR:   Polymerase chain reaction 
PI:    Phosphoinositides 
Pr A:  Protein A 
PtdIns:   Phosphatidylinositol 
RT:    Room Temperature 
SDS:   Sodium dodecyl sulfate 
SNARE:   soluble N-ethyl-maleimide-sensitive fusion protein attachment  
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SNX:  Sorting Nexins 
TGN:  Trans-Golgi Network 
YTH:   Yeast two-hybrid 
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Summary 
 
The phox homology (PX) domain is a phosphoinositide-binding domain that is conserved 
from yeast to man. In this work I show for the first time by yeast genome-wide two-hybrid 
screens and in vitro binding assays that, the PX domain is a bona fide protein interaction 
domain and that it forms a complex network of interactions in yeast. 
The yeast PX domain-only proteins Grd19p (YOR357C) and Ypt35p (YHR105W), as well 
as the isolated PX domains from Mvp1p (YMR004W), Snx42p/Cvt20p/Atg20p 
(YDL113C), Vam7p (YGL212W), and Vps17p (YOR132W) yielded a total of 40 
reproducible two-hybrid interactions. 35 interactions were found for the full-length 
proteins of Bem1p (YBR200W), Snx42p, Snx4p/Cvt13p (YJL036W), Vam7p, Vps5p 
(YOR069W), and Vps17p, but these appear not to require the PX domain, since these 
interactions could not be reproduced with their isolated PX domains.  
Interactions of Grd19p, Vam7p, Vps5p, Vps17p, and Ypt35p with members of the Yip1p 
family of proteins were detected consistently and were verified by in vitro binding assays. 
The N-terminal cytoplasmic domain of Yip1p and Yif1p mediates these interactions with 
PX domains although C-terminal cytosolic loops seem to contribute to the interactions.  
Peptide array results demonstrated that PX-domains bind to Yip1 family peptides which 
contain basic residues at their C-terminus. It was not the case for peptides interacting 
with PX domains of non-Yip1 family interactors. 
Alanine scans further identified lysines which are essential for Yip-PX protein 
interactions. Compared to the yeast proteome, Yip1 family proteins contain relatively few 
lysines of which most are embedded in a candidate consensus motif. 
A mutation in the lipid-binding pocket of Ypt35-PX that reduces lipid-binding markedly 
does not affect these PX domain protein interactions, arguing that lipid binding uses a 
different interaction surface than protein binding. 
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Zusammenfassung 
Die PX Domäne ist eine Phosphatidylinositol-bindende Domäne, die von der Hefe bis zum 
Menschen konserviert wurde. In dieser Arbeit zeige ich mittels systematischen two-hybrid 
Screens, die das gesamte Hefegenom umfassen,  und in vitro Bindungsanalysen, dass die 
PX-Domäne eine neuartige Protein-Interaktionsdomäne ist und ein komplexes 
Interaktions-Netzwerk in Hefe bildet. 
Die hauptsächlich aus der PX-Domäne bestehenden Proteine Grd19p (YOR357C) und 
Ypt35p (YHR105W), und die isolierten PX Domänen von Mvp1p (YMR004W), 
Snx42p/Cvt20p/Atg20p (YDL113C), Vam7p (YGL212W), und Vps17p (YOR132W) 
ergaben insgesamt 40 reproduzierbare two-hybrid-Interaktionen. 35 Interaktionen wurden 
für die Gesamtproteine von Bem1p (YBR200W), Snx42p, Snx4p/Cvt13p (YJL036W), 
Vam7p, Vps5p (YOR069W), und Vps17p gefunden, aber diese scheinen die PX-Domäne 
nicht zu benötigen, da diese mit den entsprechenden PX-Domänen, nicht reproduziert 
werden konnten. 
Interaktionen zwischen Grd19p, Vam7p, Vps5p, Vps17p, and Ypt35p und  Mitgliedern der 
Yip1 Proteinfamilie wurden mehrfach detektiert und über in vitro Bindeversuche verifiziert. 
Die N-terminale cytoplasmatische Domäne von Yip1p und Yif1p vermittelt diese 
Interaktionen mit der PX Domäne, obwohl C-terminale, cytosolische Schleifen zu den 
Interaktionen beizutragen scheinen. 
Peptid-array-Ergebnisse zeigten bei Yip1-Proteinen, die eine Affinität zur PX-Domäne 
aufwiesen, dass diese Affinität mit basischen Aminosäuren am C-Terminus einherging. Bei 
entsprechenden Versuchen mit Proteinen, die nicht zur Yip1-Familie gehören, konnte eine 
solche Korrelation nicht gezeigt werden. 
Alanin-Scans identifizierten Lysine, die unabdingbar für Yip-PX-Protein-Interkationen sind. 
Verglichen zum Hefe-Proteom, enthalten Yip-Proteine einen relativ niedrigen Gehalt an 
Lysinen, von denen die meisten in dem von mir identifiziertem Motiv auftreten. 
Eine Mutation in der Lipid-bindenden-Tasche von Ypt35-PX, die die Lipid-Bindefähigkeit 
signifikant reduziert, beeinflusst diese Interaktion mit der PX-Domäne nicht. Dies legt 
nahe, dass die Lipid-Bindung eine andere Interaktionsstelle benötigt als die 
Proteinbindung. 
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